Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,ligand-gated ion channel activity (GO:0015276),-0.7312931788781334,-2.4090376856420264,0.0,0.0,0.0,14/30,10.84%,GRIK2;GRID2;GRIA4;GRIN2A;GABRB1;GRIA1;GRIN2B;GRIA2;GRIA3;GRIK1;GRIK4;GRIN2D;GRIN3A;CHRNA4
prerank,ligand-gated channel activity (GO:0022834),-0.731299944926798,-2.38598891060012,0.0,0.0,0.0,14/29,10.84%,GRIK2;GRID2;GRIA4;GRIN2A;GABRB1;GRIA1;GRIN2B;GRIA2;GRIA3;GRIK1;GRIK4;GRIN2D;GRIN3A;CHRNA4
prerank,glutamate receptor activity (GO:0008066),-0.8036844399537396,-2.3793951392827988,0.0,0.0,0.0,12/19,9.95%,GRIK2;GRM7;GRID2;GRIA4;GRM8;GRM5;GRM1;GRIA1;GRIA2;GRIK1;GRIK4;GRIN2D
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.7474568251384571,-2.127809419527048,0.0,0.0024956930120595662,0.009,11/17,10.33%,GRIK2;GRIA4;GRIN2A;GRIA1;GRIN2B;GRIA2;GRIA3;GRIK1;GRIK4;GRIN2D;GRIN3A
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6372157409022926,-2.0803045991228557,0.0,0.005324145092393741,0.02,14/29,11.15%,GRIK2;GRID2;GRIA4;GABRB1;GRIA2;GABRA3;GABRG1;GABRA2;GABRG3;GRIK1;GABRB3;GRIK4;GRIN2D;GABRG2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.7061132945773116,-1.883161624978333,0.0022471910112359553,0.06618208135683888,0.273,9/15,15.34%,HS6ST3;HS3ST5;NDST4;HS3ST2;HS6ST2;HS3ST4;HS3ST1;NDST1;HS3ST3B1
prerank,microtubule minus-end binding (GO:0051011),0.7296042160343494,1.836456215525261,0.0018214936247723133,0.5452180461422605,0.416,6/13,9.05%,NUMA1;CAMSAP1;MACF1;HAUS7;CAMSAP2;TUBGCP5
prerank,triglyceride lipase activity (GO:0004806),0.6454340143426966,1.8303323351621041,0.0018832391713747645,0.29326122178864017,0.437,5/20,7.55%,LIPC;LIPH;DAGLB;PLA2G15;PNPLA1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6311805337937956,-1.828295322924139,0.00437636761487965,0.10933512243308575,0.447,9/19,11.15%,GRIK2;GRID2;GABRA3;GABRG1;GABRA2;GABRG3;GRIK1;GRIK4;GABRG2
prerank,syntaxin-1 binding (GO:0017075),-0.6043385322162864,-1.826419432718392,0.0,0.09677742902319875,0.448,11/22,11.80%,LRRK2;SYT1;SNPH;STXBP5;SYNPR;UNC13C;DAPK1;CPLX2;SNAP25;UNC13B;SYPL1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5661464557798142,-1.823760967395032,0.0,0.08824277514245182,0.458,10/28,11.15%,GRIK2;GRID2;GABRA3;GABRG1;GABRA2;GABRG3;GRIK1;GRIK4;CHRNA4;GABRG2
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.5122325413468809,-1.8101587847306222,0.0,0.09073230594954335,0.5,11/42,6.19%,LRRC4C;PDLIM5;CD47;NPTN;PALLD;TMOD3;EMB;CNTN6;STXBP6;S100A11;PDLIM1
prerank,R-SMAD binding (GO:0070412),0.6422793803498921,1.7943379514314022,0.005535055350553505,0.30198103902492207,0.586,6/18,3.84%,LDLRAD4;SMAD3;PMEPA1;DDX5;SMURF1;PAX6
prerank,cyclic nucleotide binding (GO:0030551),-0.59752944681828,-1.78607226042137,0.0022123893805309734,0.10406283589678678,0.582,6/21,3.54%,PDE4B;PDE4D;HCN1;PDE11A;RAPGEF2;KCNH1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.7374855986217488,1.777023236193646,0.0038022813688212928,0.28132884030741223,0.666,6/11,13.40%,PRMT2;PRMT8;FBXO11;PRMT1;PRMT6;CARM1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6182379695456274,-1.7744403415051826,0.004464285714285714,0.10842399641281006,0.636,6/18,10.26%,PDLIM5;TMOD3;STXBP6;S100A11;PDLIM1;ANXA2
prerank,I-SMAD binding (GO:0070411),0.6938579315821668,1.7703929715681401,0.0037243947858473,0.24195198141936006,0.689,5/13,3.80%,TGFBR1;SMAD3;SMAD7;TGFB1I1;SMURF1
prerank,cAMP binding (GO:0030552),-0.7126636216105462,-1.759243243665738,0.0066518847006651885,0.11723357943828527,0.699,7/11,18.07%,PDE4B;PDE4D;HCN1;RAPGEF2;PDE2A;PDE10A;PDE4A
prerank,metalloaminopeptidase activity (GO:0070006),-0.6212307770933068,-1.7462138811374384,0.0022522522522522522,0.1268445876922973,0.761,9/16,13.40%,NPEPPS;MMP16;RNPEPL1;TRHDE;XPNPEP3;ENPEP;MMP15;ANPEP;MMP14
prerank,GTPase activator activity (GO:0005096),0.3874136179629914,1.740089124880287,0.0,0.2785752138117442,0.802,72/313,9.87%,DOCK4;SRGAP2;RAPGEF5;ELMO1;CHN2;TBC1D16;DOCK8;FGD2;HPS4;ARHGAP45;ARHGAP39;SIPA1L2;OPHN1;ARHGAP22;CYTH4;RASGRP3;ARHGEF2;PREB;ASAP1;DENND4A;PREX1;VAV2;HERC2;SMAP2;RAB3IL1;DENND6B;ARHGAP27;RAP1GDS1;RGS10;TBC1D9B;ASAP3;RCBTB2;TBC1D8;CDC42EP2;ARAP3;TBC1D17;TBCK;DENND2C;GARNL3;ARHGAP25;RGL2;TBC1D7;RANBP2;SIPA1;ARHGAP28;TBC1D15;NCKAP1L;CCZ1;HACD3;FLCN;RAB3GAP2;EIF2B3;RP2;RASA4;ACAP2;AKAP13;LAMTOR2;CYTH3;TBC1D10B;FRMD7;ARHGAP8;ARHGAP17;EIF2B4;RALGPS1;ARFGAP3;LAMTOR5;TBC1D9;RGS14;RAB3GAP1;FGD3;RAPGEF3;SPATA13
prerank,muscle alpha-actinin binding (GO:0051371),-0.6322082063452718,-1.7305210909038928,0.0045871559633027525,0.13694884320990566,0.812,6/15,15.14%,PDLIM5;PALLD;PDLIM1;PKD2;LDB3;PDLIM4
prerank,transforming growth factor beta receptor binding (GO:0005160),0.6159737274349755,1.7243793779251555,0.009191176470588236,0.27968977691713365,0.836,4/18,1.05%,TGFBR1;TGFBR2;SMAD3;SMAD7
prerank,ligand-gated anion channel activity (GO:0099095),-0.5995045818324738,-1.7073294820554707,0.010869565217391304,0.16180409694852854,0.868,11/17,17.10%,GABRB1;GABRA3;GLRA1;GABRG1;GABRA2;GABRG3;GABRB3;GABRG2;GLRA2;GABRA5;CFTR
prerank,glycine binding (GO:0016594),-0.683241087735141,-1.6946602041980574,0.01545253863134658,0.17022909982910872,0.896,7/11,17.82%,GRIN2B;GLRA1;GRIN3A;GNMT;SRR;GLRA2;GLDC
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.6974582092010572,-1.6926415327105726,0.005964214711729622,0.16409951829912656,0.899,6/10,16.17%,B3GALT1;B4GALT5;B4GALT6;B4GALT7;B3GALT4;B3GALT2
prerank,GABA receptor activity (GO:0016917),-0.5665771007139095,-1.6730211249326503,0.011185682326621925,0.18727913877630614,0.929,11/21,16.40%,GABRB1;GABBR1;GABBR2;GABRA3;GABRG1;GABRA2;GABRG3;GABRB3;GABRG2;GABRA5;GABRQ
prerank,myosin V binding (GO:0031489),-0.6208761104127521,-1.659008613463727,0.02088167053364269,0.2002654992566021,0.951,5/15,11.02%,RAB3C;RAB6A;RAB3D;RAB3A;RAB8A
prerank,lipase activity (GO:0016298),0.4886191828306807,1.6501393237556736,0.005190311418685121,0.5143544825033153,0.974,10/43,10.57%,LIPC;LIPH;ABHD12;DAGLB;PLA2G15;SMPD2;PNPLA1;ABHD15;ABHD6;PLBD2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.39835186113921156,1.649414795935877,0.0,0.46016158327607176,0.975,32/147,9.87%,DOCK4;RAPGEF5;ELMO1;DOCK8;FGD2;HPS4;CYTH4;ARHGEF2;PREB;DENND4A;PREX1;VAV2;HERC2;RAB3IL1;DENND6B;RCBTB2;DENND2C;RGL2;CCZ1;RAB3GAP2;EIF2B3;AKAP13;LAMTOR2;CYTH3;FRMD7;EIF2B4;RALGPS1;LAMTOR5;RAB3GAP1;FGD3;RAPGEF3;SPATA13
prerank,water transmembrane transporter activity (GO:0005372),-0.6464145862895945,-1.6338795177046468,0.03497942386831276,0.23377645018784426,0.98,5/11,32.18%,AQP4;AQP11;AQP1;SLC5A1;SLC4A11
prerank,voltage-gated ion channel activity (GO:0005244),-0.5867408894470141,-1.607965141144096,0.027659574468085105,0.2777025678873554,0.991,5/14,9.69%,KCND2;CACNA1E;HCN1;PKD2;ANO6
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5146975596940088,-1.6078018530826728,0.02207505518763797,0.2658214470042962,0.991,7/23,2.57%,PDE7B;PDE4B;PDE4D;PDE11A;PDE1C;PDE9A;PDE7A
prerank,ligand-gated cation channel activity (GO:0099094),-0.3970877207930291,-1.606654529424356,0.002386634844868735,0.2571950298539164,0.991,16/75,10.84%,GRIK2;GRIA4;GRIN2A;KCNN2;GRIA1;GRIN2B;KCNJ3;GRIA2;KCNH2;KCNJ6;GRIA3;GRIK1;GRIK4;GRIN2D;GRIN3A;CHRNA4
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.5329865576596952,-1.6031629442170336,0.018223234624145785,0.25369551365256177,0.991,7/21,2.57%,PDE7B;PDE4B;PDE4D;PDE11A;PDE1C;PDE9A;PDE7A
prerank,calcium channel regulator activity (GO:0005246),-0.47083095573974815,-1.5993694231213114,0.009174311926605505,0.25157438789940617,0.992,7/37,9.06%,NRXN1;PRKG1;ITPR1;YWHAE;CALM1;MCUB;STIM2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.4859184566340161,-1.592521893333401,0.0215311004784689,0.25515636704365374,0.994,16/29,23.85%,SLC25A30;SLC1A6;SLC1A5;SLC13A3;SLC26A7;SLC1A1;SLC26A2;SLC46A1;SLC25A18;SLC13A5;SLC25A12;ABCC2;SLC1A4;SLC26A3;SLC26A4;SLC26A8
prerank,MHC class II protein complex binding (GO:0023026),-0.6531863776527282,-1.584751328565997,0.02754237288135593,0.26093856937200577,0.996,4/11,10.61%,CD74;YWHAE;HSPA8;HSP90AB1
prerank,insulin-like growth factor I binding (GO:0031994),0.6207223753579092,1.5834626031605048,0.039603960396039604,0.7287013583036038,0.995,4/13,3.40%,ITGA6;IGFBP3;ITGAV;IGF1R
prerank,O-acyltransferase activity (GO:0008374),0.5084962416960186,1.5755307591447443,0.02264808362369338,0.7060131448438425,0.995,9/30,10.38%,LPCAT2;DGAT1;LPCAT4;MBOAT2;PLA2G15;MOGAT2;MOGAT1;PLA2G4A;MBOAT1
prerank,ion channel activity (GO:0005216),-0.38447805158316434,-1.568438178016149,0.005221932114882507,0.2839926530964334,0.997,20/80,10.96%,GRIK2;GRID2;GRIA4;GRIN2A;UNC80;GABRB1;GRIA1;GRIN2B;TRPM3;GRIA2;NALCN;MCUB;PKD2;GRIA3;GRIK1;GRIK4;GRIN2D;GRIN3A;CHRNA4;CALHM6
prerank,alpha-actinin binding (GO:0051393),-0.5092754193886728,-1.5681433500771975,0.013574660633484163,0.27511780300348493,0.997,11/24,15.14%,PDLIM5;PPARG;KCNN2;PALLD;PDLIM1;CACNA1C;PKD2;LDB3;RARA;DAG1;PDLIM4
prerank,glutamate receptor binding (GO:0035254),-0.5547025001769144,-1.5637554307460415,0.025477707006369428,0.2760111239430465,0.997,5/17,6.51%,HIP1;SHISA6;SHANK3;HOMER1;SYNDIG1
prerank,cell adhesion mediator activity (GO:0098631),-0.5076975132268329,-1.5635077077216293,0.015730337078651686,0.2679057123640054,0.997,7/24,4.89%,LRRC4C;CD47;NPTN;NINJ1;PALLD;EMB;CNTN6
prerank,semaphorin receptor activity (GO:0017154),-0.6337353033482792,-1.562040481412453,0.0423728813559322,0.2626107677201534,0.998,6/11,15.53%,PLXNC1;PLXND1;PLXNA2;PLXNA1;PLXNB2;PLXNB1
prerank,GTPase regulator activity (GO:0030695),0.3620433983976228,1.5614241575788916,0.0,0.7253511127338745,0.998,48/212,9.65%,SRGAP2;CHN2;TBC1D16;ARHGAP45;ARHGAP39;SIPA1L2;OPHN1;ARHGAP22;RASGRP3;SIRPA;PREB;ASAP1;PREX1;SMAP2;ARHGAP27;RAP1GDS1;RGS10;TBC1D9B;ASAP3;TBC1D8;CDC42EP2;ARAP3;TBC1D17;TBCK;GARNL3;RHOH;ARHGAP25;TBC1D7;RANBP2;GPS2;SIPA1;ARHGAP28;TBC1D15;NCKAP1L;HACD3;FLCN;RAB3GAP2;RP2;RASA4;ACAP2;TBC1D10B;ARHGAP8;ARHGAP17;ARFGAP3;TBC1D9;RGS14;RAB3GAP1;RGS12
prerank,potassium channel activity (GO:0005267),-0.37450481742744257,-1.5458560113858841,0.0,0.2870536315439493,1.0,21/89,9.55%,GRIK2;KCND2;KCNT2;KCNB2;KCNK10;HCN1;KCNN2;KCNMB2;KCNQ5;KCNC2;KCNQ3;KCNH1;KCNA6;KCND3;PKD2;KCNH7;KCNH2;KCNH5;GRIK1;GRIK4;TMEM38B
prerank,phospholipase activity (GO:0004620),0.4221871406125767,1.5393924549490003,0.009819967266775777,0.7881726300292742,0.998,14/67,11.81%,LIPC;LIPH;ABHD12;PLCL1;PNPLA7;PLA2G15;PLA2G6;SMPD2;PLD4;PLA2G4B;PLA2G4A;ABHD6;PLBD2;PDIA3
prerank,nucleoside-diphosphatase activity (GO:0017110),0.6311971182937596,1.5360273040535635,0.041353383458646614,0.7514122206393036,0.998,5/12,18.25%,SLC25A42;ENTPD1;NUDT15;ENTPD7;ENTPD6
prerank,myosin binding (GO:0017022),-0.4155606182018824,-1.5303327728010716,0.011990407673860911,0.31092373512782734,1.0,13/55,11.02%,DMD;STXBP5L;RAB3C;GSN;STXBP5;SPATA6;MYRIP;RAB6A;GIPC1;RAB3D;SHROOM1;RAB3A;RAB8A
prerank,BMP binding (GO:0036122),0.6487638969956073,1.5277198000358934,0.03917910447761194,0.746538738825542,0.999,4/11,31.84%,GREM1;ENG;BMPR2;GREM2
prerank,GABA-A receptor activity (GO:0004890),-0.5313156212228513,-1.525646452551001,0.04310344827586207,0.3128551462278128,1.0,9/18,16.40%,GABRB1;GABRA3;GABRG1;GABRA2;GABRG3;GABRB3;GABRG2;GABRA5;GABRQ
prerank,vinculin binding (GO:0017166),-0.609885562527182,-1.5214482378504925,0.04329896907216495,0.3132132203002805,1.0,5/11,12.13%,DMD;CTNNA1;UTRN;SYNM;DAG1
prerank,SH2 domain binding (GO:0042169),0.48116799073344463,1.5142180738273623,0.03672787979966611,0.7714743565363131,0.999,9/31,11.79%,PAG1;ARHGAP5;BLNK;LAT2;SRC;AFAP1L2;KHDRBS1;TRPV4;ABL1
prerank,insulin-like growth factor binding (GO:0005520),0.5750387915557535,1.5116445791551991,0.0550098231827112,0.7391597397195036,0.999,4/15,3.40%,ITGA6;IGFBP3;ITGAV;IGF1R
prerank,sequence-specific mRNA binding (GO:1990825),0.6668623800302754,1.5105084755697944,0.044444444444444446,0.7035515696431696,0.999,6/10,16.92%,ETF1;SSB;RBM24;DHX9;SHFL;TYMS
prerank,MAP kinase kinase activity (GO:0004708),-0.5549514508025115,-1.5047582172857121,0.06960556844547564,0.339764522343548,1.0,7/15,21.48%,MAPK10;LRRK2;PAK3;MAPKAPK5;SBK2;MAP2K6;MAP2K5
prerank,serotonin receptor activity (GO:0099589),-0.5045857618095547,-1.4994489614421533,0.04328018223234624,0.3258333510812511,1.0,8/22,13.95%,HTR2C;HRH1;HTR2B;HTR1D;CHRM3;CHRM2;HTR4;HTR6
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.5045857618095547,-1.4994489614421533,0.04328018223234624,0.3258333510812511,1.0,8/22,13.95%,HTR2C;HRH1;HTR2B;HTR1D;CHRM3;CHRM2;HTR4;HTR6
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.5045857618095547,-1.4994489614421533,0.04328018223234624,0.3258333510812511,1.0,8/22,13.95%,HTR2C;HRH1;HTR2B;HTR1D;CHRM3;CHRM2;HTR4;HTR6
prerank,sodium:proton antiporter activity (GO:0015385),0.6181842962447948,1.4961299004352575,0.04891304347826087,0.7350733466330531,0.999,2/11,2.72%,SLC9A9;SLC9A8
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.6042488307643272,1.495502305103653,0.06390977443609022,0.7014404559964909,0.999,2/12,0.62%,TGFBR1;TGFBR2
prerank,3'-5' DNA helicase activity (GO:0043138),0.5692497379955439,1.494687636599136,0.043402777777777776,0.6721034067283582,0.999,9/16,24.36%,NAV2;FANCM;DHX9;BLM;MCM2;FBH1;MCM6;HELQ;RECQL
prerank,ligand-gated calcium channel activity (GO:0099604),-0.509360044624826,-1.4923668847330662,0.0449438202247191,0.33289111552392414,1.0,5/19,2.82%,ITPR1;GRIN2A;RYR2;RYR3;GRIN2B
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.5657528918540997,-1.4918257553800958,0.06396588486140725,0.32612968218572713,1.0,4/14,9.12%,CYBB;NCF2;CYBA;KMO
prerank,anion channel activity (GO:0005253),-0.39083428394623304,-1.4880589482544748,0.01715686274509804,0.32711224772207004,1.0,20/61,17.18%,LRRC8C;GABRB1;GABRA3;GLRA1;CLCN5;GABRG1;GABRA2;GABRG3;ANO3;LRRC8B;GABRB3;ANO6;SLC26A7;GABRG2;ANO5;GLRA2;GABRA5;GABRQ;CFTR;CLCC1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5736353054731846,-1.4873705137259814,0.07641921397379912,0.3213713134936556,1.0,8/12,16.36%,GABRB1;GABRA3;GABRG1;GABRA2;GABRG3;GABRB3;GABRG2;GABRA5
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5880157183882959,-1.4836335545103614,0.07017543859649122,0.32152242147635035,1.0,4/11,5.48%,ITPR1;TRPC5;TRPC4;TRPC3
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.45206705773447176,1.481956930482616,0.037953795379537955,0.7001721189439407,1.0,13/37,18.47%,AARS2;CARS2;KARS1;NARS1;RARS1;DARS2;EPRS1;QARS1;FARSA;SARS2;SARS1;WARS2;MARS2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.47704983568037784,1.47942246857243,0.046181172291296625,0.6813030657107797,1.0,12/29,22.92%,GANAB;HPSE2;NEU3;ACER3;ACER2;CHIT1;GUSB;HEXD;PGGHG;MGAM;GAA;PARG
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6349285457178495,1.4727667750056679,0.06420233463035019,0.6833200638624979,1.0,4/10,6.12%,SIRPA;DSP;DSG2;CXADR
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.4865587240153606,-1.4714485953145322,0.05263157894736842,0.34064144620395065,1.0,3/21,1.96%,GRM5;GRM1;GRIA1
prerank,tRNA binding (GO:0000049),0.43452778471574516,1.4704555883066106,0.029668411867364748,0.6672220574103233,1.0,17/43,19.99%,TRNT1;XPOT;AARS2;SSB;KARS1;EIF2A;NSUN6;PSTK;DARS2;HSD17B10;TRMT10B;SARS2;SARS1;NEMF;ELP1;TYW5;AIMP1
prerank,O-methyltransferase activity (GO:0008171),0.6293189382216198,1.4701505782646451,0.06896551724137931,0.642865878027102,1.0,4/10,13.88%,COMT;ASMT;BCDIN3D;FTSJ3
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5455078638002044,-1.4673884067760739,0.05077262693156733,0.3424183245620246,1.0,9/15,23.96%,SLC26A7;SLC26A2;SLC4A8;CFTR;SLC26A3;SLC4A1;SLC26A4;SLC26A8;SLC39A8
prerank,calcium channel inhibitor activity (GO:0019855),-0.58855558672051,-1.46253181347898,0.06236559139784946,0.3448244140834773,1.0,3/11,7.72%,ITPR1;CALM1;MCUB
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.5225174883924488,-1.4608413084157301,0.05664488017429194,0.3409671252920492,1.0,9/16,20.54%,SLC25A30;SLC1A6;SLC1A5;SLC13A3;SLC1A1;SLC25A18;SLC13A5;SLC25A12;SLC1A4
prerank,cysteine-type endopeptidase activity (GO:0004197),0.38919944647842813,1.4584443242549023,0.02508361204013378,0.6690292522808136,1.0,18/78,12.03%,USP35;CAPN3;CFLAR;USP12;USP8;UCHL1;CASP1;LGMN;CAPN9;USP25;CAPN5;USP28;CTSS;PIGK;USP36;CTSF;PDIA3;USP9Y
prerank,potassium:proton antiporter activity (GO:0015386),0.6189437019462005,1.4561961304554547,0.07414104882459313,0.6548386056840907,1.0,2/10,2.72%,SLC9A9;SLC9A8
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.605038054573922,-1.4549480233566012,0.06540084388185655,0.34713512998242035,1.0,3/10,8.26%,CYBB;NCF2;CYBA
prerank,FMN binding (GO:0010181),0.5976012785213927,1.4533977927323176,0.09245283018867924,0.6431142156951464,1.0,7/11,29.55%,PPCDC;NOS2;HAO1;NOS1;PNPO;NDOR1;POR
prerank,voltage-gated cation channel activity (GO:0022843),-0.3525041489368207,-1.4509564413920306,0.019337016574585635,0.34969565162140626,1.0,23/97,10.33%,KCND2;KCNB2;CACNA1E;CACNA2D3;GRIN2A;HCN1;KCNQ5;KCNC2;GRIN2B;CACNG2;KCNQ3;KCNH1;KCNA6;CACNA1C;KCND3;PKD2;KCNH7;KCNH2;KCNH5;OPRM1;GRIN2D;CACHD1;GRIN3A
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5950475588315706,1.449431604945272,0.09532710280373832,0.6375563212969936,1.0,5/11,13.48%,SLC25A42;SLC25A25;LRRC8A;SLC17A9;SLC19A1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5551397076812428,-1.4440367377823318,0.07792207792207792,0.35789388846315007,1.0,8/13,16.36%,GABRA3;GLRA1;GABRG1;GABRA2;GABRG3;GABRG2;GLRA2;GABRA5
prerank,acylglycerol lipase activity (GO:0047372),0.5962142051986468,1.4376773398622595,0.062146892655367235,0.6652524742437445,1.0,4/11,17.09%,ABHD12;ABHD15;ABHD6;LIPE
prerank,voltage-gated potassium channel activity (GO:0005249),-0.35551275139911814,-1.437174195437569,0.015384615384615385,0.36560362075430636,1.0,17/80,9.01%,KCND2;KCNT2;KCNB2;HCN1;KCNN2;KCNQ5;KCNC2;KCNJ3;KCNQ3;KCNH1;KCNA6;KCND3;PKD2;KCNH7;KCNH2;KCNJ6;KCNH5
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5694905003257167,1.4351053849034598,0.0830188679245283,0.6553057387503202,1.0,5/12,7.11%,BLNK;GAB2;PIK3R1;TRADD;FRS2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5737108755406192,1.434718683786376,0.09888059701492537,0.6370890392250015,1.0,5/12,13.48%,SLC25A42;SLC25A25;LRRC8A;SLC17A9;SLC19A1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.581000407971651,-1.4306543267848162,0.09586056644880174,0.3731136680090023,1.0,5/11,17.92%,KCNJ3;KCND3;KCNH2;KCNQ1;KCNE3
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5203590274608585,-1.42896914925943,0.06756756756756757,0.3702934988924888,1.0,10/16,23.85%,SLC12A5;SLC26A7;SLC1A1;SLC26A2;SLC4A8;CFTR;SLC26A3;SLC4A1;SLC26A4;SLC26A8
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.4191714536794934,-1.4286737013606605,0.028639618138424822,0.36434199036874276,1.0,14/35,18.19%,FOXP1;TBPL1;DRAP1;MYC;GTF2B;MMP12;KLF10;RELA;NR3C1;HDAC1;NPM1;PIH1D1;H3-3A;BAZ2A
prerank,amino acid binding (GO:0016597),-0.44275648541781515,-1.4268485144337533,0.04914004914004914,0.36175118020014374,1.0,12/31,18.31%,GRM7;GRIN2B;GLRA1;PADI4;GRIN3A;DDAH2;GNMT;SRR;SHMT1;GLRA2;GLDC;AARS1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5635182067431166,1.4268098382108747,0.08906882591093117,0.649396915228366,1.0,3/14,4.99%,CAPN3;CAPN9;CAPN5
prerank,low-density lipoprotein particle binding (GO:0030169),-0.5083844427823714,-1.4258738698601594,0.0743801652892562,0.35780059815832516,1.0,7/16,10.15%,STAB1;CD36;MSR1;PLTP;LDLR;CDH13;SCARF1
prerank,nuclear receptor coactivator activity (GO:0030374),0.4054432569733633,1.4231319868628183,0.03237410071942446,0.6457909757697531,1.0,25/52,26.87%,BRD8;ETS1;ELK1;CALCOCO1;TACC1;RBM14;CCDC62;PRKCB;ZMIZ2;CARM1;MED4;CCAR1;RNF4;NCOA3;MED12;WDR77;NCOA2;ATXN7L3;KDM1A;PPRC1;PKN1;ZMIZ1;NCOA6;ACTN4;SRA1
prerank,amyloid-beta binding (GO:0001540),-0.36018725123479634,-1.4230076740819253,0.019704433497536946,0.35827059684232887,1.0,15/79,4.62%,NLGN1;CD74;GRIA4;GRIN2A;CD36;LILRB1;LILRB3;MSR1;GRIA1;APOE;GRIN2B;IAPP;GRIA2;LDLR;APBA2
prerank,adenylate cyclase binding (GO:0008179),-0.5826402461113573,-1.4153202934913802,0.09803921568627451,0.3684715715582882,1.0,4/10,6.92%,AKAP6;ADCY2;ADCY5;CALM1
prerank,syntaxin binding (GO:0019905),-0.37185454090903103,-1.4104441307567785,0.04656862745098039,0.37338787709458926,1.0,17/61,11.87%,STXBP5L;LRRK2;SYT1;NAPB;SNPH;STXBP5;SYNPR;SYT10;UNC13C;DAPK1;NAPA;CPLX2;SNAP25;PTPN2;UNC13B;SYPL1;SCFD1
prerank,actinin binding (GO:0042805),-0.47538420931747233,-1.4100461949842515,0.06387665198237885,0.3683942192898368,1.0,9/21,15.14%,PDLIM5;PPARG;KCNN2;CACNA1C;PKD2;RARA;DAG1;RELA;PDLIM4
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5162547171809504,1.4085549586705268,0.08348794063079777,0.6870298106691617,1.0,2/18,0.62%,TGFBR1;TGFBR2
prerank,sodium channel activity (GO:0005272),-0.4120803819060607,-1.4054147018989924,0.057971014492753624,0.37241285724399975,1.0,12/37,21.58%,GRIK2;HCN1;SCN2A;SCN3A;PKD2;GRIK1;GRIK4;CACNA1G;HCN2;ASIC3;GRIK3;SCN9A
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.49668132592351294,-1.4043939705895068,0.06465517241379311,0.3684752082694168,1.0,4/16,4.50%,CD38;MACROD2;NEIL3;RPS3
prerank,hyaluronic acid binding (GO:0005540),-0.588139214411344,-1.4036002192816306,0.12,0.3645560459097381,1.0,2/10,1.10%,LYVE1;CD44
prerank,lysophospholipase activity (GO:0004622),0.49725995162746695,1.3962586515164013,0.0812274368231047,0.717009609047673,1.0,6/20,14.99%,ABHD12;PNPLA7;PLA2G6;PLA2G4B;PLA2G4A;ASPG
prerank,solute:anion antiporter activity (GO:0140323),-0.5237412041542031,-1.388039000553618,0.10991379310344827,0.3927384764516689,1.0,7/14,23.85%,SLC26A7;SLC26A2;SLC7A11;SLC26A3;SLC4A1;SLC26A4;SLC26A8
prerank,deubiquitinase activity (GO:0101005),0.3596255142152427,1.3843145601317985,0.05065359477124183,0.748334232125349,1.0,21/88,12.57%,USP35;OTUD6B;USP12;OTUD5;USP8;OTULIN;UCHL1;UCHL5;JOSD2;ZRANB1;USP25;USP28;UFD1;MYSM1;STAMBPL1;USP36;MINDY2;OTUB2;USP9Y;USP4;USP19
prerank,thiol-dependent deubiquitinase (GO:0004843),0.3646042213202594,1.3834264443747968,0.04809286898839138,0.732770606347202,1.0,20/83,12.57%,USP35;OTUD6B;USP12;OTUD5;USP8;OTULIN;UCHL1;UCHL5;JOSD2;ZRANB1;USP25;USP28;UFD1;MYSM1;STAMBPL1;USP36;OTUB2;USP9Y;USP4;USP19
prerank,galactosyltransferase activity (GO:0008378),-0.5636808636827486,-1.3821172595887266,0.10706638115631692,0.39940875224372896,1.0,4/11,13.39%,B4GALT5;B4GALT6;B4GALT2;B4GALT7
prerank,metalloexopeptidase activity (GO:0008235),-0.37670218070696526,-1.3794051707143873,0.04081632653061224,0.3998092167660771,1.0,15/51,13.57%,AGBL4;CPQ;NPEPPS;MMP16;RNPEPL1;AGBL1;TRHDE;XPNPEP3;ENPEP;MMP15;AEBP1;CPXM1;ANPEP;MMP14;VASH2
prerank,chloride channel activity (GO:0005254),-0.36618497536115335,-1.3787286768366205,0.046798029556650245,0.395539612489085,1.0,18/59,17.18%,GABRB1;GABRA3;GLRA1;CLCN5;GABRG1;GABRA2;GABRG3;ANO3;GABRB3;ANO6;SLC26A7;GABRG2;ANO5;GLRA2;GABRA5;GABRQ;CFTR;CLCC1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5075572915605304,-1.377615281441153,0.11554621848739496,0.3866629562326114,1.0,4/16,1.58%,PTPRD;PTPRN2;PTPRG;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5075572915605304,-1.377615281441153,0.11554621848739496,0.3866629562326114,1.0,4/16,1.58%,PTPRD;PTPRN2;PTPRG;PTPRT
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.46693755225102235,1.3701590277169309,0.10243055555555555,0.770579427925221,1.0,9/25,13.36%,ADAP2;DAPP1;ARAP3;GAB2;FCHSD2;PLEK;PLEKHA4;HIP1R;AKT1
prerank,potassium channel regulator activity (GO:0015459),-0.37158564236584096,-1.3695082410764656,0.0472636815920398,0.39820168503528186,1.0,9/49,7.62%,KCNIP4;DPP6;DPP10;KCNIP1;KCNMB2;YWHAE;NEDD4L;SGK2;KCNAB2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.5105940152440447,-1.367836717310532,0.10722100656455143,0.3964179765161522,1.0,3/14,19.43%,RDH10;DHRS9;RDH12
prerank,histone methyltransferase binding (GO:1990226),-0.5557829358089391,-1.3640956161645341,0.1422680412371134,0.39908904255068084,1.0,7/11,24.27%,HSP90AB1;CTNNB1;LCOR;WIZ;LCORL;CBX3;CBX1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5609365795242393,-1.362781852242302,0.12815126050420167,0.396494105605978,1.0,3/10,1.76%,DPP6;DPP10;DPP4
prerank,lipoprotein particle binding (GO:0071813),-0.4533153122753245,-1.3597314086519467,0.10084033613445378,0.39840335719787257,1.0,7/20,10.15%,STAB1;CD36;MSR1;PLTP;LDLR;CDH13;SCARF1
prerank,anion transmembrane transporter activity (GO:0008509),0.5631940568987494,1.3552085764155541,0.11743119266055047,0.8193941737231206,1.0,3/12,13.48%,SLCO2B1;SLC22A6;SLC19A1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5283023778098238,1.3525348710688867,0.1280148423005566,0.8121231286152215,1.0,5/13,12.78%,HSD3B2;DDT;ECI1;ECH1;IDI1
prerank,potassium ion antiporter activity (GO:0022821),0.5258674253979785,1.3496381370330026,0.11948529411764706,0.8058519958485091,1.0,3/15,2.79%,SLC9A9;SLC9A8;SLC24A3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.480067871603496,-1.3485438366016267,0.11368421052631579,0.4172997802785639,1.0,3/17,5.77%,DPYD;DECR2;LBR
prerank,receptor antagonist activity (GO:0048019),0.4931862402686699,1.3455355007870744,0.11926605504587157,0.805665218857524,1.0,6/17,19.97%,AGTR2;IL18BP;FST;DKK3;PXDN;LRPAP1
prerank,receptor tyrosine kinase binding (GO:0030971),0.3744913273002416,1.3433257944847687,0.07907742998352553,0.7969403023129167,1.0,10/56,9.34%,DOCK4;BLNK;GAB2;RNF41;PIK3R1;PCNA;TRADD;FIZ1;FRS2;PTPN1
prerank,store-operated calcium channel activity (GO:0015279),-0.5484987974682952,-1.3403417255219068,0.1442687747035573,0.4306913257098576,1.0,4/10,9.06%,TRPC5;TRPC4;TRPC3;STIM2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5329435955634504,-1.3402527195478782,0.11711711711711711,0.42554338847851225,1.0,7/11,18.79%,KCND2;KCNT2;KCND3;PKD2;KCNQ1;KCNIP2;KCNT1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.5330223802125794,-1.3398718487811734,0.14965986394557823,0.4210566185723322,1.0,3/11,6.89%,NEIL3;RPS3;APEX2
prerank,SUMO binding (GO:0032183),0.5413653318331383,1.335971278558837,0.13962264150943396,0.8101049427364089,1.0,5/13,17.81%,HERC2;UBA2;USP25;SIMC1;RNF4
prerank,cGMP binding (GO:0030553),-0.5382123408211831,-1.335213390408131,0.11940298507462686,0.4256475447722405,1.0,4/11,14.96%,PDE11A;RAPGEF2;PDE2A;PDE10A
prerank,GTPase inhibitor activity (GO:0005095),-0.512819737960273,-1.3285613305175294,0.1186046511627907,0.43559364780766563,1.0,3/13,1.74%,IQGAP2;IQGAP1;SLIT2
prerank,tropomyosin binding (GO:0005523),-0.490380951578001,-1.3283793871039586,0.12694877505567928,0.43085696979096083,1.0,10/16,34.84%,TMOD3;NEBL;SMTNL2;LMOD3;LMOD1;TNNT2;TMOD4;TNNT1;CALD1;TNNT3
prerank,omega peptidase activity (GO:0008242),0.3466647594198856,1.3231815240185423,0.06734006734006734,0.8504604725769455,1.0,20/89,12.57%,USP35;OTUD6B;USP12;OTUD5;USP8;OTULIN;UCHL1;UCHL5;JOSD2;ZRANB1;USP25;USP28;UFD1;MYSM1;STAMBPL1;USP36;OTUB2;USP9Y;USP4;USP19
prerank,myosin II binding (GO:0045159),-0.545245161947389,-1.3229047552454645,0.16188524590163936,0.4373106625889683,1.0,4/10,9.66%,STXBP5L;GSN;STXBP5;SHROOM1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.4321362000229242,-1.3190719774611421,0.12954545454545455,0.44081548199572024,1.0,5/23,9.56%,HIP1;CLVS2;SNX14;SESTD1;PLEKHA5
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3933588482468499,-1.3183775561151891,0.0746987951807229,0.43735506046330197,1.0,14/31,24.83%,KCNK10;HCN1;SLC12A8;SLC12A4;PKD2;SLC12A5;TMEM38B;KCNK4;TMEM38A;SLC12A1;KCNK5;AQP1;SLC12A3;KCNA1
prerank,carboxylic acid binding (GO:0031406),-0.3867511868180699,-1.317408915959147,0.09701492537313433,0.43437662919998377,1.0,12/38,17.83%,GRM7;EPDR1;GRIN2B;GLRA1;PADI4;GRIN3A;GNMT;SRR;SHMT1;GLRA2;GLDC;SESN2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.46789579737209397,1.3168821548390086,0.11690647482014388,0.8622292964560371,1.0,4/20,6.91%,SENP2;OTUD5;USP25;OTULINL
prerank,kinase binding (GO:0019900),-0.26102342445683413,-1.3155905056106285,0.0,0.43333456194412545,1.0,115/435,17.52%,DLG2;UNC5C;IQGAP1;FRMD5;ANK2;CNTLN;CADPS;ATF2;SYN1;EGFR;UTRN;HTT;POLA1;STAP1;BICD1;LATS1;GSN;ATG13;SHC3;SNAP91;PTPN22;RND3;PRKAG2;NBEA;AP2A2;ABI2;ACSL3;RPS3;CD226;CDC42;MOB1B;TRIP6;USF1;RACGAP1;TAX1BP1;DLG3;RPS7;CCND2;CDK5RAP2;CSPG4;FAF1;CNKSR2;BARD1;EXOC2;ACTB;GSK3B;PFKM;PRKN;CALM1;SKAP1;PDE8A;SLC12A4;TPX2;KIF14;SP100;ZFP36;JAK2;TNS2;DNM1;BCAR1;TRAP1;PTPN2;ERCC6L2;CEBPA;AURKB;FBXO7;LRBA;IRGM;SRCIN1;AXIN1;HSP90AB1;KIF11;PRC1;EEF1A2;MSN;SMCR8;SIK1;ADRA2A;MAP3K13;PER1;TPRKB;KIF20A;THY1;DNAJC3;ARHGAP33;TIAM1;RELA;FAM83D;CACUL1;CDKN2A;RGCC;RCC2;CTNNB1;INKA2;NR3C1;BECN1;CDKN1A;NEFH;NPM1;PIH1D1;TFRC;CDC25C;WWC1;LAX1;UBQLN1;FLNA;FAM83B;RICTOR;ADD2;FAM83H;TEX14;CARD16;PPP1R12A;CD3E;ACVRL1
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.39279907277767506,-1.3094609282201644,0.09133489461358314,0.44143571509110885,1.0,7/32,8.27%,KCNB2;KCNQ5;KCNC2;KCNQ3;KCNH1;KCNA6;KCNH2
prerank,actin binding (GO:0003779),-0.28675148123250227,-1.3093779414813234,0.033846153846153845,0.43668228498190975,1.0,37/170,13.65%,IQGAP2;DMD;EPS8;PDLIM5;MTSS1;SORBS1;LRRK2;UTRN;MAP1B;GSN;ABLIM1;SYNE2;MYRIP;GAS2L3;NCALD;FXYD5;PHACTR2;PDLIM1;SYNE1;PRKN;MICAL3;GIPC1;ADCY8;CCDC88A;PAWR;SPTBN4;MSRB1;LDB3;FHL3;PHACTR1;DAG1;ALKBH4;SNCA;VPS16;MYO6;VASH2;KLHL2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4985082060826559,1.309141276525121,0.17173524150268335,0.8792685311575473,1.0,6/15,10.36%,PI4KB;ATM;PIK3CG;PIK3CB;PIK3CD;PIK3C3
prerank,poly(A) binding (GO:0008143),-0.4424525920915361,-1.3077579571720195,0.12731481481481483,0.43546828938444193,1.0,6/21,8.08%,KHDRBS2;RBMS3;RBMS1;EIF4A3;PABPC1;ELAVL4
prerank,cysteine-type peptidase activity (GO:0008234),0.3566246321276031,1.306225547559272,0.07304347826086957,0.8738909046651909,1.0,16/73,12.03%,USP35;CAPN3;USP12;USP8;OTULIN;UCHL1;CASP1;LGMN;USP25;USP28;CTSS;OTULINL;USP36;CTSF;PDIA3;USP9Y
prerank,ATPase activator activity (GO:0001671),-0.44352580954525544,-1.3047441629410201,0.10454545454545454,0.4374290891770449,1.0,8/20,19.65%,DNAJA2;DNAJC15;DNAJB4;ATP1B3;DNAJB2;MYBPC3;TOR1AIP2;DNAJC19
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5454864527459244,-1.304337357594927,0.15,0.4336251858494796,1.0,2/10,1.73%,ADARB2;GDA
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5038425952455626,-1.3029176006584584,0.13894736842105262,0.4319913251611316,1.0,5/12,7.01%,PDE7B;PDE4B;PDE4D;PDE7A;PDE8A
prerank,tubulin binding (GO:0015631),-0.2686587822042254,-1.301673253464491,0.011194029850746268,0.43049549044596014,1.0,81/296,16.66%,UNC5C;DNM3;AGBL4;LRRK2;KIF5C;CCDC88C;TTLL11;HTT;REEP3;MAP1B;TPPP;KIF1B;SNPH;MTUS2;SGIP1;SYBU;MACO1;APC2;MAP2;MID2;EML5;VAPA;RPS3;KIF23;GAS2L3;NCALD;RACGAP1;ARL4C;CDK5RAP2;STMN4;TTLL7;TOGARAM2;DNM1L;DLGAP5;EML1;TTLL5;KIF26B;KIF22;AGBL1;PRKN;SAXO2;RMDN3;TPX2;BIRC5;KIF14;CCDC88A;DNM1;REEP2;CCDC69;KIF5B;CENPE;MDM1;NUSAP1;CCSAP;IFT81;PRC1;MAP9;SPAG5;MTCL1;KIF20A;DAG1;TTLL12;EFHC1;SNCA;ALMS1;PAK1;KIF18B;VASH2;REEP4;FAM83D;PHF6;RCC2;KIF6;TBCE;NEFH;TBCA;BRSK1;STMN2;GPAA1;RAD51D;CCDC61
prerank,Wnt-activated receptor activity (GO:0042813),0.4984765216336311,1.2981472470072313,0.14575645756457564,0.8927689040366684,1.0,9/15,25.22%,LRP5;FZD2;RYK;FZD1;TSPAN12;FZD6;FZD9;FZD3;FZD10
prerank,voltage-gated chloride channel activity (GO:0005247),-0.541476055979069,-1.2938304259937863,0.1719077568134172,0.4429469164496649,1.0,5/10,33.26%,CLCN5;ANO6;ANO1;CLCNKB;CLCN6
prerank,ribosomal small subunit binding (GO:0043024),0.4820515610229037,1.289813560516563,0.1487758945386064,0.9143275567250374,1.0,10/17,26.30%,ABCE1;EIF4H;MTIF2;EIF1B;NME1;LARP1;DHX29;CPEB2;DDX3X;EIF1
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.5214209615198546,1.289634287234042,0.18085106382978725,0.8979766504835256,1.0,2/12,2.72%,SLC9A9;SLC9A8
prerank,peptide hormone receptor binding (GO:0051428),0.5388365628635142,1.2881551769009298,0.19360902255639098,0.8883505033524431,1.0,3/11,21.35%,GNRH1;VIP;PTHLH
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.36283792354407407,1.284668507127662,0.10034602076124567,0.8882698415662064,1.0,20/57,23.98%,NDUFB2;NDUFB8;COX8A;NDUFS3;NDUFS4;COX7A2L;NDUFB10;CYB561A3;NDUFB3;NDUFS5;CYB561D2;NDUFV3;NDUFA13;COX5A;NDUFC2;COX6B1;NDUFV1;NDUFA9;COX6A2;NDUFV2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.528565315828817,-1.2817215989973745,0.1511879049676026,0.46525150545905003,1.0,7/10,34.62%,SLC10A6;SLC6A1;SLC6A11;SLC6A12;SLC6A13;SLC10A2;SLC10A1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.4485408932416633,1.2809595579525035,0.1583629893238434,0.8883723575309801,1.0,9/21,13.70%,PJA2;AKAP8;PRKACA;AKAP8L;AKAP14;AKAP5;AKAP7;PRRC1;ACBD3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.41880941644395053,-1.279574782569968,0.1440677966101695,0.4655153713044351,1.0,9/23,18.69%,PLCB1;PLCH1;CCR1;CHRM3;PLCB4;PLCD4;PLCH2;CCL5;PLCD1
prerank,damaged DNA binding (GO:0003684),0.3833807440675559,1.27704795405754,0.10517529215358931,0.8903070274414704,1.0,16/44,17.61%,MPG;PCNA;CRY2;NBN;CUL4B;FANCG;DCLRE1B;ERCC2;DCLRE1C;DDB2;ERCC4;RAD1;HMGB2;DCLRE1A;NTHL1;APTX
prerank,translation initiation factor activity (GO:0003743),0.39667736654660046,1.2737892687750927,0.13333333333333333,0.8896903905744731,1.0,12/36,17.68%,EIF4A2;EIF4G1;EIF2S1;EIF2A;EIF2B3;EIF3K;EIF2B4;EIF2S2;EIF2D;EIF3D;EIF1B;EIF5
prerank,pre-mRNA binding (GO:0036002),0.41831720453139687,1.2722422150885027,0.1524822695035461,0.8813627223676735,1.0,8/28,14.18%,DDX5;CELF2;SNRPC;RBM24;U2AF2;TRA2B;U2AF1L4;SLU7
prerank,NF-kappaB binding (GO:0051059),-0.4080127436560754,-1.264061285619435,0.14219114219114218,0.4971420480022656,1.0,11/24,21.54%,ANXA4;FAF1;GSK3B;NFKBIA;TAF4B;RELA;CDKN2A;HDAC1;NPM1;FOXP3;CDK5RAP3
prerank,aminopeptidase activity (GO:0004177),-0.40208092042637156,-1.261554726966294,0.1510791366906475,0.4979305661904542,1.0,9/26,13.40%,NPEPPS;MMP16;RNPEPL1;TRHDE;XPNPEP3;ENPEP;MMP15;ANPEP;MMP14
prerank,ephrin receptor binding (GO:0046875),0.4393340072052647,1.261203255752115,0.17229129662522202,0.9162998122834731,1.0,9/21,22.82%,SRC;LYN;PIK3CG;PTPN1;ABL1;EFNB1;EFNA1;EFNA3;EFNA2
prerank,translation elongation factor activity (GO:0003746),-0.4756514542031245,-1.2589175876267107,0.19294605809128632,0.49916035137062403,1.0,7/14,24.54%,GFM2;GFM1;EEF1A2;EIF5A;EIF5AL1;EEF1A1;EIF5A2
prerank,protein serine/threonine kinase activity (GO:0004674),0.27724449854102245,1.2581499393390396,0.03319502074688797,0.9145952221841055,1.0,84/335,17.97%,TGFBR1;NUAK1;TGFBR2;ULK2;PIM2;MAP4K4;RPS6KA1;CHEK2;BMP2K;CLK1;PRKCA;PRKACA;CSNK1E;CSNK2A2;CSNK2A1;IRAK2;RIPK2;PRKCD;CDKL3;CAMK1D;CDK9;RPS6KA5;CAMKK1;NEK3;ATM;NRBP1;NEK8;PDPK1;MKNK1;MAP4K3;MAP3K8;PKN3;NEK6;VRK3;TSSK6;TSSK4;PTK2B;ULK3;CDK11B;WNK1;MAP3K2;ARAF;MAP3K10;NUAK2;CLK4;UHMK1;LATS2;GRK2;STK19;MTOR;MARK2;PINK1;PHKG2;CDC42BPB;MAPK14;PRKCB;ROCK2;DYRK4;AKT1;MAP3K11;PRKD3;STK35;ULK1;STK39;PASK;EIF2AK2;TRIO;MAST3;AURKA;RPS6KA4;MAPK7;MASTL;PLK3;WNK2;MAP4K2;TAOK2;WNK3;DYRK1A;MAP3K15;CAMK1G;CLK3;MARK4;TAF1;MINK1
prerank,cytochrome-c oxidase activity (GO:0004129),0.4851954815499705,1.2563692822056387,0.1963302752293578,0.9080157391682798,1.0,10/15,36.55%,COX8A;COX7A2L;COX5A;COX6B1;COX6A2;COX6A1;COX4I1;CYB5A;COX10;COX15
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.5090148094073006,-1.2520600967163544,0.1831578947368421,0.5113613060524207,1.0,3/11,2.74%,ITPR1;RYR2;RYR3
prerank,ubiquitin binding (GO:0043130),0.33320084197351685,1.2513529112952801,0.12479474548440066,0.9162582893442528,1.0,20/73,17.65%,MVB12B;SMAD3;NBR1;SIRT2;WDR48;UCHL1;USP25;OTULINL;CKS1B;AUP1;OTUB2;VPS36;UBXN2A;RNF31;GGA3;TSG101;UBXN7;NUP62;USP5;MARK4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3537857145397434,1.2509885248089312,0.11627906976744186,0.9035193520863919,1.0,14/54,15.18%,TGM2;HDAC10;SIRT2;SUDS3;ACER3;ACER2;ASAH1;VNN1;HDAC8;NTAN1;PM20D2;NIT2;ASPG;MIER3
prerank,1-phosphatidylinositol binding (GO:0005545),-0.4593782608040829,-1.2499283125231166,0.19703389830508475,0.5116064021174587,1.0,6/15,13.29%,SNAP91;EEA1;SESTD1;FRMPD2;SNX9;EPB41
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3313377713628854,1.2498988102132835,0.10526315789473684,0.8939824932705057,1.0,16/85,14.99%,LIPC;ABHD12;DAGLB;PNPLA7;AARS2;PLA2G15;PLA2G6;PLA2G4B;PNPLA1;PTRH1;ABHD15;PLA2G4A;ABHD6;PON3;PON2;ASPG
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5153162359087179,-1.2497763977370302,0.203125,0.5071882027301752,1.0,6/10,16.36%,GABRA3;GABRG1;GABRA2;GABRG3;GABRG2;GABRA5
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3411538312965218,1.248175435844444,0.13870967741935483,0.8884756681931552,1.0,28/69,26.81%,DGAT1;LPCAT4;CERS3;PLA2G15;PORCN;MOGAT2;ZDHHC13;PNPLA1;MOGAT1;PLA2G4A;ZDHHC5;ASPG;CERS2;ZDHHC12;DBT;ZDHHC7;HHAT;NMT1;ZDHHC2;SCP2;KAT6B;CERS4;ZDHHC6;LPCAT3;KAT2B;PLA2G4E;EP300;AWAT2
prerank,fatty acid synthase activity (GO:0004312),-0.5268731101055063,-1.2467213017102245,0.2175824175824176,0.5095399393259057,1.0,4/10,23.61%,ELOVL7;ELOVL5;CBR4;MCAT
prerank,hexosaminidase activity (GO:0015929),0.5029452517166564,1.246513495881681,0.19047619047619047,0.8818317606947879,1.0,2/12,4.08%,HEXB;HEXA
prerank,protein kinase C binding (GO:0005080),0.36890919928968907,1.2462320433062126,0.14664310954063603,0.8698490129109615,1.0,12/43,12.95%,TWF2;PRKCSH;DSP;ITGAV;ADCY4;PLEK;ADCY6;TOP2B;TRPV4;ABL1;PRKCB;DACT3
prerank,small GTPase binding (GO:0031267),0.2922935182672203,1.2439716072004636,0.08682634730538923,0.8672859257877559,1.0,40/170,14.93%,DOCK4;SRGAP2;FGD2;HPS4;ARHGEF2;CDC42EP2;MLPH;KIF3B;RNF41;PIH1D2;RHOH;TBC1D7;RANBP2;GOLGA5;CYRIB;PICALM;ARFIP2;RAB3GAP2;AKAP13;RAB34;RABGGTA;RAB3GAP1;FGD3;MYO5B;KIF3A;TNPO3;SOD1;SGSM2;GOLGA4;GCC1;STK19;IFT20;CIB1;SGSM3;ULK1;GGA3;LZTR1;TNFAIP1;PDE6D;CYFIP1
prerank,microtubule motor activity (GO:0003777),-0.3374888562915306,-1.2418799209896667,0.11491442542787286,0.5162119415224515,1.0,26/51,23.99%,KIF5C;KIF1B;DYNC1I2;KIF23;KIF26B;KIF22;DNAH8;DNAH2;KIF14;KIF5B;CENPE;KIF11;KIF20A;DYNLRB1;DNAH3;KIF18B;KIF6;APPBP2;DNAH17;KIF21A;KIF4A;KIF3C;KIF5A;KIFC1;KIF24;KIF2C
prerank,calcium ion binding (GO:0005509),-0.2554081943549942,-1.2405300328523345,0.015444015444015444,0.5149549284965707,1.0,68/323,15.53%,KCNIP4;NRXN1;IQGAP1;AOAH;ADGRL3;ITPR1;KCNIP1;SPOCK1;CDH8;MCTP2;SLIT2;SYT1;PAM;ITSN1;RYR2;GSN;ANXA4;RYR3;ASTN2;RAPGEF2;SYT10;SPARCL1;ATP2A2;S100A11;RASGRP2;CDH22;RCN3;TPT1;LETM1;EML1;CDH4;PCLO;CALM1;RET;PKD2;FBN1;CDH13;MICU2;EFCAB11;CALB1;STIM2;SLC25A24;CDH7;CDH20;HSPA5;PADI4;ANXA2;MMP12;MCTP1;ENPP2;CDH11;PLSCR2;TESC;CDHR3;SNCA;DYSF;CDH5;SRR;MICU3;PLSCR4;CDH10;CDH1;CLEC6A;AGRN;GJB2;CHP2;MELK;KCNIP2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.38007196327992526,1.2387927869662592,0.14915254237288136,0.8763875260212632,1.0,12/35,17.94%,CLK1;SRC;LYN;CSK;PTK2B;PKDCC;ABL1;BMX;FES;DYRK1A;TNK2;TEC
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.35957765674689673,-1.2329064330596575,0.16458852867830423,0.5283237096844385,1.0,8/38,5.07%,MAGI2;SORBS1;LRRK2;STAP1;DEDD2;NCK2;IRS1;SHANK3
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3901484663121142,-1.232140551494573,0.20093457943925233,0.5255778229275503,1.0,13/27,28.22%,DCUN1D2;ZMYM2;RNF19A;PRKN;SIAH2;RNF19B;UBE3D;DCUN1D3;ANKIB1;ARIH1;PPARA;RNF14;RNF217
prerank,transforming growth factor beta binding (GO:0050431),0.4246653384631108,1.2269329823668667,0.17375886524822695,0.9144496252163135,1.0,3/23,2.42%,TGFBR1;TGFBR2;ITGAV
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.40922567692152,-1.2251259272256232,0.18912529550827423,0.5373109639977692,1.0,10/21,31.39%,FGF10;NPTN;FGF9;FGF7;FGF5;FGF22;KL;FGF16;FGF23;KLB
prerank,retinoid binding (GO:0005501),-0.4100874003669912,-1.2227018595259074,0.19002375296912113,0.5382179858467825,1.0,10/22,25.95%,RARA;RBP4;ABCA4;CYP26C1;RBP1;CRABP1;UGT1A7;UGT1A4;UGT1A8;UGT1A1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.47432093910824513,-1.221572795394285,0.22828282828282828,0.5360660246788477,1.0,5/12,25.56%,TENT5A;PAPOLA;TUT1;TENT2;PAPOLB
prerank,organic cation transmembrane transporter activity (GO:0015101),0.4591161512403878,1.2215589112509833,0.2,0.9253204887109484,1.0,4/16,8.20%,SLC7A8;SLC25A42;SLC22A2;SLC29A4
prerank,metal ion binding (GO:0046872),-0.24106181456385556,-1.2175807457157988,0.017777777777777778,0.5407334859462394,1.0,102/477,16.13%,KCNIP4;NRXN1;IQGAP1;AOAH;ADGRL3;LRRK2;ITPR1;KCNIP1;NLRC4;SPOCK1;CDH8;MCTP2;SLIT2;SYT1;PAM;LATS1;ITSN1;RYR2;APOE;GSN;ANXA4;ERN1;TPPP;RYR3;PAPOLA;GSS;ASTN2;ADCY2;RAPGEF2;TOP2A;SYT10;PPA1;SIK3;ACVR1C;STK26;SPARCL1;ATP2A2;S100A11;RASGRP2;RAN;CDH22;RCN3;TPT1;LETM1;EML1;CDH4;PCLO;CALM1;RET;PKD2;FBN1;CDH13;POSTN;MICU2;YDJC;EFCAB11;CALB1;STIM2;SLC25A24;EYA2;CDH7;CDH20;HSPA5;PADI4;ANXA2;NUDT3;MMP12;MCTP1;HMGCLL1;SIK1;PGM1;ENPP2;SRPK2;IDH2;CDH11;PLSCR2;TESC;CDHR3;SNCA;DYSF;CDH5;SRR;STK38L;MICU3;PLSCR4;GNAI1;CDH10;CDH1;CLEC6A;FIGNL1;AGRN;GEN1;MTHFD2;GJB2;PDE2A;CHP2;CDC42BPG;MELK;KCNIP2;NUCB1;ABL2;BRSK1
prerank,phosphate ion binding (GO:0042301),-0.4974888798235814,-1.2152216067430786,0.21670428893905191,0.5421079255760692,1.0,4/10,14.88%,ADSS2;RELA;MTHFD2;PDE2A
prerank,NAD binding (GO:0051287),0.40539387504270624,1.2119395011285428,0.18339100346020762,0.9556592776403882,1.0,6/26,11.24%,QDPR;SIRT2;HPGD;SORD;CRYL1;NNT
prerank,metal ion:proton antiporter activity (GO:0051139),0.4811219045705181,1.2116564083554278,0.25220458553791886,0.9440969688796074,1.0,2/13,2.72%,SLC9A9;SLC9A8
prerank,leucine zipper domain binding (GO:0043522),0.5186549024257275,1.2111295493680319,0.23597678916827852,0.9339322006107337,1.0,2/10,3.66%,DDIT3;AATF
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5033878839262166,1.2090763300429286,0.2379182156133829,0.93042382280599,1.0,8/11,37.49%,MAP3K11;MAP4K2;TCF3;TRAF6;PPEF2;STK38;SASH1;DUSP19
prerank,CCR chemokine receptor binding (GO:0048020),-0.38087589523670484,-1.2070099690902534,0.20316027088036118,0.5575818042881894,1.0,11/28,31.69%,CCR2;CCL4;CCL2;CCL5;CX3CL1;CCL14;CCL7;NES;CCL19;CCL8;MSMP
prerank,cation channel activity (GO:0005261),-0.28178606226006897,-1.2033373549110178,0.12465373961218837,0.5619551718246641,1.0,20/94,13.12%,KCNK10;CACNA1E;UNC80;HCN1;TRPC5;MCU;TMEM63C;RYR2;TRPM3;SLC24A2;NALCN;TRPC3;PKD2;ANO10;TMEM38B;ANO6;ANXA2;CALHM6;KCNK4;TMEM38A
prerank,clathrin adaptor activity (GO:0035615),-0.44156028382422347,-1.203003762364992,0.21413276231263384,0.5580576374386151,1.0,4/15,7.58%,DAB2;HIP1;AP2A2;AP1M1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5179021817071038,1.2003123300843224,0.2613430127041742,0.9559494510545377,1.0,2/10,8.10%,SLCO2B1;SLC22A6
prerank,RNA polymerase binding (GO:0070063),0.4315948024146042,1.197041987983886,0.22686025408348456,0.9573912155322895,1.0,5/18,10.68%,BIN1;PHRF1;PABPN1;BRCA1;DHX9
prerank,methyl-CpG binding (GO:0008327),0.4109491651928418,1.1938715295548892,0.22563176895306858,0.9590753278962417,1.0,8/22,21.72%,ZBTB21;TET3;CXXC5;PRMT1;MBD1;ERH;WDR77;ZCWPW1
prerank,double-stranded RNA binding (GO:0003725),-0.3086166066261829,-1.1932831432748479,0.12953367875647667,0.5770154095669372,1.0,25/70,24.01%,ADARB2;OAS2;LRRFIP1;STAU2;VIM;AGO4;DDX60;DHX15;HSP90AB1;DROSHA;MSN;ZFR;SIDT1;OAS3;TFRC;TARBP2;SLC3A2;STRBP;IFIH1;RFTN1;TLR8;DUS2;EIF4B;ADAR;AGO2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.44969809046587506,1.1914827699158645,0.24682395644283123,0.9574932997624173,1.0,3/15,9.38%,PLA2G5;PLA2G4B;PLA2G4A
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.42750606562288596,1.1913731261406557,0.2379182156133829,0.9462956436223946,1.0,5/20,7.57%,LPCAT2;DGAT1;PLA2G15;MOGAT2;MOGAT1
prerank,DNA binding (GO:0003677),0.2503638552278883,1.1911714316008923,0.03268765133171913,0.9354494562722492,1.0,186/694,23.32%,IKZF1;ARID3B;ETV5;MLXIPL;DENND4A;SMAD3;NFE2L2;DNMT3A;LYL1;ETS1;FLI1;SOX8;CEBPZ;DDIT3;QRICH1;POLR2H;SRRT;COLEC11;GTF3C2;MAU2;PPARD;CHD8;CTC1;ERF;WDR48;ZCCHC3;KMT2D;CDK9;RNF138;PAX6;ZBTB21;CALCOCO1;MPG;ZBTB18;PCNA;REXO4;SLPI;FAM111A;MLX;MYCL;CRY2;MEIS3;POLR2D;TAF6L;FOXE1;CUX1;NBN;ZMYND11;KDM5B;SLTM;KLF12;SWSAP1;CHD3;CHTF18;RAD51B;CUL4B;ILF2;FOXK2;NUP35;TAL2;ALX4;ZBTB32;TIGD3;POU4F1;NR2F1;CGAS;CXXC5;BRCA1;FANCG;TAF6;TAF12;TBX6;DCLRE1B;LIN9;ERCC2;IMPDH1;DCLRE1C;PATZ1;SMARCA2;PCBP2;GTF3C6;DHX9;DDB2;ARNT;KHDRBS1;SMARCA5;ERCC4;RAD1;BLM;E2F2;EXO1;HP1BP3;ABL1;MEF2A;RNF11;CNBP;MCM2;PRDM2;MBD1;PAX2;PROX1;POLG2;TERF1;ARID1A;SPTY2D1;IRF3;RFC1;CEBPG;TAF4;RLF;C1D;TOP3A;FBH1;ZNF3;NLRP3;CUX2;KDM5A;HMGB2;TSG101;SAFB;POU2F1;MCM3;DCLRE1A;NR1H2;GATA3;PALB2;PLAGL2;TOPORS;NTHL1;EGR1;ZNF292;DNASE2;SAP30L;SAFB2;E2F3;APTX;AIM2;TAF1;RNF4;HMGN1;TCF7L2;TCF4;GZF1;POU2F2;THAP1;MCMDC2;TCF7L1;TCF3;JUN;IRF5;RTF2;ZFPL1;IRF2;PARK7;SPRTN;RPA3;XRCC6;MAPT;PRDM9;NABP1;NFYA;HIF1A;IRX1;SSBP1;TFAP4;MBD6;GLYR1;YY1;RAD51C;TARDBP;SCRT1;MTERF2;ZNF76;TSNAX;TP53;DDX3X;ZBTB14;CSRNP2;RAD51AP2;JRK;RPL7;OTP;DNTTIP1;SYCP2;APLP2;RPL6
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.3687126608872531,1.1873416353461161,0.20320855614973263,0.9295019215377035,1.0,13/34,23.98%,NDUFB2;NDUFB8;NDUFS3;NDUFS4;NDUFB10;NDUFB3;NDUFS5;NDUFV3;NDUFA13;NDUFC2;NDUFV1;NDUFA9;NDUFV2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.3687126608872531,1.1873416353461161,0.20320855614973263,0.9295019215377035,1.0,13/34,23.98%,NDUFB2;NDUFB8;NDUFS3;NDUFS4;NDUFB10;NDUFB3;NDUFS5;NDUFV3;NDUFA13;NDUFC2;NDUFV1;NDUFA9;NDUFV2
prerank,cadherin binding (GO:0045296),-0.24227757214237783,-1.1869244918230872,0.05653710247349823,0.588003760256138,1.0,60/315,12.91%,CTNND2;AHNAK;PDLIM5;CTNNA2;ANK3;CTNNA3;IQGAP1;CTNNA1;SPTBN1;CDH8;EGFR;PTPRT;TRPC4;SEPTIN9;LRRFIP1;SLK;DIAPH3;CTTN;RTN4;TMOD3;YWHAE;PRDX1;EHD1;VAPA;PUF60;CAST;FXYD5;STXBP6;PKP4;S100A11;BAG3;RAN;RPS2;AFDN;CDH22;UBAP2;PDLIM1;CDH4;RPL7A;TBC1D2;GIPC1;HSPA8;CNN2;CDH13;KIF5B;EIF3E;SPTBN2;CDH7;CDH20;HSPA5;ANXA2;HSP90AB1;EPS15;BZW1;CDH11;SNX9;GIGYF2;RPL23A;CDHR3;CDH5
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.4126175825504881,-1.184361796932778,0.23595505617977527,0.5895885673338296,1.0,7/18,18.83%,ALDH9A1;ALDH2;FAR2;FAR1;ALDH3A2;ALDH6A1;ALDH18A1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.447146528666245,1.1806705761775513,0.2486865148861646,0.9361156058470662,1.0,6/16,15.01%,ATP6V0B;ATP6V0A2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V0E2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.447146528666245,1.1806705761775513,0.2486865148861646,0.9361156058470662,1.0,6/16,15.01%,ATP6V0B;ATP6V0A2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V0E2
prerank,exonuclease activity (GO:0004527),0.35075034614921935,1.1792667478590189,0.21514629948364888,0.9315381281034656,1.0,14/46,19.62%,REXO5;DXO;REXO4;REXO2;DCLRE1B;DCLRE1C;RAD1;ISG20L2;EXO1;EXOSC5;ISG20;RAD9A;EXOSC10;EXOG
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.463437283839805,-1.1792055497610072,0.27251732101616627,0.5979753191117294,1.0,5/12,16.89%,TBPL1;GTF2B;RELA;HDAC1;H3-3A
prerank,ubiquitin-protein transferase activity (GO:0004842),0.25914176162510216,1.1777784660066482,0.08609271523178808,0.9274714696772615,1.0,99/346,23.68%,HERC2;PJA2;RNF38;FBXO22;RNF216;TRIM11;TRAF5;UBA7;RNF41;ITCH;UBE2H;FBXO24;RNF138;TRIM5;SEL1L;SMURF1;RFFL;NEURL1B;NEURL3;RNF141;HLTF;DTX4;TRIM44;BCOR;TRIM36;TRIM72;CDC34;TRIM45;MAEA;CUL4B;TRIM69;ASB4;MIB2;RNF103;RNF8;AKTIP;BRCA1;DTX1;WWP2;ZFP91;RNF166;FBXO11;BFAR;MSL2;DDB2;TRIM62;XIAP;UHRF2;AREL1;FBXO21;RNF11;UBE2U;DTX3L;RNF31;ANAPC11;PELI2;MYLIP;RNF25;TRIM47;FBXL22;MKRN3;RNF187;TNFAIP1;MGRN1;RNF144B;RNF123;TRIM3;ZNRF3;TOPORS;TRIM14;TRAF7;RNF121;UBE2A;TAF1;RNF4;SYVN1;RNF20;RNF182;RNFT2;RNF2;DTX3;ANKRD39;UBE2R2;RING1;KLHL9;TRIM39;RNF180;OBI1;CUL4A;UBE3A;STUB1;TRAF6;FBXL14;CUL1;NFX1;UBE2G2;ZNRF1;UBE3C;MEFV
prerank,thioesterase binding (GO:0031996),0.4945295376458191,1.1747371437231569,0.25343811394891946,0.9294572309703579,1.0,3/11,6.25%,RAC1;TRAF5;HAUS7
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.5041679332876816,1.171483174138232,0.27389705882352944,0.9323983286664802,1.0,5/10,10.36%,ATM;PIK3CG;PIK3CB;PIK3CD;PIK3C3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.36677380327227516,-1.171317465393378,0.22037914691943128,0.6136023111818214,1.0,13/27,26.30%,SLC25A30;GET3;SLC26A7;SLC26A2;XPR1;SLC22A8;SLC26A3;SLC4A1;SLC26A4;SLC5A5;SLC26A8;SLC39A8;ANO1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.40580362135591186,1.1705543812015449,0.24721189591078066,0.926418801273323,1.0,6/22,11.33%,AP2A1;PICALM;CLU;MESD;ANKRA2;LDLRAP1
prerank,microtubule binding (GO:0008017),-0.24662173826123515,-1.1695425628067786,0.09748427672955975,0.6132695957483577,1.0,54/222,13.80%,DNM3;LRRK2;KIF5C;CCDC88C;REEP3;MAP1B;TPPP;KIF1B;SNPH;MTUS2;SGIP1;SYBU;MACO1;APC2;MAP2;MID2;EML5;VAPA;RPS3;KIF23;GAS2L3;RACGAP1;CDK5RAP2;TOGARAM2;DNM1L;DLGAP5;EML1;KIF26B;KIF22;SAXO2;RMDN3;TPX2;BIRC5;KIF14;CCDC88A;DNM1;REEP2;CCDC69;KIF5B;CENPE;MDM1;NUSAP1;CCSAP;PRC1;MAP9;SPAG5;MTCL1;KIF20A;CLIP4;ALMS1;KIF18B;VASH2;REEP4;FAM83D
prerank,GTPase binding (GO:0051020),0.27188378692754245,1.1692366639666967,0.13798219584569732,0.9217864463324502,1.0,43/195,14.93%,DOCK4;SRGAP2;FGD2;HPS4;ARHGEF2;CDC42EP2;MLPH;ATG14;KIF3B;RNF41;PIH1D2;RHOH;TBC1D7;RANBP2;GOLGA5;CYRIB;PICALM;ARFIP2;RAB3GAP2;AKAP13;RAB34;RABGGTA;RAB3GAP1;FGD3;MYO5B;RASIP1;KIF3A;TNPO3;SOD1;SGSM2;GOLGA4;GCC1;STK19;IFT20;CIB1;SGSM3;ULK1;GGA3;LZTR1;EPRS1;TNFAIP1;PDE6D;CYFIP1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4510628601594593,1.1680393686878985,0.2513863216266174,0.9168984052833379,1.0,8/15,27.16%,KMT2D;CXXC1;SETD4;SETD3;PRDM9;WDR5;KMT2C;KMT2B
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.40323314624407725,-1.1663616320638759,0.2302325581395349,0.6169885540320487,1.0,6/21,31.09%,GRIK2;CHRNA4;P2RX1;CHRNB2;CHRNA9;CHRNB4
prerank,5'-3' exonuclease activity (GO:0008409),0.4509824050395902,1.1652588752884934,0.25383304940374785,0.9179340863537744,1.0,6/14,19.62%,DXO;DCLRE1B;DCLRE1C;EXO1;DCLRE1A;EXOG
prerank,phospholipase inhibitor activity (GO:0004859),-0.4831941870191397,-1.1644343156833723,0.2766884531590414,0.6173032842492168,1.0,8/10,37.38%,ANXA4;ANXA2;SNCA;ANGPTL3;ANXA1;APOC1;ANXA5;SNCB
prerank,adrenergic receptor binding (GO:0031690),-0.42217267269788294,-1.1643680356884705,0.2650862068965517,0.6126435066454254,1.0,5/16,11.35%,MAGI2;PDE4D;RAPGEF2;ARRDC3;ADRA2A
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4938552904144319,1.1616528198685108,0.2888086642599278,0.9230832342793804,1.0,4/10,16.20%,DCLRE1B;DCLRE1C;EXO1;DCLRE1A
prerank,C2H2 zinc finger domain binding (GO:0070742),0.48715200335052344,1.1606858635596682,0.2808988764044944,0.917005429072988,1.0,3/11,7.35%,SRRM2;EHMT2;GATA2
prerank,GTPase activity (GO:0003924),-0.24989410884792304,-1.1602665844666664,0.11585365853658537,0.6191918350128619,1.0,40/192,13.93%,DNM3;RIT2;GFM2;LRRK2;SEPTIN9;RAB3C;GNAO1;TPPP;RND3;RAB6A;CDC42;GBP3;DNAJC27;SAR1B;RAB22A;RAN;DNM1L;RAB1B;RHOU;RAB5C;ATL2;RRAGB;GPN2;DNM1;GBP4;GFM1;RASL12;RAB3A;IRGM;TRIM23;EEF1A2;TBCC;RAB8A;RHOT2;AGAP3;RAB28;RERG;GBP2;GNAI1;IFT22
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4546954516383162,-1.1587523730629017,0.2729083665338645,0.618493347288395,1.0,8/12,37.99%,SLC2A2;SLC2A8;SLC2A4;MFSD4A;SLC2A3;SLC5A1;SLC2A1;SLC2A6
prerank,estrogen receptor binding (GO:0030331),0.36070411788342516,1.1558723738661831,0.24273504273504273,0.9262310043830555,1.0,8/32,10.70%,CNOT1;PRMT2;PHB2;TACC1;PADI2;PPID;MMS19;CCDC62
prerank,carboxy-lyase activity (GO:0016831),0.3979208540439224,1.15585196621634,0.2703180212014134,0.916835864062732,1.0,7/23,17.24%,PPCDC;GAD1;CSAD;FAHD1;BCKDHA;PCK2;UROD
prerank,single-stranded DNA binding (GO:0003697),0.3015520000790049,1.1558090005880366,0.20253164556962025,0.9077788680718782,1.0,29/93,20.66%,POLR2H;CTC1;WDR48;RNF138;REXO4;FAM111A;CRY2;POLR2D;SWSAP1;RAD51B;NUP35;POU4F1;PCBP2;DHX9;ERCC4;BLM;MCM2;TOP3A;FBH1;HMGB2;MCM3;APTX;MCMDC2;PARK7;SPRTN;RPA3;MAPT;NABP1;SSBP1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.3847878215738799,-1.1548966679569739,0.24193548387096775,0.6239488498662973,1.0,9/22,26.91%,HCN1;SCN2A;SCN3A;PKD2;CACNA1G;HCN2;SCN9A;HCN4;HCN3
prerank,single-stranded telomeric DNA binding (GO:0043047),0.478798469720384,1.1548226450764536,0.2923076923076923,0.9025377989751235,1.0,8/11,33.56%,CTC1;TERF1;HNRNPA2B1;HNRNPA1;RPA1;RPA2;STN1;TERF2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.343180512837188,-1.1493783457067959,0.24480369515011546,0.6334022295271925,1.0,9/33,14.27%,DCUN1D2;ZMYM2;RPS3;RNF19A;PRKN;SIAH2;RNF19B;UBE3D;DCUN1D3
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3071279411261261,1.1484452366028517,0.23289902280130292,0.9185025620154036,1.0,13/70,11.32%,HEXB;LARGE1;B3GNT2;MGAT4A;XXYLT1;HEXA;POMGNT1;RFNG;CHPF2;B3GNT4;GCNT2;GXYLT2;CHSY1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.44063193030170444,1.1484074613443676,0.2966252220248668,0.9096686117453758,1.0,9/14,33.54%,NME4;CMPK1;NME6;NME1;DTYMK;AK1;AK7;CMPK2;AK8
prerank,chemokine activity (GO:0008009),-0.35503838355380424,-1.1477354945189209,0.24263038548752835,0.6329312762772749,1.0,11/31,30.56%,CCL4;PF4;CCL2;CCL5;CX3CL1;CCL14;CCL7;CXCL16;CCL19;CCL8;CXCL9
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.436284877788877,-1.1467474156629092,0.27578947368421053,0.6307410609926984,1.0,5/13,17.53%,ERN1;PDGFD;VEGFD;IL1R1;PDGFA
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3478285369016041,-1.1443845788817786,0.2444933920704846,0.6322008417779416,1.0,13/33,24.85%,SCAF8;DRAP1;WAC;CDC73;GTF2B;CCAR2;UVSSA;ESRRB;SMYD2;SUPT4H1;AGO2;ZNF326;ELP2
prerank,leak channel activity (GO:0022840),-0.4033797518535468,-1.142673089270736,0.28699551569506726,0.6318724974236739,1.0,9/18,29.45%,KCNK10;NALCN;KCNK4;PANX1;KCNK5;KCNK12;KCNK2;RHAG;KCNK7
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.3112147280455098,-1.1406413396813775,0.24473684210526317,0.6325603082429015,1.0,10/49,12.87%,MCTP2;SYT1;ANXA4;CPNE8;SYT10;CPNE4;PCLO;ANXA2;MCTP1;DYSF
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.4627040110851902,1.140605784684284,0.3089887640449438,0.931955530475591,1.0,5/12,10.36%,ATM;PIK3CG;PIK3CB;PIK3CD;PIK3C3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3631542495418854,1.1377536295013935,0.28376068376068375,0.9343001745445779,1.0,9/34,13.36%,ADAP2;DAPP1;MYO1B;ARAP3;GAB2;CYTH3;FCHSD2;HIP1R;AKT1
prerank,ribonuclease activity (GO:0004540),0.3203243119894148,1.1353441979260752,0.2596491228070175,0.9350528828861137,1.0,20/56,24.49%,RNASE1;INTS11;DIS3L2;YBEY;PIWIL1;RCL1;RNASE6;KHNYN;EXOSC5;ZC3H12B;ZC3H12C;ELAC2;EXOSC10;EXOG;AGO1;TSNAX;RNASEH1;SND1;ZC3H12A;EXOSC8
prerank,dynactin binding (GO:0034452),-0.4467066880897708,-1.1345513268694594,0.3045356371490281,0.6448644045986452,1.0,5/12,18.91%,HTT;BICD1;GSK3B;BBS4;BICDL1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3597900855095005,1.1322098225208925,0.27615780445969124,0.9387874733580012,1.0,12/32,21.46%,PHYHD1;PHYH;EGLN1;TET3;KDM4A;JMJD7;KDM7A;KDM8;ALKBH5;TYW5;PHF8;KDM2A
prerank,monocarboxylic acid binding (GO:0033293),-0.3894297043857863,-1.131497792812582,0.2985781990521327,0.6484220365922105,1.0,11/18,36.76%,NAPEPLD;RARA;CYP26C1;NR1H4;UGT1A7;UGT1A4;UGT1A8;UGT1A1;AKR1C1;PSAP;CYP26B1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.24245996263186015,1.129802063737417,0.12779973649538867,0.939475596736966,1.0,97/431,18.58%,TGFBR1;TWF2;ABCD2;TUBA4A;DNM2;MYO1F;GUK1;MYO1B;RAC1;TRNT1;RND1;MAP4K4;TGM2;ABCF3;CHD8;TBCK;RHOH;UBA2;ARL5C;PFKL;AARS2;CARS2;RPS6KA5;KSR1;FICD;RHOBTB1;EIF4G1;TUBB;TUBB1;ARFIP2;TAP2;RND2;RHOQ;TUBG1;MKNK1;MAP4K3;RAB4A;NEK6;RRAS2;RHOB;RAB39A;TSSK6;TSSK4;ABCE1;PEX6;PDK2;CDK11B;GBP6;RAB35;WNK1;DHX9;TUBA1A;SMARCA5;NUAK2;RRAD;BLM;UHMK1;RAB27A;LATS2;NMUR2;ABL1;PRPS1L1;PRPS1;DIRAS2;MYH9;MARK2;PINK1;SCG5;CDC42BPB;MRAS;PXK;RRAGA;AKT1;DARS2;HSPA13;GBP5;ABCF1;SARS2;RPS6KA4;GNL1;GBP7;ARL11;NME1;RAB13;WNK2;MAP4K2;WNK3;P2RX5;MARK4;NDUFA13;NUDT16;MINK1;ABCD1;RAB9A;ABCA1;RAB32;TRIB1
prerank,Tat protein binding (GO:0030957),-0.468111582196959,-1.1282469908033865,0.31938325991189426,0.652774342016015,1.0,3/10,15.88%,MDFIC;ACTB;NPM1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.33233816569425056,1.1275546889352714,0.270979020979021,0.9396920393411168,1.0,13/46,15.17%,HEXB;LARGE1;B3GNT2;MGAT4A;HEXA;POMGNT1;RFNG;MGAT2;B3GNT4;GCNT2;MGAT1;MGAT5;GCNT1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.37576598276629997,1.1268394547001708,0.3021978021978022,0.9339088467142567,1.0,9/24,21.77%,CAMK1D;CAMKK1;MKNK1;PTK2B;EEF2K;PHKG2;CAMK1G;CAMK1;PHKA2
prerank,hydro-lyase activity (GO:0016836),0.33736260386441363,1.125211992481054,0.2667844522968198,0.9319523709747576,1.0,19/41,31.38%,TBXAS1;ECHS1;HACD3;FAHD2A;ECI1;ACO2;HADHB;ECHDC2;PARK7;APIP;NAXD;L3HYPDH;ECHDC3;PCBD2;TGDS;HSD17B4;IREB2;HACD2;ALAD
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.3890756913163824,1.1215233531097268,0.302491103202847,0.9379281839974202,1.0,7/22,15.01%,ATP2C1;ATP6V0B;ATP6V0A2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V0E2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4160741347934528,1.1202748064090393,0.29135338345864664,0.93456116386903,1.0,8/17,22.57%,PITPNC1;PCTP;ABCB4;PITPNM1;ABCA1;PITPNM2;MTTP;PITPNB
prerank,calcium channel activity (GO:0005262),-0.27516594544404765,-1.119169539762491,0.2442528735632184,0.6718088675065995,1.0,15/84,10.26%,CACNA1E;CACNA2D3;TRPC5;TRPC4;MCU;RYR2;CACNG2;SLC24A2;TRPC3;CACNA1C;PKD2;STIM2;OPRM1;CACHD1;ANXA2
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3600753388842428,-1.1156397814084136,0.29906542056074764,0.6771922371950693,1.0,8/25,23.90%,HIP1;LINGO1;CCDC88A;ERBB4;ATXN2;FAM83B;SNX2;FER
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.4265464061112584,1.114302588692088,0.31086142322097376,0.9494731595239838,1.0,1/15,0.03%,CX3CR1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4052978380137308,1.1106842210576822,0.30185497470489037,0.9553312601286478,1.0,4/20,11.98%,SLC30A5;SLC30A10;SLC30A8;SLC39A2
prerank,metalloendopeptidase activity (GO:0004222),-0.2748301942210324,-1.1034181616491612,0.2630272952853598,0.7062772167899901,1.0,19/76,15.90%,MMP16;MME;ADAMTS12;TRABD2B;ADAMTS17;THSD4;ADAMTS19;MMP15;ADAM33;MMP12;ADAMTSL5;ADAMTSL4;MMP14;MMP8;MMP19;ADAMTS10;ADAMTSL1;PHEX;ADAM19
prerank,snoRNA binding (GO:0030515),0.3552613583916858,1.1031125614589545,0.31876138433515483,0.9764439368899409,1.0,13/30,30.78%,UTP6;TBL3;IMP4;WDR3;NHP2;ISG20;NUDT16;BYSL;NOP14;HEATR1;NUDT16L1;NOP56;DHX37
prerank,P-type ion transporter activity (GO:0015662),-0.4354218966558876,-1.0992757173310534,0.33608247422680415,0.7128102586767303,1.0,4/12,11.08%,ATP2B1;ATP2A2;ATP7A;ATP2A3
prerank,lipoprotein particle receptor binding (GO:0070325),0.3650084553743165,1.0976231563058305,0.3174311926605505,0.9899445506322699,1.0,7/27,14.38%,AP2A1;PICALM;CLU;MESD;ANKRA2;LDLRAP1;LRP1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.4030987500281218,1.0973691242928933,0.33568904593639576,0.98241705177497,1.0,8/17,22.72%,THEM4;PLA2G6;PPT1;ABCD1;ACAA2;ACOT8;ACOT1;ACOT4
prerank,phospholipase A2 activity (GO:0004623),0.36326811242324153,1.0965789423757437,0.29636048526863085,0.9770784682128557,1.0,5/26,9.38%,PLA2G15;PLA2G6;PLA2G5;PLA2G4B;PLA2G4A
prerank,manganese ion binding (GO:0030145),0.32022165980016837,1.0959297591188863,0.30574324324324326,0.9713899540936537,1.0,14/48,17.93%,LARGE1;XXYLT1;PRIMPOL;POMGNT1;MGAT2;GALNT3;GALNT1;MGAT1;IMPA1;ABL1;MGAT5;PCK2;NUDT16;GALNT2
prerank,single-stranded DNA helicase activity (GO:0017116),0.3962442678768975,1.0955883252424805,0.34458259325044405,0.9645112228451267,1.0,9/19,28.71%,RFC2;CHTF18;DHX9;MCM2;DSCC1;MCM6;HELQ;MCM7;DNA2
prerank,insulin-like growth factor receptor binding (GO:0005159),0.4439293717218198,1.0952212441487454,0.3653483992467043,0.9580192765589556,1.0,2/12,3.22%,YWHAH;PIK3R1
prerank,motor activity (GO:0003774),-0.29169701328010006,-1.0949674967060632,0.3012658227848101,0.7199535146857144,1.0,27/60,23.99%,KIF5C;KIF1B;DYNC1I2;KIF23;KIF26B;KIF22;DNAH8;DNAH2;KIF14;KIF5B;CENPE;KIF11;KIF20A;DYNLRB1;DNAH3;KIF18B;MYO6;KIF6;APPBP2;DNAH17;KIF21A;KIF4A;KIF3C;KIF5A;KIFC1;KIF24;KIF2C
prerank,GTP binding (GO:0005525),0.26072119155504886,1.0925494674953304,0.2610062893081761,0.9605792799478288,1.0,45/172,21.96%,TUBA4A;DNM2;RAC1;RND1;TGM2;RHOH;ARL5C;RHOBTB1;TUBB;TUBB1;ARFIP2;RND2;RHOQ;TUBG1;RAB4A;RRAS2;RHOB;RAB39A;GBP6;RAB35;TUBA1A;RRAD;RAB27A;NMUR2;DIRAS2;SCG5;MRAS;RRAGA;GBP5;GNL1;GBP7;ARL11;NME1;RAB13;NUDT16;RAB9A;RAB32;RAC3;ARHGEF5;TUBB3;SEPHS1;ARF1;RHOC;PIP4K2B;ARL3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.40297214442270585,-1.0922218847252143,0.34623655913978496,0.7230816305438482,1.0,8/14,32.35%,SPOCK1;SPOCK3;TIMP3;COL4A3;BST2;TIMP4;RARRES1;NGF
prerank,neurexin family protein binding (GO:0042043),-0.44973520199536116,-1.0916736279111097,0.36637931034482757,0.7198915760844089,1.0,1/10,0.15%,NLGN1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4565590637199526,1.0904177396575607,0.3240556660039761,0.9607096884886072,1.0,5/11,23.97%,CFLAR;CASP1;PYCARD;CASP12;CASP2
prerank,four-way junction DNA binding (GO:0000400),0.40363444164836254,1.0902295285151677,0.33511586452762926,0.9536430341126279,1.0,7/17,21.42%,FANCM;RAD51B;BLM;ABL1;HMGB2;YY1;RAD51C
prerank,kinase activity (GO:0016301),0.2745034175770513,1.0901157722725177,0.30866141732283464,0.9464471270750452,1.0,37/109,22.41%,PI4KB;MAP4K4;CSNK2A1;LYN;DGKK;PANK4;PIK3CG;PIK3CB;CERK;GK5;CHKB;CKB;PIK3CD;PIK3C3;DGKD;PANK2;NADK2;ABL1;PAPSS1;MTOR;PSTK;PINK1;FCSK;AKT1;PRKD3;STK39;MASTL;IP6K1;TAF1;DCAKD;COQ8B;SHPK;PIK3CA;NADK;SEPHS1;CDC7;MVK
prerank,death receptor activity (GO:0005035),0.45692979163027336,1.0886177305267295,0.3702213279678068,0.9440932280742722,1.0,4/11,18.97%,TNFRSF25;EDA2R;TNFRSF19;TNFRSF14
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.46590484741287,1.0879529935367251,0.3412698412698413,0.9391745465421715,1.0,2/10,3.71%,CFLAR;CASP1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.3417538754807237,-1.0869559184749658,0.3125,0.7284782650227628,1.0,4/26,2.97%,B3GALT1;B3GALNT2;CHSY3;EXTL2
prerank,poly-purine tract binding (GO:0070717),-0.34241625929665453,-1.0869166451418335,0.32018561484918795,0.7236610386139568,1.0,6/27,8.08%,KHDRBS2;RBMS3;RBMS1;EIF4A3;PABPC1;ELAVL4
prerank,nucleotidyltransferase activity (GO:0016779),-0.37354278696683607,-1.0864007260112734,0.3450413223140496,0.7204122164028411,1.0,8/19,24.84%,CRPPA;PAPSS2;TUT4;TUT1;DNTT;TERT;TENT2;NUDT5
prerank,protein heterodimerization activity (GO:0046982),-0.23360778825724834,-1.0839200355507257,0.2515151515151515,0.7224125425782141,1.0,33/178,12.95%,HIP1;CYBB;KCNB2;TENM3;ADRA1A;TENM2;EXT1;GABBR2;SDCBP;NPAS3;TOP2A;YWHAE;VAPA;USF1;TAF7;NR4A2;RAN;MIGA1;PSMF1;BARD1;UBA3;ADCY8;MICU2;CYBA;FBXO7;TENM4;ERBB3;BAK1;ADRA2A;ATP1A1;PPP2R1A;AHR;EXT2
prerank,steroid hydroxylase activity (GO:0008395),0.407041172608158,1.0826566064294358,0.3466424682395644,0.9512560489136361,1.0,4/16,14.15%,CH25H;CYP46A1;CYP7B1;CYP2R1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.31292495606052323,-1.082348090709886,0.3170731707317073,0.7217639684648619,1.0,9/35,12.85%,MPPED2;PDE11A;APEX2;PLCXD2;PLCB4;NAPEPLD;ENPP2;GDPD1;GPCPD1
prerank,PDZ domain binding (GO:0030165),-0.2824608202814298,-1.0821352502884987,0.28967254408060455,0.7175190383151138,1.0,10/61,7.50%,NLGN1;GRID2;CCDC88C;GRIA1;KIDINS220;ATP2B1;PLEKHA1;RAPGEF2;PRKN;KIF14
prerank,magnesium ion binding (GO:0000287),-0.2428298915531482,-1.0811234957035947,0.2549019607843137,0.7155987388071915,1.0,46/135,25.08%,LRRK2;NLRC4;LATS1;ERN1;TPPP;PAPOLA;GSS;ADCY2;TOP2A;PPA1;SIK3;STK26;RAN;YDJC;EYA2;NUDT3;SIK1;PGM1;SRPK2;IDH2;TESC;SNCA;SRR;STK38L;GNAI1;FIGNL1;GEN1;MTHFD2;PDE2A;CDC42BPG;ABL2;BRSK1;ENDOV;CDC42BPA;NLK;PIF1;BRSK2;MSH6;GEM;DCTPP1;FEN1;NIM1K;IRAK3;NUDT5;MSH2;PLK1
prerank,ubiquitin-specific protease binding (GO:1990381),0.3887836418691933,1.0811219531774858,0.36983842010771995,0.9499371031799735,1.0,9/19,30.76%,SUMO1;BAG6;SART3;SYVN1;PARK7;RHBDD2;PTEN;SELENOS;CHMP3
prerank,protein kinase binding (GO:0019901),-0.21281664159316782,-1.0776641761243253,0.18442622950819673,0.7208267271397094,1.0,111/480,17.52%,PDLIM5;UNC5C;NEDD9;IQGAP1;FRMD5;ANK2;CNTLN;CADPS;BANK1;ATF2;GRK5;SYN1;GRM5;UTRN;POLA1;STAP1;BICD1;LATS1;RYR2;ATG13;SHC3;IRS1;SNAP91;RND3;PRKAG2;NBEA;TOP2A;AP2A2;PKIA;DUSP16;ACSL3;SIRT1;RPS3;CD226;CDC42;USF1;RACGAP1;RPS7;CCND2;CDK5RAP2;CSPG4;FAF1;CNKSR2;EXOC2;ACTB;GSK3B;PRKN;CALM1;SKAP1;SLC12A4;TPX2;KIF14;CCDC88A;MAPKAPK5;ZFP36;JAK2;DNM1;HINT1;BCAR1;TRAP1;PTPN2;ERCC6L2;FBXO7;LRBA;IRGM;SRCIN1;AXIN1;DUSP10;KIF11;PRC1;EEF1A2;MSN;SMCR8;SIK1;ADRA2A;MAP3K13;TPRKB;RARA;KIF20A;THY1;DNAJC3;ARHGAP33;RELA;CDH5;FAM83D;CACUL1;KCNQ1;CDKN2A;RGCC;RCC2;INKA2;NR3C1;SPAG9;DACT2;BECN1;CDKN1A;NEFH;NPM1;MAPKAPK2;PIH1D1;TFRC;CDC25C;LAX1;FAM83B;RICTOR;ADD2;FAM83H;TEX14;PPP1R12A;CD3E;ACVRL1
prerank,AMP binding (GO:0016208),-0.4371493913294896,-1.076813626550734,0.3600867678958785,0.7186164652932521,1.0,5/11,18.14%,MPPED2;PRKAG2;PFKM;APRT;PFKP
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.3680863109401213,-1.0758806827751466,0.350561797752809,0.716569634630664,1.0,12/19,33.20%,NRG3;GRM5;ERCC6;ERBB3;CCL5;EFNA5;GHRL;ANGPT4;ABI1;NRG1;ALKAL2;DGKQ
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.3512113371861033,1.0758088064303293,0.3504132231404959,0.962801973919931,1.0,6/30,11.98%,SLC30A5;SLC30A10;SLC40A1;SLC25A37;SLC30A8;SLC39A2
prerank,G protein-coupled receptor activity (GO:0004930),-0.22431037550467844,-1.0745364584345474,0.23333333333333334,0.7157075297768785,1.0,89/239,32.23%,GRM8;ADGRE5;ADGRB3;ADGRL3;GRM5;GPR176;GRM1;ADRA1A;GPR141;ADGRG6;HRH1;GABBR1;GABBR2;RORB;GPR35;GPR45;P2RY1;S1PR5;PTAFR;OPRM1;LGR4;OPRD1;GPR173;HCRTR2;GALR1;GPR161;ADRA2A;LGR5;FFAR1;NPFFR2;XPR1;GPR171;ADGRG5;GPR174;TSHR;LPAR4;LPAR2;FFAR4;LANCL1;APLNR;RXFP2;FPR3;NTSR1;CNR2;ADCYAP1R1;ADGRL4;GPR65;RRH;AVPR2;ADGRL2;S1PR2;MC4R;LPAR3;P2RY10;FPR2;GPR83;GPR15;NPR3;ADRA1B;PTH1R;PAX8;CXCR6;TM2D1;CELSR2;S1PR4;GPR156;OXTR;ADGRG4;MC2R;NMUR1;OPN1MW;OPN1MW3;OPN5;GPR151;CRHR2;OPN4;AVPR1A;BDKRB1;ADGRD1;GPR143;CYSLTR2;DRD1;LGR6;GPR12;GPR3;FPR1;TAS1R3;AGTR1;ADRA2C
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.39174685094330175,1.0743949330666844,0.34944237918215615,0.9605111657980798,1.0,4/18,12.35%,RPS6KA1;CD27;XIAP;DPEP1
prerank,cytokine receptor activity (GO:0004896),0.28367730102505007,1.0738697325913973,0.3168,0.9550007810316794,1.0,19/83,17.48%,CX3CR1;CSF3R;IL1RL2;IL6R;EBI3;IL6ST;IL12RB2;IL12B;IFNGR2;IL10RA;GFRA4;IL1RL1;IL10RB;IL1R2;GHR;IL7R;IL20RA;CCR5;IL4R
prerank,kinase activator activity (GO:0019209),0.34327217311213665,1.071506277911178,0.3609022556390977,0.9564676774125741,1.0,7/30,12.27%,FGF13;NCKAP1L;STRADA;GPRC5A;RPTOR;WNK1;MARK2
prerank,chemorepellent activity (GO:0045499),-0.3439306579568566,-1.0699630637095556,0.3556581986143187,0.7237790544313059,1.0,5/25,7.91%,NRG3;DPP4;SEMA5A;SEMA4A;SEMA6D
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.28300524955957784,-1.0698231807068657,0.3333333333333333,0.719638573691239,1.0,12/55,11.08%,ITPR1;TRPC5;MCU;RYR2;ATP2B1;SLC24A2;ATP2A2;TRPC3;PKD2;TMEM165;ANXA2;ATP2A3
prerank,microtubule plus-end binding (GO:0051010),0.38116005761852445,1.0694174470348685,0.37105751391465674,0.9571660497479135,1.0,10/20,32.51%,DST;NUMA1;MAPRE1;CLIP3;TTBK2;CLASP1;CLIP2;KIF18A;MAPRE2;MAPRE3
prerank,protein tyrosine kinase binding (GO:1990782),0.2879686870567813,1.0684260883705479,0.3372093023255814,0.9540533913546345,1.0,13/71,14.13%,DOCK4;BLNK;SIRPA;RNF41;PCNA;FIZ1;PTPN1;CEACAM1;TJP2;PTPN11;KHDRBS1;PITPNM1;ACP4
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.3089364787190196,1.0653540962922596,0.35423728813559324,0.9584577439443559,1.0,10/48,11.35%,CALHM2;SLC12A6;TRPV2;TRPM6;MCOLN1;ABCC9;TRPM2;TRPM4;TRPV4;CALHM5
prerank,sodium channel regulator activity (GO:0017080),0.32346965311423526,1.0650847153437428,0.35334476843910806,0.9523728776951534,1.0,5/37,4.86%,SNTA1;FGF13;YWHAH;FXYD1;SCN4B
prerank,phospholipase binding (GO:0043274),0.42572885726986215,1.062384252437444,0.39750445632798576,0.9554817889098752,1.0,4/13,7.30%,BLNK;SRC;PDPK1;SELE
prerank,ion gated channel activity (GO:0022839),-0.34109119331190296,-1.0622602223972586,0.3555045871559633,0.7363819531305312,1.0,6/24,13.02%,KCNT2;TMEM63C;ANO3;ANO10;ANO6;ANO5
prerank,rRNA binding (GO:0019843),-0.30038677241355327,-1.0616148966551262,0.32281553398058255,0.7336614066176267,1.0,18/42,27.32%,MRPL18;RPS3;RPS14;MRPS7;TST;MRPL16;PPAN;ERI1;MDM2;CAVIN1;RPLP0;RPS9;RRS1;RPL23;RPS5;MRPS6;CIRBP;UTP23
prerank,ATP binding (GO:0005524),0.23808684907154729,1.0605561987213254,0.2937771345875543,0.9549603100659975,1.0,61/266,18.58%,TGFBR1;TWF2;ABCD2;MYO1F;GUK1;MYO1B;TRNT1;MAP4K4;ABCF3;CHD8;TBCK;UBA2;PFKL;AARS2;CARS2;RPS6KA5;KSR1;FICD;EIF4G1;TAP2;MKNK1;MAP4K3;NEK6;TSSK6;TSSK4;ABCE1;PEX6;PDK2;CDK11B;WNK1;DHX9;SMARCA5;NUAK2;BLM;UHMK1;LATS2;ABL1;PRPS1L1;PRPS1;MYH9;MARK2;PINK1;CDC42BPB;PXK;AKT1;DARS2;HSPA13;ABCF1;SARS2;RPS6KA4;NME1;WNK2;MAP4K2;WNK3;P2RX5;MARK4;NDUFA13;MINK1;ABCD1;ABCA1;TRIB1
prerank,phospholipid transfer activity (GO:0120014),0.37041730811906304,1.059582666590107,0.3903345724907063,0.9517647732133937,1.0,9/21,25.11%,PITPNC1;CPTP;C2CD2L;PITPNM1;PRELID2;PITPNM2;MTTP;PITPNB;PRELID3A
prerank,NAD+ binding (GO:0070403),0.42971220248505726,1.0594289923837013,0.3963302752293578,0.9455159195976166,1.0,3/12,10.49%,SIRT2;HPGD;CRYL1
prerank,mRNA methyltransferase activity (GO:0008174),0.4295059538893242,1.0573204811019035,0.3996316758747698,0.94648477289831,1.0,5/12,21.58%,RNMT;METTL14;PCIF1;TRMT61A;METTL8
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.22140637441820493,-1.054862454958796,0.28771929824561404,0.7482491616924707,1.0,52/248,15.68%,DNM3;RIT2;GFM2;LRRK2;SEPTIN9;RAB3C;ATP2B1;GNAO1;TPPP;RND3;RAB6A;ATAD1;CDC42;GBP3;DNAJC27;SAR1B;RAB22A;RAN;DNM1L;TOR1A;RAB1B;CLPX;RHOU;RAB5C;VWA8;ATL2;RRAGB;KIF14;GPN2;DNM1;GBP4;GFM1;RASL12;RAB3A;IRGM;TRIM23;EEF1A2;TBCC;RAB8A;RHOT2;AGAP3;RAB28;RERG;GBP2;KIF18B;MYO6;GNAI1;IFT22;HSPA1B;ATL3;ABCA4;HBS1L
prerank,retinoic acid binding (GO:0001972),-0.4123338891276945,-1.0543208062354994,0.365296803652968,0.7451013124893312,1.0,6/12,25.95%,RARA;CYP26C1;UGT1A7;UGT1A4;UGT1A8;UGT1A1
prerank,pentosyltransferase activity (GO:0016763),0.3254505995166679,1.0542949264291213,0.3685121107266436,0.9508355732768686,1.0,8/36,15.27%,LARGE1;QTRT1;ART4;SIRT2;UPP1;PNP;PARP8;QTRT2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.4389040129900665,1.0541196693881,0.39552238805970147,0.9447870982428235,1.0,5/11,17.53%,NAA11;NAA25;NAA40;NAA20;NAA50
prerank,peptidase inhibitor activity (GO:0030414),0.32760702442375284,1.053790066350942,0.36777583187390545,0.939436077508282,1.0,6/33,14.03%,CST3;UCHL5;PROS1;SLPI;SIMC1;SPINT2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3976605678568526,-1.052453960743768,0.3760869565217391,0.7457861166769221,1.0,6/14,23.85%,SLC25A30;SLC26A7;SLC26A2;SLC26A3;SLC26A4;SLC26A8
prerank,mRNA 5'-UTR binding (GO:0048027),-0.34476349852809746,-1.052419539773081,0.3922413793103448,0.7413334248724709,1.0,12/24,27.79%,RPS7;RPL41;RPS14;RPL26;SHMT1;SYNCRIP;MYH10;SHMT2;LARP6;FMR1;UTP23;GNL3
prerank,sulfotransferase activity (GO:0008146),0.3271600408237118,1.048717741917601,0.3642611683848797,0.9508121405897946,1.0,9/33,18.60%,GAL3ST4;TPST2;CHST1;SULT2A1;CHST7;CHST11;CHST2;CHST15;CHST8
prerank,voltage-gated calcium channel activity (GO:0005245),-0.31082979246302644,-1.0473967768269121,0.3432098765432099,0.7511200727674107,1.0,12/37,21.86%,CACNA1E;CACNA2D3;CACNG2;CACNA1C;PKD2;OPRM1;CACHD1;CACNA1G;CACNB3;CACNA2D1;TMC1;CACNA1B
prerank,iron ion binding (GO:0005506),0.30816560945921206,1.047248272482104,0.41408934707903783,0.9493954680574271,1.0,16/48,21.06%,AGMO;FECH;PHYH;EGLN1;ISCU;JMJD6;ABCE1;KDM3A;ACO2;DNAJC24;CYP2R1;KDM7A;SCD;TYW5;PHF8;DOHH
prerank,kinesin binding (GO:0019894),-0.3298852603643013,-1.0464364078656134,0.37104072398190047,0.7491728364477944,1.0,9/27,15.88%,KIF1B;TOR1A;ACTB;PRC1;SNCA;KIF18B;FAM83D;SPAG9;NEFH
prerank,alkali metal ion binding (GO:0031420),0.4235693504627935,1.0461636699139814,0.4052532833020638,0.9468505953752754,1.0,3/13,13.59%,CAPN3;IMPA1;ADPRH
prerank,diacylglycerol kinase activity (GO:0004143),-0.41024929770931395,-1.0460444304749437,0.40997830802603036,0.7458292735827959,1.0,3/11,10.11%,DGKB;DGKI;DGKH
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.44528790910449056,1.0441760064045007,0.43087971274685816,0.9476048083280159,1.0,7/10,27.63%,KDM4A;KDM7A;KDM8;PHF8;KDM2A;KDM2B;KDM4B
prerank,histone deacetylase activity (GO:0004407),0.37482139502251843,1.0426108123927242,0.40852575488454707,0.9467212658906139,1.0,6/19,19.13%,HDAC10;SIRT2;SUDS3;HDAC8;MIER3;HDAC5
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.40587459689028726,1.0412321211660371,0.39893617021276595,0.9451746963309278,1.0,5/14,17.28%,QDPR;CRYM;MTHFD1;ALDH4A1;PYCR1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.24525527122258672,1.0409387864642268,0.35014836795252224,0.9399648970672957,1.0,49/188,22.83%,ETV5;SMAD3;NFE2L2;ETS1;FLI1;BASP1;DDIT3;MEF2C;ZNF568;KMT2D;ELK1;PAX6;CALCOCO1;CREB3L2;ATMIN;CRY2;TFE3;BCOR;KLF11;CHD3;FOXK2;SOX17;BRCA1;SMARCA2;DHX9;PAX2;PROX1;CARM1;RUNX1;KDM5A;HMGB2;TAL1;GATA3;BNC2;DMTF1;EGR1;TCF7L2;POU2F2;HDAC5;JUN;XRCC6;PRDM9;NFYA;TFAP4;YY1;TP53;ZBTB48;ZBTB14;TBL1XR1
prerank,phospholipase C activity (GO:0004629),-0.3362084050707672,-1.0405006808112163,0.37445887445887444,0.7572401874197828,1.0,8/25,15.19%,PLCB1;PLCH1;CCR1;CHRM3;PLCB4;PLCD4;PLCH2;CCL5
prerank,transcription coactivator binding (GO:0001223),0.36524569209203644,1.03847566755024,0.40834845735027225,0.9425201557329095,1.0,3/20,3.50%,SMAD3;PPARD;CDK9
prerank,sterol binding (GO:0032934),0.2908725533210269,1.0382275696432994,0.3771331058020478,0.9371628044866903,1.0,15/56,24.63%,GRAMD1A;OSBPL11;OSBPL3;NPC2;NPC1;OSBPL5;TSPO;VDAC1;SCAP;PTCH1;ABCA1;OSBP;SCP2;ERLIN2;INSIG2
prerank,androgen receptor binding (GO:0050681),0.3540756979262922,1.0362363092443572,0.3931034482758621,0.9380924466338663,1.0,10/25,26.64%,TGFB1I1;DDX5;PRMT2;KDM3A;PRKCB;PARK7;KDM1A;SMARCA4;PKN1;EP300
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.4098738044217162,-1.0359701700785284,0.43283582089552236,0.7657308136007807,1.0,3/11,22.14%,PPP1R14C;PABIR1;PPP1R17
prerank,nuclease activity (GO:0004518),0.30300213331215237,1.035771502941906,0.3776595744680851,0.9336735480022945,1.0,18/52,29.48%,RNASE1;REXO5;REXO4;DIS3L2;RNASE6;ISG20L2;EXO1;ISG20;NME1;NTHL1;EXOG;RNASEH1;SND1;ZC3H12A;PARN;DFFB;DNA2;DDX1
prerank,retinoid X receptor binding (GO:0046965),-0.42648616190929334,-1.035093187425817,0.41509433962264153,0.7639642258124484,1.0,4/11,13.62%,PPARG;NR4A2;RARG;NSD1
prerank,DNA polymerase activity (GO:0034061),-0.3445475908263065,-1.0338767281596297,0.4172494172494173,0.7629533451259826,1.0,10/22,27.34%,POLA1;POLL;POLE2;POLD3;POLG;TERT;POLB;POLD1;POLH;POLQ
prerank,aspartic-type peptidase activity (GO:0070001),0.4460056834797077,1.0325307119866745,0.42745098039215684,0.9386183155552087,1.0,2/10,11.16%,CTSD;CTSE
prerank,protease binding (GO:0002020),0.2647722196723221,1.0325172138049734,0.3980891719745223,0.9327415960294423,1.0,17/99,14.23%,BIN1;CST3;SUMO1;CRADD;BAG6;CFLAR;ITGAV;RIPK2;RFFL;NFRKB;SART3;UBC;BFAR;ADAMTS4;PINK1;ANXA9;INSL3
prerank,ubiquitin protein ligase binding (GO:0031625),0.23572799393120436,1.0314040856861495,0.38705035971223023,0.9306045266963462,1.0,66/254,22.92%,SUMO1;SMAD3;SMAD7;HERC2;FHIT;BAG6;ARRB2;CHEK2;PRKACA;SKI;TRAF5;SNCAIP;UCHL1;RFFL;USP25;HLTF;TUBB;CLU;NEK6;CUL4B;ASB4;LAPTM4B;ARRDC1;RNF8;CKB;BRCA1;DTX1;UBC;RPS27A;ANKRA2;KDM4A;AUP1;PATZ1;PCBP2;MID1;BAG4;PINK1;RNF31;RRAGA;DET1;LRPPRC;TSG101;UBXN7;SYT11;DBT;TNK2;SPOPL;UBE2A;TMBIM6;RNF20;TRIB1;TNFRSF14;JUN;SLF2;HIF1A;AXIN2;SPART;MFN2;FZD6;CUL4A;TP53;STUB1;ARRB1;NPLOC4;TRAF6;CUL1
prerank,neuropeptide receptor binding (GO:0071855),-0.38412297862710987,-1.0304621920823702,0.39072847682119205,0.7679617664700596,1.0,6/14,32.29%,NTS;APLN;AGRP;GAL;NPPA;GHRH
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.4131712255079395,-1.0279061773582303,0.41014799154334036,0.7708982161976383,1.0,2/11,11.57%,EGFR;MAP3K13
prerank,growth factor receptor binding (GO:0070851),-0.24993946063040545,-1.027683901226794,0.40336134453781514,0.7672156460819052,1.0,30/95,25.62%,HIP1;FGF10;LINGO1;ERN1;SDCBP;TRIP6;PDGFD;CD300LF;VEGFD;CCDC88A;JAK2;FGF9;ERBB4;FGF7;ATXN2;VEGFC;IL1R1;FAM83B;PDGFA;IL27RA;FGF5;FYN;TSLP;FGF22;KL;SNX2;IL2;FER;IL1RAP;FGF16
prerank,ferrous iron binding (GO:0008198),0.35780252628985965,1.0272924940631234,0.4154676258992806,0.9382810182332672,1.0,4/21,5.21%,FECH;PHYH;EGLN1;ISCU
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.23661780951305325,1.0267500850154259,0.3802612481857765,0.9343174422692582,1.0,76/232,28.24%,HERC2;RNF38;RNF216;TRIM11;RNF41;ITCH;RNF138;TRIM5;SMURF1;RFFL;NEURL1B;NEURL3;HLTF;DTX4;TRIM44;TRIM72;TRIM69;RNF8;DTX1;WWP2;RNF166;BFAR;MSL2;TRIM62;XIAP;UHRF2;AREL1;PIAS2;RNF11;PIAS3;DTX3L;ANAPC11;PELI2;MYLIP;RNF25;FBXL22;MKRN3;RNF187;MGRN1;RNF144B;TRIM3;ZNRF3;TOPORS;TRIM14;RNF121;SYVN1;RNFT2;RNF2;DTX3;RING1;TRIM39;RNF180;UBE3A;STUB1;TRAF6;NFX1;ZNRF1;UBE3C;MEFV;RNF111;RNF13;FBXO2;RNF157;RNF34;LTN1;PIAS4;GID4;BIRC2;RNF181;FBXO17;RBX1;RNF5;CBL;RFWD3;BIRC3;RC3H2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.38407810168852263,1.0258669909407785,0.40036563071297987,0.9315189812752709,1.0,2/16,7.18%,BCO2;ALOXE3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.2331850733214418,1.024517211631644,0.3977110157367668,0.9302076908372066,1.0,69/269,22.92%,SUMO1;SMAD3;SMAD7;HERC2;FHIT;BAG6;ARRB2;CHEK2;PRKACA;SKI;TRAF5;ITCH;SNCAIP;UCHL1;RFFL;USP25;HLTF;TUBB;CLU;NEK6;CUL4B;ASB4;LAPTM4B;ARRDC1;RNF8;CKB;BRCA1;DTX1;UBC;RPS27A;ANKRA2;KDM4A;AUP1;PATZ1;PCBP2;MID1;BAG4;PINK1;DTX3L;RNF31;RRAGA;DET1;LRPPRC;TSG101;UBXN7;SYT11;DBT;TNK2;SPOPL;UBE2A;TMBIM6;RNF20;TRIB1;TNFRSF14;JUN;SLF2;HIF1A;AXIN2;SPART;MFN2;FZD6;CUL4A;TP53;STUB1;HGS;ARRB1;NPLOC4;TRAF6;CUL1
prerank,acetylcholine receptor activity (GO:0015464),0.35429196882231406,1.021088586235459,0.42435424354243545,0.9361434596979867,1.0,4/22,13.27%,CHRM1;CHRNB3;ANXA9;CHRNA3
prerank,protein homodimerization activity (GO:0042803),-0.19781407074316493,-1.0200879499683106,0.35960591133004927,0.7845173169878762,1.0,123/590,17.53%,HIP1;DPYD;ZBTB16;TENM3;XDH;LRRK2;NLRC4;ABCB7;CPQ;PTPRT;MKLN1;SLIT2;DPP4;KCNN2;LILRB1;TENM2;APOE;LRRFIP1;SLK;ERN1;B2M;TPPP;GSS;MTUS2;NTRK2;MME;EXT1;CENPF;CACYBP;CRPPA;TOP2A;EEA1;PEX11A;CEBPB;MID2;ZBTB7B;STK26;USF1;GBP3;S100A11;DNM1L;MIGA1;PSMF1;SYNE1;BARD1;JAML;IKZF3;SYNDIG1;TAP1;TRIM37;SLC8B1;ADCY8;CCDC88A;PKD2;LRP6;MFF;GGCT;TPD52L1;KCNH2;MTHFD1L;NAGA;ERBB4;XPNPEP3;XPA;NECTIN1;GBP4;CEBPA;INPP5F;TENM4;HMGCS1;AXIN1;HSP90AB1;GNPTG;DROSHA;ATG7;PPCS;BAK1;ADRA2A;MAP3K13;MTCL1;NDP;GLIPR2;CR2;SNX9;TESC;RELA;AHR;EXT2;GYG1;GBP2;SRR;JCHAIN;KIT;GEN1;TFAP2B;ACHE;SHMT1;FOXP2;PDE2A;RBPMS2;PDLIM4;MTMR1;CCL5;BANF1;TIMM10;GLA;BCL2;NPM1;TFRC;MVD;PECAM1;TARBP2;HMOX1;FLNA;S100A1;ADD2;CADM3;ALDH3A2;SERPINF2;SRF;CAT;WDR54;PDGFA
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.3111823597835092,1.0191308202795712,0.426497277676951,0.9370396263894815,1.0,18/40,28.61%,DNMT3A;PRMT8;COMT;ASMT;ARMT1;GAMT;FBL;SETD3;HNMT;METTL8;RRP8;ICMT;METTL4;METTL2A;METTL2B;CARNMT1;LRTOMT;PEMT
prerank,adenyl nucleotide binding (GO:0030554),0.43093547087772976,1.0187990834257303,0.43493761140819964,0.9269443283321464,1.0,5/11,23.78%,HSPH1;BAG4;GRPEL1;SIL1;BAG5
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.43093547087772976,1.0187990834257303,0.43493761140819964,0.9269443283321464,1.0,5/11,23.78%,HSPH1;BAG4;GRPEL1;SIL1;BAG5
prerank,alanine transmembrane transporter activity (GO:0022858),0.41103972950551326,1.0174174981148552,0.42723880597014924,0.9259123727129935,1.0,2/12,3.11%,SLC7A8;SLC36A1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3176531964408983,1.017351178614946,0.4493006993006993,0.9206128314037589,1.0,8/34,17.71%,CNOT1;DIS3L2;PAN3;REXO2;EXOSC5;ISG20;ERI3;EXOSC10
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.24678159873272465,-1.015728366221273,0.4301675977653631,0.7922736483004513,1.0,16/91,10.64%,HIP1;PLCB1;CLVS2;FRMPD4;GSN;SNAP91;SNX14;SDCBP;KCNH1;SESTD1;STXBP6;MYO1G;PLEKHA5;ACTN2;ANXA2;VILL
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3371378743163243,1.0141138634605888,0.44283121597096187,0.9256018505467802,1.0,8/27,20.06%,PRIMPOL;POLR2D;POLR2J;POLR3H;POLR1D;POLR1C;POLR2E;POLR2I
prerank,pyrophosphatase activity (GO:0016462),0.29245593418056826,1.0131484211457882,0.4276094276094276,0.9232056176791877,1.0,14/50,19.57%,DXO;TRPM2;ENTPD1;NUDT15;DCPS;NUDT14;DHX9;PLPP1;BNIP2;ENTPD7;ATCAY;NUDT16;ENTPD6;DHX29
prerank,chloride channel regulator activity (GO:0017081),0.40350804103963805,1.012494846585961,0.42908438061041293,0.9199727373404856,1.0,6/14,28.11%,STX1A;WNK1;WNK2;WNK3;STX8;STX7
prerank,transition metal ion binding (GO:0046914),0.2212311393853384,1.0124037877567271,0.43157894736842106,0.914925563427687,1.0,94/397,20.32%,LARGE1;ARHGEF2;SLC30A5;SMAD3;AGMO;XXYLT1;SKI;PRIMPOL;HDAC10;SIRT2;PLSCR3;ATAD3A;PITRM1;LOXL3;PLA2G15;SNRPC;ISCU;JMJD6;ZMYND11;KDM5B;POMGNT1;SHH;TAB2;CHD3;ACER3;MGAT2;SLC30A8;ZBTB32;PAPPA2;ABCE1;TET3;KDM3A;CXXC5;RNF8;PTPN1;GALNT3;SORD;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;KDM4A;MT2A;MDM4;RNPEP;ZEB1;BLM;LIMS1;GALNT1;SOD1;HPF1;MGAT1;IMPA1;UBA5;ABL1;ACO2;RNF11;PRDM2;DPEP1;MBD1;RBSN;CCS;DNAJC24;CYP2R1;SLU7;MGAT5;EPRS1;ZNF3;KDM5A;CHMP1A;KDM7A;SCD;PCK2;EGR1;TRAF7;DUSP12;BAZ1B;SAP30L;NUDT16;GALNT2;THAP1;NOS1;CZIB;TES;ZFPL1;RNF2;PARK7;TYW5;ERAP1;PHF8
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4258351157106567,1.0118460198345667,0.4418604651162791,0.9113817931610377,1.0,7/10,35.27%,OTUD5;STAMBPL1;CYLD;STAMBP;OTUD4;DESI2;TNFAIP3
prerank,ubiquitin protein ligase activity (GO:0061630),0.23212810224718738,1.01136791796889,0.42368045649072755,0.9076844580205983,1.0,74/228,28.24%,HERC2;RNF38;RNF216;TRIM11;RNF41;ITCH;RNF138;TRIM5;SMURF1;RFFL;NEURL1B;NEURL3;HLTF;DTX4;TRIM44;TRIM72;TRIM69;RNF8;DTX1;WWP2;RNF166;BFAR;MSL2;TRIM62;XIAP;UHRF2;AREL1;RNF11;DTX3L;ANAPC11;PELI2;MYLIP;RNF25;FBXL22;MKRN3;RNF187;MGRN1;RNF144B;TRIM3;ZNRF3;TOPORS;TRIM14;RNF121;SYVN1;RNFT2;RNF2;DTX3;RING1;UBE4A;TRIM39;RNF180;UBE3A;STUB1;TRAF6;NFX1;ZNRF1;UBE3C;MEFV;RNF111;RNF13;FBXO2;RNF157;RNF34;LTN1;GID4;BIRC2;RNF181;FBXO17;RBX1;RNF5;CBL;RFWD3;BIRC3;RC3H2
prerank,RNA binding (GO:0003723),0.20322875523044928,1.0088381521963063,0.4434389140271493,0.9107202418286147,1.0,339/1321,22.88%,SRRM1;SNRNP70;UTP6;TLR7;CCDC59;TWF2;FBRSL1;SUMO1;SON;PRPF38B;GDI2;ADAT1;AKAP8;FAM98B;WDR46;TRNT1;CEBPZ;DSP;SRRT;SECISBP2;CSNK1E;NCBP1;XPOT;QKI;PNISR;DDX5;CNOT1;TRMT6;RBM18;POP1;EIF4A2;HNRNPDL;ETF1;RBM19;SNRPA;CELF2;UBFD1;ZCCHC3;EMG1;BUD23;CSTF2;PRKRIP1;AKAP8L;MRPS24;AARS2;AATF;DXO;SSB;TBL3;UCHL5;THUMPD1;STXBP1;NTPCR;HNRNPA3;MOV10;REXO4;FSCN1;SLPI;HLTF;SF3B2;SF3B1;KARS1;CCDC124;ATXN2L;HNRNPC;SNRPC;EIF4G1;ZCCHC9;NUP42;POLR2D;ZFP36L1;EIF2S1;EIF2A;GANAB;MRPL43;SNRPF;JMJD6;EWSR1;SRSF5;TNPO1;FUS;RNMT;SLTM;MACF1;DHX38;SRRM2;PABPN1;MRPL2;MRPL37;CHD3;SRP72;KRR1;RBM14;ZFP36L2;ILF2;MRPL9;TOP3B;SRP9;DUT;NSUN5;TIAL1;NANOS2;PKP3;PIWIL1;PTRH1;RPL15;ANP32A;RRBP1;SART3;EIF4H;G3BP1;NIP7;BRCA1;PTPN1;U2AF2;HNRNPH1;UBC;RPS27A;ESRP1;MTDH;CDK11B;ZRANB2;DDX17;PRMT1;PCBP2;RPP21;USP36;DHX9;HNRNPR;BOP1;MRPS5;KHDRBS1;CSDC2;MRPS21;LUC7L3;ISG20L2;CFAP20;IMP4;KHNYN;RPS27L;RBM39;CHCHD1;SNRPA1;DUSP11;BAG4;MRPL13;PDIA3;NSUN6;KCTD12;HADHB;MYH9;EIF2S2;CNBP;TRA2B;MARK2;IGF2BP2;CCT3;PSTK;SLC4A1AP;SHFL;ZC3H12B;ZC3H12C;HNRNPUL2;ERH;SLC25A11;ROCK2;LUC7L;ALYREF;RBM8A;R3HDM2;GCN1;DARS2;SNUPN;NELFE;METTL14;PES1;BRIX1;MRPS11;FTSJ3;TRMT2A;EIF2AK2;MAPRE1;MKRN3;HSD17B10;EPRS1;LRPPRC;C1D;LRP1;WDR3;MTIF2;PDIA4;FARSA;ABCF1;TRMT10B;SARS2;SARS1;CCAR1;NOM1;PDCD11;NHP2;HMGB2;EIF3D;MAP4;ELAC2;DUS3L;DDX39B;UBTF;DAZAP1;IBA57;EIF1B;RPS24;NME1;ZCCHC7;SRP14;CAPRIN1;SAFB;DDX43;RTCB;NSRP1;FASTKD3;RSRC2;PSMC1;TNRC6B;NDUFV3;RPL39;TRA2A;NQO1;ERI3;DCP1B;SRSF9;PCF11;SF3A1;NEMF;SREK1;BUD13;TDRD7;C1QBP;SAFB2;DHX30;LARP1;ALKBH5;APTX;CLK3;RPL28;EIF5;EXOSC10;PRRC2B;METAP2;NUDT16;RBMX;PRPF3;ELP1;PCDH20;SBDS;MRPL11;RBM34;ZNFX1;LSM7;FBL;API5;FIP1L1;CRKL;DDX46;SNIP1;RPL10;NANOS1;PNN;WBP4;ACAA2;MYEF2;MPHOSPH10;WDR6;GNL3L;MRPL54;MEX3A;MRPL41;HDLBP;TRMT1L;DDX19B;JUN;ANXA7;TES;MRPS28;MRPS35;BYSL;DHX29;PARK7;GTPBP1;TYW5;XRCC6;MAPT;AIMP1;DDX54;RPS8;TUFM;NOVA2;DDX56;DEK;MTO1;AGO1;NGRN;TFB1M;SSBP1;POLR1G;NVL;CPEB2;ARF1;XPO5;TASOR;YY1;SYF2;NGDN;TARDBP;MYO18A;PLEC;RBM25;TSNAX;DDX27;HNRNPH3;RBM4;HNRNPUL1;DDX3X;FASTKD2;RRP8;KDM1A;SNRNP40;PCBP4;LSM8;DDX47;DAP3;CCDC9B;RRP12;HNRNPA2B1;EIF3G;MAGOHB;MAGOH;RNASEH1;PPP1CC;RPL7
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.4105183146110128,-1.0052803595996742,0.47109207708779444,0.8175778141529069,1.0,4/11,24.23%,HCN1;HCN2;AQP1;HCN4
prerank,actin monomer binding (GO:0003785),0.348725592817918,1.0034204497309567,0.44346289752650175,0.9233723800727702,1.0,5/22,13.27%,TWF2;ABITRAM;MYL3;ABL1;PFN4
prerank,hormone activity (GO:0005179),0.28562762046015944,1.0030078358171255,0.44594594594594594,0.9194946721882783,1.0,9/54,14.41%,HCRT;GNRH1;INHA;EDN3;EDN2;PPY;NPFF;VIP;NMB
prerank,chloride channel inhibitor activity (GO:0019869),0.43882011722161846,1.002497872750674,0.4838095238095238,0.9157782299587349,1.0,6/10,28.11%,STX1A;WNK1;WNK2;WNK3;STX8;STX7
prerank,endopeptidase regulator activity (GO:0061135),0.300735926870513,1.0021707696666269,0.43493761140819964,0.9116390444741387,1.0,5/40,4.27%,CST3;VSIR;UCHL5;PROS1;SLPI
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.27066423406615514,1.0016538675325501,0.459546925566343,0.9081997723060228,1.0,12/72,11.33%,ADAP2;TWF2;MYO1B;FLII;SNX18;PICALM;AVIL;CGAS;RAB35;PLEKHA4;HIP1R;LDLRAP1
prerank,acetylation-dependent protein binding (GO:0140033),0.3569305096039302,1.0011608472671683,0.4548872180451128,0.8997336642484695,1.0,11/20,32.43%,BRD9;CARM1;DPF2;BRD3;PSME4;TAF1;SMARCA4;BRD7;ZMYND8;TRIM24;KMT2A
prerank,lysine-acetylated histone binding (GO:0070577),0.3569305096039302,1.0011608472671683,0.4548872180451128,0.8997336642484695,1.0,11/20,32.43%,BRD9;CARM1;DPF2;BRD3;PSME4;TAF1;SMARCA4;BRD7;ZMYND8;TRIM24;KMT2A
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.37525119703458726,-1.0006069488737948,0.4407894736842105,0.8265561750281848,1.0,6/14,17.92%,KCNJ3;KCND3;KCNH2;KCNQ1;KCNIP2;KCNE3
prerank,snRNA binding (GO:0017069),0.2997310502902552,0.9974909523070962,0.4423728813559322,0.9061326783190332,1.0,15/42,26.13%,SNRNP70;SNRPA;CDK9;SNRPC;COIL;SART3;SNRPA1;ISG20;DDX39B;LSM7;PRPF4;LSM8;RBM7;SF3B3;PRPF31
prerank,histone methyltransferase activity (GO:0042054),0.3179626958471571,0.9966506108971703,0.4716981132075472,0.9038940220428548,1.0,13/32,22.38%,PRMT2;EHMT2;PRMT8;PRMT1;EED;SETD2;PRMT6;CARM1;EZH2;FBL;PRDM9;SMYD1;SUZ12
prerank,neuropeptide hormone activity (GO:0005184),0.3487132652226026,0.995012546731488,0.45293072824156305,0.9042504756983968,1.0,5/22,14.41%,HCRT;PPY;NPFF;VIP;NMB
prerank,solute:proton symporter activity (GO:0015295),0.36824894729319224,0.9946501867087391,0.45136186770428016,0.900504582035194,1.0,4/16,17.03%,SLC36A1;SLC15A4;SLC15A2;CTNS
prerank,poly-pyrimidine tract binding (GO:0008187),0.34278948784519864,0.9942724045484942,0.4614003590664273,0.8970231248627354,1.0,6/23,10.86%,SSB;HNRNPC;DIS3L2;U2AF2;HNRNPH1;KHDRBS1
prerank,transcription cis-regulatory region binding (GO:0000976),-0.19768602446016603,-0.9935982330383624,0.47844827586206895,0.8425274742564054,1.0,112/406,22.60%,TRPS1;ATF2;PPARG;NFYB;SUV39H1;CIITA;FOXP1;TFDP2;SOX5;NPAS3;PURG;RFX3;CEBPB;ZBTB7B;RPS3;DACH1;SOX11;TAF7;DRAP1;MYC;CDK5RAP2;HDAC4;HOXC8;PEG3;SP3;PRDM5;XRN2;ZNF177;ZBTB20;NFIL3;E2F6;KCNH2;PER2;NFE2;ERBB4;CTCF;TCF7;SOX13;XRCC5;FOSL2;THRA;BBX;CEBPA;CREB3L1;GABPB2;GABPB1;MMP12;POLRMT;FOXK1;KLF10;PSPC1;PER1;E2F7;RARA;PRDM16;AEBP1;PBX1;SALL2;KLF4;RELA;SNCA;AHR;ATF1;PLAGL1;TFAP2B;ZNF35;NR3C1;HDAC1;ESRRB;SCX;NPM1;ZBTB22;NCOR1;FOXC2;HMGB1;SNAI2;VEZF1;TCF24;NR1H4;NR2C2;NKX2-2;ZNF25;TFDP1;ZFP3;LHX5;RFX5;SUV39H2;ZBTB8A;HOXD8;ZBTB46;ZBTB10;GLI3;TIPARP;E2F1;FOXC1;PURB;SOX10;REST;LEF1;ZBTB5;STOX1;CREB3;ZNF436;CREM;RBL1;TBX21;FOXN1;SCRT2;GBX1;SOX12;LHX2;MSX1
prerank,ion channel inhibitor activity (GO:0008200),-0.2933783890801953,-0.9919850884091973,0.46064814814814814,0.8426832316471723,1.0,5/35,7.72%,ITPR1;KCNMB2;NEDD4L;CALM1;MCUB
prerank,histone demethylase activity (GO:0032452),0.3301154985281284,0.9915343478840001,0.44673539518900346,0.9006495493846813,1.0,12/27,22.29%,JMJD6;KDM5B;UTY;KDM3A;KDM4A;KDM5A;KDM7A;KDM8;HR;PHF8;KDM2A;KDM1A
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4185953835020791,-0.9906986858152937,0.4810924369747899,0.8417463639893016,1.0,2/10,5.07%,SHISA6;SHANK3
prerank,C-C chemokine receptor activity (GO:0016493),0.3494559165944485,0.9906337169296092,0.4981751824817518,0.8985904512389652,1.0,2/21,7.55%,CX3CR1;CCR7
prerank,active ion transmembrane transporter activity (GO:0022853),0.30643969017837674,0.9904524140049771,0.4664429530201342,0.8943471297553127,1.0,4/37,8.10%,SLCO2B1;COX8A;COX7A2L;SLC22A6
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.28111077173090077,0.9893651999092307,0.47952218430034127,0.8928968554312283,1.0,12/53,19.70%,SLC7A8;SLC1A3;SLC36A1;SLC15A4;SLC7A5;SLC22A2;SLC17A8;SLC6A9;CTNS;SLC38A7;SLC38A1;SLC7A7
prerank,ribosome binding (GO:0043022),0.2853632600013197,0.9887991614473107,0.46563573883161513,0.8898541387762433,1.0,16/46,24.75%,BAG6;GTPBP6;ETF1;EIF2S1;EIF2A;SRP72;SHFL;SEC61A1;MAIP1;C1QBP;SBDS;EFL1;CPEB2;ZC3H12A;OXA1L;YTHDF3
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3963483982694961,0.9865140069243075,0.4681647940074906,0.8919573440142946,1.0,5/12,29.05%,CNOT1;PAN3;PARN;CNOT2;CNOT6L
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.40618841064503014,-0.9860399783651597,0.4636363636363636,0.8514631765588434,1.0,2/11,2.89%,SGMS1;SGMS2
prerank,carbohydrate kinase activity (GO:0019200),0.41156127332027426,0.9859294468954799,0.4782608695652174,0.8890683290628523,1.0,7/11,27.19%,HK2;GNE;KHK;XYLB;HK3;GALK1;NAGK
prerank,protein tyrosine kinase activity (GO:0004713),0.2504139041629802,0.9859073377105003,0.49169435215946844,0.8846212438863712,1.0,24/108,17.94%,MERTK;CSF1R;CLK1;SRC;LYN;IGF1R;CSK;MET;RYK;EPHA8;PTK2B;CAMKK2;PKDCC;MUSK;AXL;ABL1;BMX;TYK2;FES;DDR2;DYRK1A;TNK2;BAZ1B;TEC
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.35811526902110735,0.9802391948529757,0.5146804835924007,0.8967923176881472,1.0,10/17,33.54%,NME4;CMPK1;NME6;NME1;DTYMK;AK1;CLP1;AK7;CMPK2;AK8
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.2988445717137372,-0.9796200080087575,0.4908675799086758,0.8660235599166409,1.0,12/33,24.85%,SCAF8;WAC;CDC73;GTF2B;CCAR2;UVSSA;ESRRB;SMYD2;SUPT4H1;AGO2;ZNF326;ELP2
prerank,chemokine receptor binding (GO:0042379),0.31192450615313905,0.9794181010685018,0.5070921985815603,0.8948451678649528,1.0,3/35,8.27%,CX3CR1;ITCH;CXCL1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2507097275164482,0.9783916658396794,0.4885145482388974,0.8933880562352216,1.0,32/100,23.42%,ADAP2;ZFYVE26;DAPP1;MYO1B;ARFIP1;ARAP3;GAB2;SNX22;ARFIP2;CYTH3;LAPTM4B;RLBP1;PLA2G4A;FCHSD2;PLEKHA4;HIP1R;OSBPL5;AKT1;DENND1C;SNX3;SAP30L;GAP43;WDR45B;MAPT;SH3PXD2B;KIF16B;OSBP;ZFYVE16;ANKFY1;GOLPH3L;SNX13;ATG2A
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3931566980467428,0.9768130718905588,0.4805914972273567,0.8936573535265943,1.0,4/12,19.34%,CASP1;RPS27L;APAF1;PYCARD
prerank,hexosyltransferase activity (GO:0016758),0.24561456833853368,0.9762701883199791,0.49390243902439024,0.8907091237255982,1.0,15/101,8.19%,HEXB;LARGE1;B3GNT2;MGAT4A;DPY19L4;ALG12;PIGV;HEXA;ALG6;POMGNT1;RFNG;CHPF2;POMT1;B3GNT4;FUT7
prerank,purinergic nucleotide receptor activity (GO:0001614),0.37090090088010685,0.9756508527251788,0.47802197802197804,0.8880899842340411,1.0,2/15,4.98%,P2RY12;GPR34
prerank,platelet-derived growth factor binding (GO:0048407),-0.39303627161916643,-0.9750671815105383,0.451271186440678,0.8743949008834666,1.0,4/11,17.53%,COL4A1;COL1A1;COL5A1;PDGFA
prerank,Hsp90 protein binding (GO:0051879),0.3056445744827946,0.9744689277101318,0.4966996699669967,0.8874544820324243,1.0,10/33,22.13%,CSNK2A1;PPID;USP19;HDAC8;NOD2;MAPT;TELO2;HIF1A;CHORDC1;STUB1
prerank,guanyl ribonucleotide binding (GO:0032561),0.22685785054007146,0.9739205646185771,0.5248868778280543,0.884611510512737,1.0,36/196,15.97%,TUBA4A;DNM2;RAC1;RND1;TGM2;RHOH;ARL5C;RHOBTB1;CNGB3;TUBB;TUBB1;ARFIP2;RND2;RHOQ;TUBG1;RAB4A;RRAS2;RHOB;RAB39A;GBP6;RAB35;TUBA1A;RRAD;RAB27A;NMUR2;DIRAS2;SCG5;MRAS;RRAGA;SLC19A1;GBP5;GNL1;GBP7;ARL11;NME1;RAB13
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2321967332425466,0.9725373352526874,0.5198170731707317,0.8843125973990394,1.0,51/173,23.10%,ZFHX3;HEYL;SKI;ZFP90;PPARD;ERF;DEAF1;GTF2IRD1;ZBTB21;ZBTB18;MLX;ELK3;KLF12;FOXK2;OVOL2;BCL6B;ZBTB32;HOXD9;NR2F1;PRDM1;E4F1;PATZ1;ZEB1;SKIL;PRDM2;MXD1;IRF8;PROX1;MXI1;ZBTB39;ZNF3;KCNIP3;GATA3;ZNF692;GZF1;THAP1;TCF3;JUN;BATF3;FOXP4;ZBTB45;IRX1;MNT;YY1;ZFP37;SCRT1;ZBTB2;ZBTB14;MITF;NFX1;OTP
prerank,frizzled binding (GO:0005109),-0.2927876393966458,-0.972160754765831,0.5207373271889401,0.878424306003341,1.0,11/34,22.50%,CCDC88C;SDCBP;WNT4;LRP6;NDP;WNT9A;SFRP1;BAMBI;WNT7A;WNT6;WNT8B
prerank,nuclear receptor binding (GO:0016922),0.24522179989058163,0.9695596824334136,0.5229357798165137,0.8884812040706841,1.0,32/111,22.29%,SMAD3;BRD8;YWHAH;TGFB1I1;DDX5;CNOT1;PRMT2;PHB2;TACC1;PADI2;PPID;MMS19;KDM3A;SMARCD3;CCDC62;PRKCB;PROX1;ARID1A;MED4;NRIP1;TAF1;TCF7L2;NCOA3;TAF10;MED25;MED12;PARK7;DDX54;HIF1A;NCOA2;STAT5B;KDM1A
prerank,death domain binding (GO:0070513),0.401624078467344,0.9688517166480269,0.5138121546961326,0.88628639202598,1.0,2/11,4.52%,CRADD;TRADD
prerank,mRNA binding (GO:0003729),0.22002577914085855,0.9680047766644919,0.5446808510638298,0.8845363187887321,1.0,85/249,25.46%,SNRNP70;SECISBP2;NCBP1;QKI;DDX5;ETF1;CELF2;CSTF2;DXO;SSB;SLPI;SF3B1;HNRNPC;EIF4G1;ZFP36L1;EIF2A;SRSF5;SRRM2;RBM14;NANOS2;PIWIL1;RBM24;G3BP1;ESRP1;PCBP2;DHX9;HNRNPR;KHDRBS1;CSDC2;LUC7L3;KHNYN;MRPL13;EIF2S2;CNBP;TRA2B;IGF2BP2;SLC4A1AP;SHFL;ZC3H12B;ZC3H12C;LUC7L;RBM8A;METTL14;MRPS11;EIF3D;DAZAP1;NSRP1;DCP1B;PCF11;TYMS;TDRD7;C1QBP;LARP1;NUDT16;RBMX;RNF20;SNIP1;NANOS1;MYEF2;HDLBP;BOLL;PARK7;NOVA2;CPEB2;XPO5;TARDBP;RBM25;TP53;CCT5;RBM4;DDX3X;PCBP4;HNRNPA2B1;RPL7;ZC3H11A;PUM1;PTBP3;ZC3H12A;RPS13;YTHDF3;ELAVL1;SRBD1;UNK;DDX6;PARN
prerank,SH3 domain binding (GO:0017124),-0.2536516749544372,-0.9678068097437371,0.533498759305211,0.8871973639757231,1.0,13/62,10.45%,PTPN12;CBLB;PTPN22;SGIP1;ABI2;SHANK3;CNTNAP1;PRKN;SKAP1;ADAM12;CYBA;ENAH;REPS1
prerank,sterol transfer activity (GO:0120015),0.35447628978164103,0.9659978239247607,0.4891304347826087,0.8860748455175063,1.0,5/17,22.52%,GRAMD1A;NPC2;ABCA1;OSBP;MTTP
prerank,GABA receptor binding (GO:0050811),0.3963164193131525,0.965754240314256,0.5211538461538462,0.8825372918615884,1.0,3/11,9.57%,TRAK1;PLCL2;AKAP5
prerank,enoyl-CoA hydratase activity (GO:0004300),0.40908365675046143,0.9656274237909865,0.4959677419354839,0.878728761060708,1.0,4/10,13.96%,ECHS1;ECI1;HADHB;ECHDC2
prerank,histone acetyltransferase binding (GO:0035035),0.3326684808362912,0.9652530979285007,0.5280289330922242,0.8756748736294601,1.0,8/21,22.01%,SIRT2;PAX6;PCNA;MEF2A;EGR1;HIF1A;EID1;TP53
prerank,N-methyltransferase activity (GO:0008170),0.34236416536535685,0.9649364119675011,0.5081669691470054,0.8724859087612041,1.0,7/20,20.65%,METTL5;RNMT;PRMT1;TRMT1L;SETD3;HNMT;TFB1M
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3266761446475989,-0.9634533845572321,0.5,0.8954817926509806,1.0,9/21,27.34%,POLA1;POLL;POLE2;POLD3;POLG;POLB;POLD1;POLH;POLQ
prerank,gated channel activity (GO:0022836),0.3722413241936256,0.9616761494536555,0.46332737030411447,0.8775747593764048,1.0,6/14,24.47%,TMEM63A;PIEZO1;PACC1;TMEM63B;TMC4;TMC6
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.2683573848130978,0.9616239672813507,0.5234782608695652,0.8736893989743452,1.0,9/60,10.63%,MERTK;TGFBR2;CSF1R;IGF1R;MET;RYK;EPHA8;MUSK;AXL
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.32293181485129124,0.9594967133405381,0.515625,0.8755852348447476,1.0,6/25,18.66%,CH25H;CYP46A1;NOS2;AKR1D1;FMO5;NOS1
prerank,adenylyltransferase activity (GO:0070566),-0.31905202886392797,-0.9589735305836499,0.5241935483870968,0.9037900619804189,1.0,3/21,2.92%,GPHN;OAS2;PAPOLA
prerank,phosphatidylinositol binding (GO:0035091),0.25119461804550913,0.9584593955078917,0.5295081967213114,0.8744773298224252,1.0,31/91,23.24%,ITPR2;PITPNC1;NUMA1;SNX22;PICALM;PIGK;C2CD2L;PARD3B;APPL1;SNX31;HIP1R;SNX5;MYO1E;DPEP1;PITPNM1;SCARB1;PASK;DENND1C;FES;GRAMD2A;GAP43;PIGU;MAPT;PITPNM2;EXOC8;FCHO2;ZFYVE16;PITPNB;ANKFY1;SNX13;APPL2
prerank,MHC protein binding (GO:0042287),-0.32684735884608385,-0.9578654975918662,0.5176991150442478,0.9021682128763724,1.0,3/20,6.56%,CD74;LILRB1;TAP1
prerank,histone deacetylase binding (GO:0042826),0.24989668418849725,0.9566892817132284,0.5288461538461539,0.8755648064230163,1.0,14/88,11.81%,AKAP8;MEF2C;MTA1;HDAC10;MEF2D;SIRT2;SUDS3;AKAP8L;BCOR;PRDM1;ANKRA2;BRMS1L;TOP2B;MEF2A
prerank,calcium-release channel activity (GO:0015278),-0.34446898737121906,-0.9551207685923775,0.5243619489559165,0.9054705264626306,1.0,5/17,12.35%,ITPR1;RYR2;RYR3;PKD2;MCOLN3
prerank,chemoattractant activity (GO:0042056),-0.3010554174883098,-0.9549849981419102,0.5345622119815668,0.9010664957638118,1.0,8/26,18.10%,FGF10;VEGFD;FGF7;CCL5;VEGFC;CX3CL1;HMGB1;BMP4
prerank,phosphatidic acid binding (GO:0070300),-0.3248517848007274,-0.9546553873298598,0.5011037527593819,0.8973575288496963,1.0,3/19,4.15%,RAPGEF2;PLTP;SESTD1
prerank,exopeptidase activity (GO:0008238),-0.2654796241381541,-0.9538645291256188,0.5470737913486005,0.8950075434634144,1.0,8/50,9.42%,DPP6;DPP10;NPEPPS;DPP4;MME;TRHDE;XPNPEP3;ENPEP
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3453425410003716,0.953595636321142,0.5249537892791127,0.8798570115815586,1.0,6/18,27.09%,PIK3R1;SOCS6;WDR81;PIK3R5;SOCS3;PIK3R3
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.19911334599102148,0.9524347546045844,0.6542617046818727,0.8790618814511469,1.0,159/731,22.69%,SALL1;ZFHX3;IKZF1;MLXIPL;ZSCAN26;RREB1;SMAD3;NFE2L2;SALL3;DNMT3A;BACH2;LYL1;ETS1;HEYL;SOX8;UBP1;DDIT3;MEF2C;MTA1;SKI;FOXJ2;MLXIP;PPARD;HIVEP3;MEF2D;ZNF568;ELK1;GTF2IRD1;PAX6;CALCOCO1;HBP1;KLF3;ZBTB18;ZIM3;MLX;MYCL;ELK3;NFATC1;ZBTB24;TFE3;MEIS3;FOXN3;KLF11;FOXE1;ZNF569;KLF12;RXRB;FOXK2;ZSCAN21;PKNOX1;TAL2;OVOL2;GATA2;HOXA6;BCL6B;BHLHE22;ZBTB32;PAX1;FOXO6;DMRTB1;SOX17;NEUROD6;NEUROD4;UTY;POU4F1;HOXD9;MYNN;NR2F1;PRDM1;E4F1;TBX6;ZNF367;PATZ1;DHX9;ARNT;SMAD9;ZEB1;E2F2;NFE2L1;NRF1;ZNF83;SKIL;MEF2A;MXD1;OLIG2;SP9;IRF8;PAX2;PROX1;IRF3;CEBPG;MXI1;ZBTB39;RUNX1;TEF;SARS1;CCAR1;HMGB2;PROX2;ZFP62;HES6;SAFB;KCNIP3;POU2F1;NR1H2;TAL1;ZSCAN22;NRIP1;GATA3;ZKSCAN1;ZNF692;DMTF1;EGR1;E2F3;ZNF585B;ZNF585A;RBMX;ZSCAN12;MGA;ZNF394;TCF7L2;TCF4;GZF1;POU2F2;THAP1;CEBPD;HDAC5;ZNF260;TCF7L1;TCF3;NFIA;JUN;IRF5;IRF2;BATF3;FOXP4;ZNF740;ZBTB45;NFYA;IRF9;HIF1A;IRX1;NFIX;TFAP4;MNT;YY1;TGIF2;TEAD3;SCRT1;ZNF76;TP53;ZBTB48;STAT5B;ZBTB2;MSC;ZBTB14;ZNF628;MITF;HOXB5
prerank,calcium activated cation channel activity (GO:0005227),-0.3368196296357052,-0.951908942592886,0.5216450216450217,0.896054756687707,1.0,6/17,13.16%,KCNN2;KCNMB2;TMEM63C;ANO10;ANO6;KCNMB4
prerank,death receptor binding (GO:0005123),-0.35086300758533256,-0.9515362740405257,0.5185185185185185,0.8926771331570885,1.0,3/15,10.88%,BDNF;EDA;BID
prerank,organic anion transmembrane transporter activity (GO:0008514),0.233843920620699,0.9506089155547918,0.5850556438791733,0.8802010702872094,1.0,21/134,14.88%,SLCO2B1;SLC7A8;SLC1A3;SLC25A42;SLC25A25;SLC36A1;SLC15A4;SLC52A3;SLC7A5;SLC22A6;SLC17A8;SLC35A1;SLC52A1;LRRC8A;SLC17A9;SLC19A1;MPC1;SLC6A9;GJA1;SLC16A7;SLC35B4
prerank,sialyltransferase activity (GO:0008373),-0.3194793678162928,-0.9468478316086624,0.5213483146067416,0.9016081617915632,1.0,6/20,11.62%,ST3GAL1;ST3GAL4;ST8SIA4;ST8SIA2;ST8SIA1;ST6GALNAC2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.2909374359050214,-0.9457013736448128,0.5413533834586466,0.900432593940252,1.0,10/28,21.48%,MAPK10;LRRK2;PAK3;MAPKAPK5;AURKB;TTK;RPS6KA2;SBK2;MAP2K6;MAP2K5
prerank,RNA cap binding (GO:0000339),0.35402454966391494,0.9441815340264048,0.5276292335115864,0.8940768887826235,1.0,6/16,17.55%,NCBP1;DCPS;SNUPN;CYFIP1;EIF3D;LARP1
prerank,ADP binding (GO:0043531),-0.30025744701007884,-0.9435567127924714,0.5317286652078774,0.9021226539560664,1.0,8/25,21.24%,ERN1;PRKAG2;TAP1;MYO6;ME1;ACTA1;MYH10;MSH6
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.19750977731240682,0.9431841946558595,0.6807228915662651,0.8929570309853305,1.0,159/730,22.69%,SALL1;ZFHX3;IKZF1;MLXIPL;ZSCAN26;RREB1;SMAD3;NFE2L2;SALL3;DNMT3A;BACH2;LYL1;ETS1;HEYL;SOX8;UBP1;DDIT3;MEF2C;MTA1;SKI;FOXJ2;MLXIP;PPARD;HIVEP3;MEF2D;ZNF568;ELK1;GTF2IRD1;PAX6;CALCOCO1;CREB3L2;HBP1;KLF3;ZBTB18;ZIM3;MLX;MYCL;ELK3;NFATC1;ZBTB24;TFE3;MEIS3;KLF11;FOXE1;ZNF569;KLF12;RXRB;FOXK2;ZSCAN21;PKNOX1;TAL2;OVOL2;GATA2;HOXA6;BCL6B;BHLHE22;ZBTB32;PAX1;FOXO6;DMRTB1;SOX17;NEUROD6;NEUROD4;UTY;POU4F1;HOXD9;MYNN;NR2F1;PRDM1;E4F1;TBX6;ZNF367;PATZ1;DHX9;ARNT;SMAD9;ZEB1;E2F2;NFE2L1;NRF1;ZNF83;SKIL;MEF2A;MXD1;OLIG2;SP9;IRF8;PAX2;PROX1;IRF3;CEBPG;MXI1;ZBTB39;RUNX1;TEF;SARS1;CCAR1;PROX2;ZFP62;HES6;SAFB;KCNIP3;POU2F1;NR1H2;TAL1;ZSCAN22;NRIP1;GATA3;ZKSCAN1;ZNF692;DMTF1;EGR1;E2F3;ZNF585B;ZNF585A;RBMX;ZSCAN12;MGA;ZNF394;TCF7L2;TCF4;GZF1;POU2F2;THAP1;CEBPD;HDAC5;ZNF260;TCF7L1;TCF3;NFIA;JUN;IRF5;IRF2;BATF3;FOXP4;ZNF740;ZBTB45;NFYA;IRF9;HIF1A;IRX1;NFIX;TWIST1;TFAP4;MNT;YY1;TGIF2;TEAD3;SCRT1;ZNF76;TP53;ZBTB48;STAT5B;ZBTB2;MSC;ZBTB14;ZNF628;MITF;HOXB5
prerank,DNA-binding transcription factor binding (GO:0140297),0.22330390517481497,0.9428997319828494,0.6187683284457478,0.889777854388144,1.0,29/189,12.11%,SMAD3;NFE2L2;DDIT3;MEF2C;MTA1;SKI;PPARD;RBL2;MEF2D;ELK1;NFATC1;NBN;FIZ1;NEK6;TLE6;ANKRD2;CXXC5;BBS2;SIN3A;WWP2;TBX6;MTDH;CRTC1;MAP3K10;DHX9;MEF2A;PIAS2;GTF2I;PIAS3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.24848416911151633,0.9352039092879086,0.5827922077922078,0.9059920704346892,1.0,20/75,23.71%,HSD3B2;HPGD;SORD;IMPDH1;CRYL1;HADHB;DHRS4;KCNAB3;HSD17B10;PTGR1;KCNAB1;LDHAL6B;LDHA;NSDHL;CBR1;ME2;AKR1B10;GLYR1;SPR;RDH11
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.38893274279939316,-0.9328285949054027,0.547085201793722,0.927632454629127,1.0,1/10,1.83%,DPYSL5
prerank,methyltransferase activity (GO:0008168),0.2759980554767415,0.9327080496149055,0.5611390284757118,0.9087008049664457,1.0,11/46,16.01%,BUD23;MGMT;PRMT8;COMT;ASMT;PRMT1;ARMT1;BCDIN3D;FTSJ3;NSUN3;GAMT
prerank,growth factor activity (GO:0008083),0.2522897793287623,0.9316765707117772,0.600326264274062,0.9073947351539803,1.0,12/74,12.48%,OSGIN2;VEGFB;ARTN;JAG2;INHA;CNTF;PDGFB;AMBN;IL12B;CXCL1;OSGIN1;CSPG5
prerank,adenyl ribonucleotide binding (GO:0032559),0.2070282494523231,0.9301259106800146,0.6624649859943977,0.9075493991972393,1.0,66/291,19.48%,TGFBR1;TWF2;ABCD2;MYO1F;GUK1;MYO1B;TRNT1;MAP4K4;ABCF3;CHD8;TBCK;UBA2;PFKL;AARS2;CARS2;RPS6KA5;KSR1;FICD;EIF4G1;TAP2;MKNK1;MAP4K3;NEK6;TSSK6;TSSK4;ABCE1;PEX6;PDK2;CDK11B;WNK1;DHX9;SMARCA5;NUAK2;BLM;UHMK1;LATS2;ABL1;PRPS1L1;PRPS1;MYH9;MARK2;PINK1;CDC42BPB;PXK;AKT1;SLC19A1;DARS2;HSPA13;GCLC;ABCF1;SARS2;RPS6KA4;NME1;WNK2;MAP4K2;WNK3;P2RX5;MARK4;NDUFA13;MINK1;ABCD1;ABCA1;TRIB1;ACSS2;PEX1;ATP5F1D
prerank,C-C chemokine binding (GO:0019957),0.32495165664975506,0.9294302831446042,0.5612431444241316,0.9055062243702134,1.0,2/22,7.55%,CX3CR1;CCR7
prerank,symporter activity (GO:0015293),-0.3948201869033559,-0.9291294267559117,0.5398230088495575,0.9338113435371934,1.0,4/10,23.81%,SLC28A2;MFSD2A;SLC5A6;SLC5A5
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.3549211742643986,-0.9286465051310119,0.5444915254237288,0.9305118638737119,1.0,4/13,17.13%,ALDH1L1;ALDH9A1;ALDH2;ALDH3A2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.24649338226586634,0.9284191651080396,0.6098726114649682,0.9041552552341007,1.0,17/74,15.12%,HK2;PI4KB;DGKK;PANK4;PIK3CG;PIK3CB;GK5;CHKB;PIK3CD;PIK3C3;DGKD;PANK2;NADK2;PAPSS1;FCSK;GNE;KHK
prerank,semaphorin receptor binding (GO:0030215),-0.3042098408201282,-0.9275920663420986,0.5369127516778524,0.9288349224149267,1.0,7/23,17.21%,RIT2;SEMA5A;SEMA4A;SEMA6D;PLXNB1;SEMA6A;SEMA7A
prerank,mechanosensitive ion channel activity (GO:0008381),0.37656433393374816,0.9272890899295044,0.5294117647058824,0.9033603505203879,1.0,5/12,24.47%,TMEM63A;PIEZO1;TMEM63B;TMC4;TMC6
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3932488009266948,0.9254954117930867,0.536178107606679,0.9039135044421834,1.0,4/10,17.53%,NAA11;NAA25;NAA20;NAA50
prerank,receptor ligand activity (GO:0048018),0.21126618219719479,0.9250675144496278,0.6571834992887624,0.9010267710567497,1.0,34/245,14.41%,IL18;GREM1;SLURP1;SEMA3B;OSGIN2;SEMA4C;VEGFB;ARTN;GNRH1;SHH;WNT2B;JAG2;INHA;EDN3;WNT10B;CNTF;PDGFB;AMBN;LEFTY1;EDN2;IL12B;CTF1;CXCL1;IL33;WNT7B;TNFSF13B;OSGIN1;SEMA4D;CSPG5;SEMA4G;PPY;VIP;GPNMB;NMB
prerank,titin binding (GO:0031432),0.3682084396817168,0.9235963230243773,0.5738317757009346,0.9010595487170646,1.0,4/13,18.96%,CAPN3;MYBPC1;CALM2;ANKRD23
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3836352781023507,0.9234268430991138,0.5658153241650294,0.8976744258813918,1.0,4/11,28.98%,SLC25A45;SLC25A20;SLC25A29;SLC25A47
prerank,neuropeptide binding (GO:0042923),-0.3215716828424885,-0.9232841989512173,0.5607064017660044,0.9364177290107509,1.0,5/18,30.46%,OPRM1;OPRD1;MC4R;SORL1;NMUR1
prerank,neuropeptide receptor activity (GO:0008188),-0.28298377317343426,-0.9218204372259813,0.6033653846153846,0.9357780178703305,1.0,4/29,11.05%,SORCS1;OPRM1;HCRTR2;GALR1
prerank,LRR domain binding (GO:0030275),0.3614845869722427,0.9212217130851849,0.5850860420650096,0.8995140992819143,1.0,3/14,6.76%,DDIT3;AATF;POLR2J
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.26296879980004095,-0.9208839776810381,0.6022727272727273,0.9338576337423148,1.0,14/38,31.57%,SPOCK1;APP;SERPING1;ANXA2;SERPINI1;SERPINH1;SERPINF2;TFPI2;SERPINB2;SERPINE3;SERPINB5;HRG;SERPINA10;WFDC3
prerank,inward rectifier potassium channel activity (GO:0005242),-0.2972281632795086,-0.9206587232288092,0.5808656036446469,0.9300803503643911,1.0,4/24,8.48%,KCNN2;KCNJ3;KCNH2;KCNJ6
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.30618278031154594,0.9202933297263937,0.5636672325976231,0.8980230521188717,1.0,4/27,10.06%,SLC9A9;SLC9A8;SLC8A1;CNNM4
prerank,zinc ion binding (GO:0008270),0.2071578176658393,0.9198189618397685,0.6896551724137931,0.8954222584190489,1.0,60/293,17.39%,ARHGEF2;SLC30A5;SMAD3;SKI;PRIMPOL;HDAC10;SIRT2;ATAD3A;PITRM1;PLA2G15;SNRPC;ZMYND11;KDM5B;SHH;TAB2;CHD3;ACER3;SLC30A8;ZBTB32;PAPPA2;TET3;CXXC5;RNF8;PTPN1;SORD;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;KDM4A;MT2A;MDM4;RNPEP;ZEB1;BLM;LIMS1;SOD1;HPF1;UBA5;RNF11;PRDM2;DPEP1;MBD1;RBSN;DNAJC24;SLU7;EPRS1;ZNF3;KDM5A;CHMP1A;KDM7A;EGR1;TRAF7;DUSP12;BAZ1B;SAP30L
prerank,mannosyltransferase activity (GO:0000030),0.3174960548441301,0.919650718557029,0.5719557195571956,0.8920943344480177,1.0,6/21,16.54%,DPY19L4;ALG12;PIGV;POMT1;ALG2;ALG8
prerank,pseudouridine synthase activity (GO:0009982),-0.3632733576679384,-0.9195706413346858,0.5812356979405034,0.9285844441943255,1.0,6/13,32.46%,TRUB2;RPUSD1;PUS1;RPUSD3;RPUSD4;RPUSD2
prerank,ephrin receptor activity (GO:0005003),-0.322909450095459,-0.9190276986225491,0.579520697167756,0.9213517592626931,1.0,9/17,29.82%,EPHA5;EPHA3;EPHA1;EPHA7;EPHA6;EPHA4;EPHB2;EPHB4;EFNA4
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.322909450095459,-0.9190276986225491,0.579520697167756,0.9213517592626931,1.0,9/17,29.82%,EPHA5;EPHA3;EPHA1;EPHA7;EPHA6;EPHA4;EPHB2;EPHB4;EFNA4
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.19107982412849664,0.9177191362500322,0.792654028436019,0.8932764351946936,1.0,182/830,23.10%,SALL1;ZFHX3;IKZF1;ETV5;MLXIPL;ZSCAN26;RREB1;SMAD3;NFE2L2;SALL3;DNMT3A;BACH2;LYL1;ETS1;HEYL;SOX8;UBP1;DDIT3;MEF2C;MTA1;SKI;FOXJ2;MLXIP;ZFP90;PPARD;HIVEP3;RBL2;MEF2D;ZNF568;DEAF1;ELK1;GTF2IRD1;PAX6;CALCOCO1;HBP1;KLF3;ZBTB18;ZIM3;MLX;MYCL;ELK3;NFATC1;ZBTB24;TFE3;MEIS3;KLF11;FOXE1;CUX1;ZNF569;KLF12;HOXB8;RXRB;FOXK2;ZSCAN21;PKNOX1;TAL2;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;FOXO6;DMRTB1;SOX17;NEUROD6;NEUROD4;UTY;TWIST2;POU4F1;HMX2;HOXD9;MYNN;NR2F1;NPAS1;PRDM1;E4F1;TBX6;ZNF367;PATZ1;DHX9;ARNT;SMAD9;ZEB1;E2F2;NFE2L1;NRF1;ZNF83;SKIL;MEF2A;PRDM2;MXD1;OLIG2;SP9;IRF8;PAX2;PROX1;IRF3;CEBPG;MXI1;ZBTB39;ZBTB8B;RUNX1;TEF;ZNF3;SARS1;CCAR1;CUX2;PROX2;ZFP62;HES6;SAFB;KCNIP3;POU2F1;NR1H2;TAL1;ZSCAN22;NRIP1;GATA3;ZKSCAN1;ZNF692;DMTF1;EGR1;E2F3;TAF1;ZNF585B;ZNF585A;RBMX;ZSCAN12;MGA;ZNF394;TCF7L2;TCF4;GZF1;POU2F2;THAP1;BHLHA9;CEBPD;HDAC5;ZNF260;TCF7L1;TCF3;NFIA;JUN;IRF5;IRF2;BATF3;FOXP4;ZNF740;RFXANK;ZBTB45;NFYA;IRF9;HIF1A;IRX1;NFIX;TWIST1;TFAP4;MNT;YY1;TGIF2;TEAD3;ZFP37;SCRT1;ZNF76;TP53;ZBTB48;STAT5B;ZBTB2;MSC;ZBTB14;ZNF628;MITF;HOXB5;STAT6;NFX1;ZFP14;OTP;POU3F4
prerank,protein kinase C activity (GO:0004697),0.3518668802224177,0.9156670130830086,0.5724381625441696,0.894978123048448,1.0,4/14,13.52%,PRKCA;PRKCD;PRKCB;PRKD3
prerank,single-stranded RNA binding (GO:0003727),0.27159079411416226,0.91372650176857,0.6096345514950167,0.8962523241044748,1.0,8/43,12.14%,TLR7;SNRPC;POLR2D;JMJD6;EIF4H;U2AF2;DHX9;CNBP
prerank,phosphotyrosine residue binding (GO:0001784),0.2797452843624089,0.9131878180563239,0.5885245901639344,0.8939427448158676,1.0,11/37,18.96%,VAV2;PIK3R1;PLCG2;SHB;PTPN11;LDLRAP1;ABL1;PTPN5;SHE;CRKL;VAV1
prerank,Toll-like receptor binding (GO:0035325),0.37540725084906124,0.913057667804951,0.6023166023166023,0.8906665088795371,1.0,5/11,26.70%,UNC93B1;MYD88;S100A9;S100A8;TLR6
prerank,nuclear import signal receptor activity (GO:0061608),0.34313007260300765,0.9126813954262906,0.5753676470588235,0.8879452644418561,1.0,9/15,33.90%,TNPO1;IPO4;TNPO3;KPNA3;HIKESHI;IPO9;KPNA1;KPNA7;KPNB1
prerank,deoxyribonuclease activity (GO:0004536),-0.34163186182643923,-0.912157459712307,0.5766738660907127,0.9359781887397445,1.0,2/14,6.57%,RPS3;ZRANB3
prerank,sulfuric ester hydrolase activity (GO:0008484),0.3715592981727477,0.911172092834284,0.5674157303370787,0.8881117064747699,1.0,6/12,25.21%,ARSB;ARSK;GNS;ARSA;ARSI;SULF1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.36820804242988886,-0.9111592003327905,0.5727069351230425,0.9342838689108275,1.0,4/10,24.47%,USP15;DNAJB2;DNAJC2;ANKRD13A
prerank,RNA polymerase II complex binding (GO:0000993),-0.27857921858809537,-0.9081352916461758,0.6169265033407573,0.9378389928301629,1.0,12/32,24.85%,SCAF8;WAC;CDC73;GTF2B;CCAR2;UVSSA;ESRRB;SMYD2;SUPT4H1;AGO2;ZNF326;ELP2
prerank,poly(U) RNA binding (GO:0008266),0.3201052966240177,0.9074347487581899,0.5945454545454546,0.8939475619762289,1.0,6/20,15.78%,SSB;HNRNPC;DIS3L2;HNRNPH1;KHDRBS1;DAZAP1
prerank,cholesterol binding (GO:0015485),0.2620782488060769,0.9065101767840779,0.6092943201376936,0.8925191879083849,1.0,9/47,18.35%,GRAMD1A;OSBPL3;NPC2;NPC1;OSBPL5;TSPO;VDAC1;PTCH1;ABCA1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.2956982957776173,0.9059876849275779,0.6092362344582594,0.8903171161174216,1.0,6/29,13.34%,PKIG;INCA1;SPRY2;INKA1;RPTOR;CIB1
prerank,transferrin receptor binding (GO:1990459),-0.3772428731845052,-0.9044909428843564,0.5851063829787234,0.9430817014273106,1.0,4/10,41.57%,SNX2;RGMA;HFE;CHUK
prerank,tau-protein kinase activity (GO:0050321),-0.307942330506158,-0.9044201927871767,0.5945945945945946,0.9389067961772497,1.0,8/20,20.48%,SIK3;MARK3;GSK3B;TTBK1;BRSK1;PRKAA1;BRSK2;FYN
prerank,chemokine receptor activity (GO:0004950),0.3096144943087737,0.9030710203333118,0.5985533453887885,0.8937720879639137,1.0,1/24,0.03%,CX3CR1
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.3074871285203441,-0.9028414147110032,0.5843230403800475,0.9386219255623123,1.0,4/20,9.63%,DLG2;AK6;CASK;AK3
prerank,cytokine activity (GO:0005125),0.2221162470114033,0.9013870681090278,0.7049441786283892,0.8943654524196737,1.0,12/131,9.48%,IL18;SLURP1;WNT2B;INHA;WNT10B;CNTF;LEFTY1;IL12B;CTF1;CXCL1;IL33;WNT7B
prerank,CXCR chemokine receptor binding (GO:0045236),0.3787124163197221,0.900934127801487,0.6063432835820896,0.8919819393526823,1.0,2/11,8.27%,ITCH;CXCL1
prerank,peptidase activator activity (GO:0016504),-0.29648028513203917,-0.9003994492210732,0.6074561403508771,0.9405785202971939,1.0,5/22,11.56%,NLRC4;PSMD14;CLPX;PSME2;MAL
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.23865271720793083,0.8999216243589644,0.6589785831960461,0.8908652887269453,1.0,7/73,8.61%,CX3CR1;HCRTR1;RXFP3;CALCR;FSHR;LHCGR;NLRP6
prerank,CARD domain binding (GO:0050700),0.3516272500373854,0.8991755847584626,0.575591985428051,0.8890708308434359,1.0,4/14,17.78%,RIPK2;CASP1;MAVS;NOD2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3614907204295562,-0.898774841188991,0.5853131749460043,0.9404972051399357,1.0,4/11,31.09%,CHRNA4;CHRNB2;CHRNA9;CHRNB4
prerank,transcription corepressor binding (GO:0001222),-0.29120168103940863,-0.8985438344981113,0.5898004434589801,0.936780087518038,1.0,6/27,15.80%,ZBTB16;MTF2;PER2;PER1;LCOR;WIZ
prerank,channel activity (GO:0015267),-0.25420165594288124,-0.8976304427900058,0.6130536130536131,0.9347958498443477,1.0,11/41,23.58%,AQP4;MCUB;PANX2;SLC14A1;AQP11;PANX1;BCL2;TRPV6;TRPV3;AQP1;TMEM266
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.2419125345078556,-0.8972971819620039,0.6549295774647887,0.9313690428454131,1.0,7/53,9.12%,DPYD;CYBB;XDH;MICAL3;KDM1B;SDHA;KMO
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.2511124554507653,0.8972357144425627,0.6380789022298456,0.8901160638702537,1.0,9/60,10.63%,MERTK;CSF1R;IGF1R;EFEMP1;MET;RYK;EPHA8;MUSK;AXL
prerank,ATPase regulator activity (GO:0060590),-0.25976173531214636,-0.8954994232791451,0.6135265700483091,0.9318702862586938,1.0,11/38,20.13%,DNAJA2;DNAJC15;BAG3;DNAJB4;ATP1B3;DNAJB2;MYBPC3;TOR1AIP2;DNAJC19;BRSK2;TSC1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.3730285082535901,-0.8936667340660914,0.5862831858407079,0.9322078669480174,1.0,5/10,19.31%,SUV39H1;PRDM16;SETDB2;SETD5;SUV39H2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.26458171060504443,-0.8920431506930241,0.6343825665859564,0.931987835076919,1.0,10/34,16.68%,SUV39H1;KMT2E;NSD3;EEF1AKMT1;TTLL12;KMT5B;EEF1AKMT2;CAMKMT;SMYD2;METTL21A
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3424601047421488,-0.8868187571272182,0.6266375545851528,0.9411412403600826,1.0,7/13,27.92%,AGPAT4;GPAT3;AGPAT1;ABHD5;PNPLA3;GPAT2;AGPAT3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.32119866840118805,-0.8866051911560788,0.6091476091476091,0.9374726016253879,1.0,6/15,20.54%,SLC1A6;SLC1A5;SLC1A1;SLC25A18;SLC25A12;SLC1A4
prerank,chemokine binding (GO:0019956),0.2843286656937789,0.8854016117951653,0.6284722222222222,0.9148852322833548,1.0,3/30,7.55%,CX3CR1;ITGAV;CCR7
prerank,nuclear export signal receptor activity (GO:0005049),0.3684568285598655,0.8836463142944709,0.6109022556390977,0.9154397355598262,1.0,7/11,30.49%,NUP42;CSE1L;XPO5;NUP214;XPO1;XPO6;RANBP17
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.34824939616052897,-0.8831399369909199,0.6164948453608248,0.9419622523735348,1.0,5/12,15.65%,CADM4;VEGFD;CCDC88A;CDH5;VEGFC
prerank,GDP binding (GO:0019003),-0.2291160814984723,-0.88305872951305,0.7093596059113301,0.9379962455403371,1.0,15/63,22.47%,RIT2;RAB22A;RAN;RAB5C;RASL12;TRIM23;RAB8A;RAB28;RERG;GNAI1;NME2;RHEBL1;RAB27B;RAB9B;GEM
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.24225813831965048,-0.8806896485396637,0.6814814814814815,0.9396302354108866,1.0,13/49,16.40%,SHARPIN;OTUD7A;RNF169;ZRANB3;ZFAND6;DZIP3;IKBKE;EPS15;AGAP3;PARP10;BABAM2;UBQLN2;UBQLN1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.2871775189755183,0.8793980799215981,0.6666666666666666,0.922169590520169,1.0,5/30,12.35%,CST3;RPS6KA1;CD27;XIAP;DPEP1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3725337081234433,-0.8781304223978423,0.6353467561521253,0.9415924209325257,1.0,1/10,1.12%,ATF2
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.22227583882854465,-0.8777782753223616,0.7042606516290727,0.9384237879978091,1.0,10/71,9.29%,PTPRD;PTPRN2;PTPRG;PTPN12;PTPRT;PTPN22;PTPN3;TNS2;PTPN2;EYA2
prerank,endopeptidase inhibitor activity (GO:0004866),0.22997696764478123,0.8776850554352742,0.712171052631579,0.9227554775579695,1.0,7/82,6.62%,BIN1;CST3;UCHL5;PROS1;SLPI;LXN;GAPDH
prerank,3'-5' exonuclease activity (GO:0008408),0.2591366795863001,0.877362848127874,0.6701208981001727,0.9199583698796404,1.0,9/45,17.71%,REXO4;DIS3L2;REXO2;RAD1;EXOSC5;ISG20;ERI3;RAD9A;EXOSC10
prerank,ankyrin binding (GO:0030506),-0.3093594374443671,-0.8756162777670887,0.6407322654462243,0.9393654628801522,1.0,4/19,14.07%,NRCAM;SPTBN1;SPTBN4;CDH1
prerank,phosphatidate phosphatase activity (GO:0008195),-0.3317280043912613,-0.8747875845786859,0.612691466083151,0.9373856276807576,1.0,6/13,18.71%,PLPPR4;PLPP5;PLPP4;PLPPR1;PLPP3;PLPPR3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.33466401883019214,0.871623171828154,0.6388888888888888,0.9299591009048004,1.0,7/15,33.63%,PIK3R1;SOCS6;PIK3R5;SOCS3;PIK3R3;SOCS5;PIK3R2
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.35086804832415885,-0.870457113139001,0.620137299771167,0.9433482577701774,1.0,4/12,18.12%,TRIM37;TRAP1;BABAM2;TRAF1
prerank,endoribonuclease activity (GO:0004521),0.2771903799926365,0.8686250781681583,0.6684491978609626,0.9333182283179591,1.0,12/32,24.31%,INTS11;YBEY;PIWIL1;RCL1;KHNYN;ZC3H12B;ZC3H12C;EXOG;AGO1;TSNAX;SND1;ZC3H12A
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.3209956744122717,-0.8683211094558482,0.6791208791208792,0.9442852760012272,1.0,4/15,17.13%,ALDH1L1;ALDH9A1;ALDH2;ALDH3A2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.32088400185809296,-0.8677543669557921,0.6427015250544662,0.9415671636119419,1.0,7/15,27.92%,AGPAT4;GPAT3;AGPAT1;ABHD5;PNPLA3;GPAT2;AGPAT3
prerank,regulatory RNA binding (GO:0061980),0.2631113924328996,0.8656532261949215,0.6910994764397905,0.9366727511614034,1.0,12/38,27.15%,TLR7;PIWIL1;DHX9;AGO1;RBM4;HNRNPA2B1;PUM1;ZC3H12A;ELAVL1;TLR9;ZNF346;HNRNPA1
prerank,E-box binding (GO:0070888),-0.25550196514683204,-0.864603392283379,0.6743119266055045,0.9448111064276362,1.0,14/34,33.17%,PPARG;MYC;PER1;AHR;CLOCK;SCX;SNAI2;SCRT2;NEUROD2;BHLHE40;NEUROG2;TCF15;SNAI1;NEUROD1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.25729041190941737,-0.8637495085013124,0.7210401891252955,0.9427940576556302,1.0,8/31,16.25%,UBE2J2;UBE2N;UBE2E2;UBE2W;UBE2Q2;UBE2C;UBE2K;BIRC6
prerank,WW domain binding (GO:0050699),-0.2758726562613902,-0.8626037529681141,0.70509977827051,0.9414343447369727,1.0,6/26,16.20%,RAPGEF2;LITAF;NFE2;ENAH;NDFIP1;CDC25C
prerank,metallopeptidase activity (GO:0008237),-0.20097330443772912,-0.859318102353323,0.8230088495575221,0.9448139145210394,1.0,31/113,22.23%,MMP16;PSMD14;MME;ADAMTS12;TRABD2B;ADAMTS17;THSD4;ADAMTS19;MPND;ADAM12;MMP15;ADAM33;MMP12;ADAMTSL5;ADAMTSL4;ANPEP;MMP14;MMP8;MMP19;ADAMTS10;ADAMTSL1;PHEX;ADAM19;ADAM21;ADAM18;SPG7;ACE;ADAM23;ADAMTS14;ACE2;ADAM2
prerank,phosphatidylglycerol binding (GO:1901611),0.34542864132920337,0.8589287000906015,0.6369047619047619,0.9482801244456616,1.0,4/13,19.14%,PITPNC1;NME4;STOML2;OPA1
prerank,cholesterol transfer activity (GO:0120020),0.32089609456265294,0.8585088454976771,0.6545454545454545,0.9456022659746386,1.0,4/16,22.52%,GRAMD1A;NPC2;ABCA1;MTTP
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2719096442644557,-0.8579832123182599,0.673289183222958,0.9435721662966897,1.0,10/26,27.31%,AGBL4;AGBL1;AEBP1;CPXM1;VASH2;AGBL2;ACE2;CPXM2;CPA2;PEPD
prerank,endopeptidase activator activity (GO:0061133),-0.3507792388091927,-0.8559345469958822,0.6680327868852459,0.9442748998319334,1.0,3/10,9.38%,NLRC4;PSMD14;PSME2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.361698424047765,-0.8557811449854148,0.6520787746170679,0.9369213421940124,1.0,6/10,35.28%,DUSP16;DUSP10;DUSP2;DUSP4;DUSP9;DUSP8
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.361698424047765,-0.8557811449854148,0.6520787746170679,0.9369213421940124,1.0,6/10,35.28%,DUSP16;DUSP10;DUSP2;DUSP4;DUSP9;DUSP8
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.20303303698649025,0.855162149298904,0.8321273516642547,0.9494214301642607,1.0,49/181,22.29%,SMAD3;NFE2L2;MTA1;PPARD;RBL2;ELK1;NFATC1;TACC1;FIZ1;ANKRD2;BBS2;SMARCD3;SIN3A;WWP2;TAF6;TBX6;MTDH;DLL1;DHX9;ARNT;MEF2A;PIAS2;GTF2I;PIAS3;MAPK14;DTX3L;PROX1;ARID1A;TAF4;RNF25;COMMD7;RERE;COMMD6;MIER3;HES6;TAL1;NRIP1;TAF1;TCF7L2;NCOA3;HDAC5;TCF3;JUN;HIF1A;NCOA2;TEAD3;BRMS1;TP53;KDM1A
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.34374614891794086,0.8535359711308605,0.6500920810313076,0.9494648541973091,1.0,4/12,18.55%,DHRS4;CRYZL1;NQO1;CBR1
prerank,Hsp70 protein binding (GO:0030544),-0.2590351115262887,-0.8534657611087544,0.7036199095022625,0.9383941545371837,1.0,8/31,16.68%,ERN1;RPS3;PRKN;SPN;SNCA;DNAJB2;MVD;METTL21A
prerank,transcription coregulator binding (GO:0001221),-0.2340728379906996,-0.8480258052475523,0.7477272727272727,0.946244147264355,1.0,11/50,15.80%,ZBTB16;THRB;MTF2;PER2;CTCF;PER1;RELA;AHR;CTNNB1;LCOR;WIZ
prerank,sequence-specific DNA binding (GO:0043565),0.1788729170851167,0.845350205154881,0.9455445544554455,0.963998742358433,1.0,119/590,22.51%,ETV5;SMAD3;NFE2L2;BACH2;FLI1;SOX8;UBP1;MEF2C;FOXJ2;PPARD;CTC1;ERF;MEF2D;ELK1;PAX6;ZBTB21;CALCOCO1;KLF3;ZBTB18;MLX;ELK3;NFATC1;TFE3;MEIS3;KLF11;FOXE1;CUX1;KDM5B;CXXC1;SLTM;KLF12;HOXB8;RXRB;FOXK2;PKNOX1;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;POU4F1;HMX2;HOXD9;TET3;NR2F1;CXXC5;PRDM1;LBX1;TBX6;PRMT1;ARNT;ETV3;DPF1;E2F2;ABL1;MEF2A;PRDM2;MBD1;TEN1;ERH;OLIG2;SP9;IRF8;PAX2;PROX1;TERF1;IRF3;CEBPG;TEF;NLRP3;CUX2;HES6;SAFB;POU2F1;GATA3;PLAGL2;EGR1;SAFB2;E2F3;TAF1;TCF7L2;TCF4;GZF1;POU2F2;THAP1;CEBPD;TCF7L1;JUN;IRF5;IRF2;BATF3;ZNF740;XRCC6;MAPT;PRDM9;ZBTB45;TELO2;IRF9;HIF1A;IRX1;NFIX;ACD;TFAP4;WDR77;YY1;KDM2A;TGIF2;SCRT1;ZCWPW1;ZNF76;ZBTB2;MSC;KDM1A;ZBTB14;CSRNP2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3410069159791599,0.844757249658126,0.64,0.961616190065248,1.0,2/11,7.95%,PADI2;AGMAT
prerank,potassium ion leak channel activity (GO:0022841),-0.3097383614980799,-0.8435996456776894,0.7008733624454149,0.9518481089143639,1.0,6/15,29.45%,KCNK10;KCNK4;KCNK5;KCNK12;KCNK2;KCNK7
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.17910496033634854,0.843424834690561,0.9593596059113301,0.9610054483714754,1.0,118/597,22.46%,ETV5;SMAD3;NFE2L2;BACH2;ETS1;FLI1;SOX8;UBP1;BASP1;DDIT3;MEF2C;FOXJ2;PPARD;MEF2D;ZNF568;KMT2D;ELK1;PAX6;CALCOCO1;CREB3L2;KLF3;ZBTB18;MLX;ELK3;NFATC1;ATMIN;CRY2;TFE3;MEIS3;BCOR;KLF11;FOXE1;CUX1;KDM5B;KLF12;HOXB8;CHD3;RXRB;FOXK2;PKNOX1;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;SOX17;POU4F1;HMX2;HOXD9;NR2F1;PRDM1;BRCA1;LBX1;TBX6;SMARCA2;DHX9;ARNT;ETV3;DPF1;E2F2;ABL1;MCM2;OLIG2;SP9;IRF8;PAX2;PROX1;IRF3;CARM1;CEBPG;RUNX1;TEF;CUX2;KDM5A;HMGB2;HES6;MCM3;TAL1;GATA3;BNC2;ORC3;DMTF1;EGR1;E2F3;TCF7L2;TCF4;POU2F2;CEBPD;HDAC5;MCMDC2;TCF7L1;JUN;IRF5;IRF2;BATF3;ZNF740;XRCC6;PRDM9;ZBTB45;NFYA;IRF9;IRX1;NFIX;TFAP4;TSPYL2;YY1;TGIF2;SCRT1;ZNF76;TP53;ZBTB48;ZBTB2;MSC;ZBTB14
prerank,heme binding (GO:0020037),-0.21848805663479215,-0.8433571593321983,0.7863013698630137,0.9484706862175625,1.0,14/65,18.19%,CYBB;SDHC;GUCY1B1;CYP2U1;PGRMC2;JAK2;SDHD;THAP4;FLVCR1;FLVCR2;HMOX1;CAT;STEAP4;CYB5B
prerank,RNA methyltransferase activity (GO:0008173),0.3087088057109645,0.8422882479614707,0.6893939393939394,0.959955517722266,1.0,9/19,26.12%,BCDIN3D;FTSJ3;FBL;TRDMT1;FTSJ1;METTL8;TGS1;METTL4;TRMT9B
prerank,calcium:sodium antiporter activity (GO:0005432),-0.3454839290713993,-0.8402853386139839,0.6673960612691466,0.9509291976392105,1.0,3/10,7.30%,SLC8A3;SLC24A2;SLC8B1
prerank,tau protein binding (GO:0048156),0.25321980746762046,0.840081837220993,0.7372881355932204,0.9610426433263188,1.0,9/40,17.65%,BIN1;LGMN;PICALM;CLU;MARK2;ROCK2;TAOK2;DYRK1A;MARK4
prerank,glutathione transferase activity (GO:0004364),-0.2761444912272701,-0.8393515413614004,0.6839729119638827,0.9491220352583013,1.0,9/23,25.54%,ALOX5AP;MGST1;GSTT1;LANCL1;GSTP1;PTGES;GSTZ1;MGST3;GSTK1
prerank,cation:chloride symporter activity (GO:0015377),-0.3437208913310028,-0.8391105642814782,0.6762114537444934,0.9458179365703354,1.0,6/10,25.90%,SLC12A8;SLC12A4;SLC12A5;SLC12A1;SLC12A3;SLC6A1
prerank,cation transmembrane transporter activity (GO:0008324),0.24361251349715782,0.8390334773990612,0.7175043327556326,0.9597245693637835,1.0,6/48,8.20%,SLC7A8;SLC36A1;SLC15A4;SLC7A5;SLC22A2;SLC29A4
prerank,intracellular chloride channel activity (GO:0061778),-0.30246513287903853,-0.8371666094256953,0.6847826086956522,0.9422649537529911,1.0,4/16,13.02%,ANO3;ANO10;ANO6;ANO5
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.30246513287903853,-0.8371666094256953,0.6847826086956522,0.9422649537529911,1.0,4/16,13.02%,ANO3;ANO10;ANO6;ANO5
prerank,cytokine receptor binding (GO:0005126),0.2197414525280646,0.8369912881791545,0.7802013422818792,0.9605567092388481,1.0,20/83,23.88%,IL18;SMAD3;IL6R;VEGFB;IL6ST;CNTF;IL12B;DDT;TIMM50;TYK2;PXDN;CCRL2;PYCARD;ADAM17;ERAP1;SPRED2;TRAF6;FADD;MIF;IL34
prerank,mitogen-activated protein kinase binding (GO:0051019),0.27288190560323466,0.8368272407657371,0.6996336996336996,0.9574142373047008,1.0,8/29,17.96%,NBR1;NFATC1;PRMT1;ABL1;MAPK14;MAPK7;DUSP6;PTPRJ
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.32481679529298046,0.8358000962356495,0.672316384180791,0.9559640061102036,1.0,4/14,15.44%,POP1;TSEN2;RPP21;ELAC2
prerank,glucose transmembrane transporter activity (GO:0005355),-0.2995859565667044,-0.8356951517445723,0.7145790554414785,0.9414024790336887,1.0,9/17,37.99%,SLC2A2;SLC2A8;SLC2A4;MFSD4A;SLC2A3;SLC5A1;SLC5A10;SLC2A1;SLC2A6
prerank,cAMP response element binding (GO:0035497),-0.34691860851666495,-0.8347491556020491,0.6843267108167771,0.9397725058918854,1.0,3/10,10.01%,ATF2;CREB5;CREB3L1
prerank,double-stranded DNA binding (GO:0003690),0.17849718448912694,0.8345300023048616,0.95125,0.9550279176527806,1.0,106/531,22.69%,ETV5;BACH2;FLI1;SOX8;UBP1;MEF2C;MAU2;FOXJ2;PPARD;MEF2D;WDR48;ZCCHC3;ELK1;PAX6;KLF3;ZBTB18;REXO4;MLX;ELK3;NFATC1;TFE3;MEIS3;KLF11;FOXE1;CUX1;ZMYND11;KDM5B;KLF12;HOXB8;RAD51B;RXRB;PKNOX1;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;POU4F1;HMX2;HOXD9;NR2F1;CGAS;PRDM1;LBX1;TBX6;DHX9;ARNT;ETV3;DPF1;E2F2;ABL1;MBD1;OLIG2;SP9;IRF8;PAX2;PROX1;POLG2;TERF1;IRF3;CEBPG;TEF;FBH1;CUX2;HMGB2;HES6;SAFB;GATA3;NTHL1;EGR1;E2F3;APTX;AIM2;TCF4;POU2F2;CEBPD;TCF7L1;JUN;IRF5;IRF2;BATF3;PARK7;SPRTN;ZNF740;XRCC6;MAPT;ZBTB45;IRF9;IRX1;NFIX;TFAP4;YY1;TGIF2;TARDBP;SCRT1;ZNF76;ZBTB48;ZBTB2;MSC;ZBTB14;RAD51AP2;HOXB5
prerank,protein kinase inhibitor activity (GO:0004860),0.25000086554942114,0.8297819976405297,0.7628865979381443,0.9611345085634785,1.0,14/42,22.16%,PRKRIP1;SPRY2;ITPRIP;INKA1;RPTOR;MAPK8IP1;CIB1;QARS1;CDKN1B;TRIB1;CEP43;SPRED2;IBTK;MBIP
prerank,endopeptidase activity (GO:0004175),0.18831965885686724,0.8282864052627301,0.8929618768328446,0.9607261378703018,1.0,53/257,20.83%,USP35;KLK2;USP12;USP8;UCHL1;CASP1;LGMN;USP25;PITRM1;F12;MMP2;USP28;CTSS;KLK8;PRSS36;RCE1;ADAM28;PRSS38;PSEN2;MBTPS2;PSMA7;USP36;JMJD7;CTSE;CTSF;ADAMTS4;PDIA3;USP9Y;PSMB3;MBTPS1;RHBDD3;PSMB9;NRDC;KLK9;MIPEP;PLG;MMP28;KDM8;PSMB7;ADAMTS20;USP5;PIDD1;ADAM10;PSMB5;ADAMTS1;HPN;ADAMTS18;SPRTN;ADAM17;PSMB8;MMP24;MMP25;HTRA2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.31648035206710023,0.8282737373406618,0.6781818181818182,0.9573080855993158,1.0,4/14,19.34%,CASP1;RPS27L;APAF1;PYCARD
prerank,protein phosphatase 2A binding (GO:0051721),-0.27397895495985203,-0.8276745320166686,0.7320675105485233,0.9504430887593515,1.0,6/23,14.78%,SMG7;ADCY8;STRN3;GRIN3A;SMG5;FOXO1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.32111490925652414,-0.8265334132619766,0.7217391304347827,0.9489805241774895,1.0,7/13,25.24%,RYR2;PKIA;GSK3B;KCNQ1;EZR;PRKAR1A;PRKAR2A
prerank,SUMO transferase activity (GO:0019789),0.31186152790418387,0.825527120239883,0.7024221453287197,0.9593040215032742,1.0,4/16,16.77%,RANBP2;PIAS2;PIAS3;TOPORS
prerank,palmitoyltransferase activity (GO:0016409),0.27255355079399973,0.824870576822361,0.7310469314079422,0.957165126722907,1.0,10/28,24.03%,YKT6;ZDHHC13;ZDHHC5;ZDHHC4;ZDHHC12;ZDHHC7;HHAT;GOLGA7B;ZDHHC2;ZDHHC6
prerank,mannose binding (GO:0005537),0.33299483101666205,0.82214815021959,0.6924603174603174,0.9591896261199739,1.0,2/12,7.83%,COLEC11;LMAN1L
prerank,nucleosomal DNA binding (GO:0031492),-0.27656712224484353,-0.8203765841159705,0.7330508474576272,0.957748526056065,1.0,7/21,24.36%,ACTB;SMARCE1;MTA2;HDAC1;H3-3A;SMARCD2;SMARCC1
prerank,DNA polymerase binding (GO:0070182),0.30127246660030915,0.8192622683194156,0.7322695035460993,0.9611998684790333,1.0,7/18,24.94%,PCNA;POLG2;FANCI;CDK2AP1;ACD;RTEL1;SMARCA4
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.33608307455542424,0.8190734242126722,0.7255639097744361,0.9582137112556918,1.0,6/12,22.29%,KDM3A;KDM4A;KDM7A;HR;PHF8;KDM1A
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.30225304208329035,-0.811326256197333,0.7399103139013453,0.9715151531166446,1.0,3/14,8.89%,RSAD2;NDUFS1;ISCA2
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.27538353803137783,-0.8110497514180254,0.7488151658767772,0.9646018171225749,1.0,7/21,21.71%,CDK14;CDK7;CDK15;CDK12;CDK2;CDK4;CDK6
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.27538353803137783,-0.8110497514180254,0.7488151658767772,0.9646018171225749,1.0,7/21,21.71%,CDK14;CDK7;CDK15;CDK12;CDK2;CDK4;CDK6
prerank,transaminase activity (GO:0008483),-0.32282050198887396,-0.8110075469466084,0.697228144989339,0.9609921015885278,1.0,3/11,20.11%,PSAT1;BCAT1;GOT1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.3272049561197518,0.8108994304976097,0.7117117117117117,0.9703773352024191,1.0,4/12,17.55%,NCBP1;DCPS;CYFIP1;LARP1
prerank,protein phosphatase binding (GO:0019903),0.20294419950470477,0.8106091695608812,0.8607198748043818,0.9674887480650504,1.0,23/117,18.47%,SIRPA;CTTNBP2NL;PPP1R9B;PPP6R3;PIK3R1;MET;PPP1R3E;VRK3;AKAP5;CEACAM1;FBXL2;KIF3A;DLG4;SOD1;MTMR4;MAPK14;MASTL;PPP6R1;CD33;SNX3;PPP1R3F;PXN;CDKN1B
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2656435888911547,-0.8104985801678575,0.7447795823665894,0.9582786369719077,1.0,7/24,18.02%,SESTD1;PLEKHA3;GOLPH3;OSBPL8;PLEKHA5;CERT1;PLEKHF1
prerank,serine-type peptidase activity (GO:0008236),0.2087941254733739,0.8098922670986652,0.8403225806451613,0.9653596202677505,1.0,13/96,14.97%,KLK2;ST14;NAALAD2;F12;MMP2;KLK8;PRSS36;PRSS38;KLK11;MBTPS1;RHBDD3;KLK9;PLG
prerank,pyridoxal phosphate binding (GO:0030170),-0.27505451496847877,-0.809414038494886,0.7371937639198218,0.9565142611540082,1.0,7/20,21.20%,PLPBP;PSAT1;SRR;PYGM;SHMT1;GLDC;SHMT2
prerank,DNA secondary structure binding (GO:0000217),0.2568533918047636,0.8087379625466092,0.7688356164383562,0.9640519410248717,1.0,10/31,23.99%,MEF2C;FANCM;RAD51B;BLM;ABL1;HMGB2;MAPT;YY1;RAD51C;LIN54
prerank,solute:sodium symporter activity (GO:0015370),-0.256155548696551,-0.8086693680881971,0.7556053811659192,0.9542525522437971,1.0,6/27,20.69%,SLC5A7;SLC4A10;SLC28A2;SLC4A8;SLC13A5;SLC5A6
prerank,fibroblast growth factor binding (GO:0017134),0.2819266356526421,0.8047848439890196,0.7299813780260708,0.9679281990186305,1.0,6/21,19.80%,ITGAV;CEP57;THBS1;API5;FGFR4;FGFR2
prerank,mRNA 3'-UTR binding (GO:0003730),0.2122168805992685,0.8039047038803488,0.8466557911908646,0.9661223151398859,1.0,27/79,25.46%,SECISBP2;DDX5;CELF2;HNRNPC;ZFP36L1;ZFP36L2;RBM24;CPSF1;CSDC2;IGF2BP2;DAZAP1;LARP1;RNF20;BOLL;CPEB2;TARDBP;TP53;CCT5;RBM4;PCBP4;HNRNPA2B1;ELAVL3;PUM1;ZC3H12A;EXOSC8;ELAVL1;PARN
prerank,MAP kinase activity (GO:0004707),-0.295405296481012,-0.8023372992760657,0.7434679334916865,0.9619822808857038,1.0,6/14,29.72%,MAPK10;NLK;MAPK15;MAPK1;MAPK6;MAPK13
prerank,endonuclease activity (GO:0004519),0.23559991218499735,0.8011440789391465,0.8391003460207612,0.9676639575341736,1.0,15/49,24.31%,REXO4;INTS11;YBEY;PIWIL1;RCL1;ERCC4;KHNYN;ZC3H12B;ZC3H12C;NTHL1;EXOG;AGO1;TSNAX;SND1;ZC3H12A
prerank,endodeoxyribonuclease activity (GO:0004520),-0.2720977790813022,-0.7999741057258141,0.7709251101321586,0.9622760801588107,1.0,7/20,25.37%,RPS3;ZRANB3;RBBP8;ENDOV;SETMAR;FEN1;MRE11
prerank,protein kinase activator activity (GO:0030295),-0.21651992650029472,-0.7973150539408029,0.8746666666666667,0.9631347017302979,1.0,18/60,23.06%,IQGAP1;GRM5;PRKAG2;CALM1;TPX2;ERCC6;ERBB3;IRGM;RPLP1;RGCC;CDKN1A;ETAA1;RICTOR;DBF4;SPDYA;LTF;GPRC5C;GHRL
prerank,FAD binding (GO:0071949),-0.2609378800287937,-0.797237798792755,0.7817371937639198,0.9597109648539082,1.0,15/24,39.91%,MICAL3;KDM1B;KMO;DAO;STEAP4;CRY1;CYB5R2;MICAL2;NQO2;AGPS;MICAL1;MTHFR;CYB5R3;MTRR;QSOX1
prerank,methylation-dependent protein binding (GO:0140034),0.2243016081249588,0.7966195300458233,0.8330464716006885,0.9720990719502116,1.0,25/57,31.63%,CHD8;ZMYND11;CXXC1;KDM4A;JMJD7;MORC3;KDM5A;KDM7A;KDM8;CBX8;WDR5;PHF8;GLYR1;ZCWPW1;RRP8;SUZ12;BPTF;SPIN1;TDRD3;PHF13;ZCWPW2;ZMYND8;ATRX;TRIM24;MORC4
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.1822074790639494,0.7963727239565299,0.9353023909985936,0.9692328181180557,1.0,52/254,22.01%,ETV5;RREB1;SMAD3;ETS1;UBP1;DDIT3;MEF2C;FOXJ2;MLXIP;ELK1;ELK3;NFATC1;ATMIN;MEIS3;RXRB;FOXK2;ZSCAN21;ALX4;SOX17;POU4F1;SMARCD3;E4F1;MDM4;E2F2;NRF1;MEF2A;GTF2I;PRDM2;IRF3;CEBPG;RUNX1;RLF;ZFP62;NR1H2;GATA3;PLAGL2;EGR1;E2F3;ZNF585B;ZNF585A;TCF4;TCF3;NFIA;JUN;IRF5;IRF2;RFXANK;HIF1A;TFAP4;YY1;ZNF76;TP53
prerank,beta-tubulin binding (GO:0048487),0.2481628145411223,0.795190259958728,0.7684210526315789,0.9679697206805756,1.0,11/31,25.31%,FGF13;APPL1;TRPV4;VAPB;LRPPRC;CCT5;GJB6;EML4;GABARAPL1;UXT;PDCD5
prerank,histone acetyltransferase activity (GO:0004402),0.2575410205486892,0.7936698804431537,0.768695652173913,0.9670872693738443,1.0,14/30,27.89%,SRCAP;NAA40;EPC1;NAA50;TAF1;NCOA3;TAF10;EPC2;ARRB1;KAT6B;KAT2B;EP300;KAT14;KAT5
prerank,protein phosphorylated amino acid binding (GO:0045309),0.23542001306943364,0.7904512312204739,0.8415032679738562,0.9692548930458711,1.0,11/42,18.96%,VAV2;PIK3R1;PLCG2;SHB;PTPN11;LDLRAP1;ABL1;PTPN5;SHE;CRKL;VAV1
prerank,N-acyltransferase activity (GO:0016410),0.2505364148584695,0.7895059266879759,0.7835951134380453,0.9676040217915195,1.0,11/32,28.29%,TGM2;CERS3;CERS2;NAA50;NMT1;CERS4;GNPNAT1;NAT8L;PLA2G4E;EP300;NAA10
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.31022964094241023,-0.7893464301116224,0.7489711934156379,0.9694463018466511,1.0,1/12,0.21%,B3GALT1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.233188979654064,-0.7891699101347528,0.8746987951807229,0.9662373771921704,1.0,7/34,12.67%,UBE2J2;UBE2N;UBE2E2;UBE2W;UBE2Q2;UBE2C;UBE2K
prerank,secondary active transmembrane transporter activity (GO:0015291),0.22860313549273376,0.7880496269278782,0.8254237288135593,0.9667715552148567,1.0,7/51,12.90%,SLCO2B1;SLC7A8;SLC20A2;SLC7A5;SLC22A6;SLC35A1;SLC25A11
prerank,copper ion binding (GO:0005507),-0.2234047185308606,-0.7880394754298992,0.8427518427518428,0.9644711671277909,1.0,10/42,23.68%,PAM;ATP7A;SNCA;CUTC;MOXD1;SUMF1;DCT;ACR;GPC1;AOC2
prerank,MAP-kinase scaffold activity (GO:0005078),-0.3179044739689012,-0.786091505375633,0.7543478260869565,0.9643105893076394,1.0,2/11,5.65%,IQGAP1;SH3RF1
prerank,vitamin D receptor binding (GO:0042809),-0.2995926577536342,-0.7844235280806916,0.779874213836478,0.9634508512427261,1.0,5/14,27.95%,TAF7;MED1;SNW1;MED14;MED16
prerank,kinase inhibitor activity (GO:0019210),-0.24028479072570622,-0.7824200163050284,0.8481927710843373,0.9633435528198703,1.0,9/33,15.98%,SH3BP5;LRP6;SPRY4;SMCR8;DNAJC3;SNCA;CDKN1A;NPM1;SH3BP5L
prerank,calcium-activated potassium channel activity (GO:0015269),0.32428993766217473,0.7822284224812504,0.7607003891050583,0.972868479259479,1.0,3/11,9.03%,KCNMA1;KCNN1;KCNU1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.3319321315453214,0.7808616084069507,0.7267657992565055,0.9718563360159217,1.0,2/10,13.14%,CACNB2;CACNA1D
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.23447801763044562,-0.7777082203538204,0.8140703517587939,0.9674688592031362,1.0,9/34,21.44%,IQGAP1;CALM1;IRGM;ETAA1;RICTOR;DBF4;CCNB1;LTF;CKS2
prerank,aspartic-type endopeptidase activity (GO:0004190),0.31432242330932586,0.7754085194491425,0.7552581261950286,0.9772547489377441,1.0,2/12,11.20%,CTSE;SPPL2B
prerank,G protein-coupled receptor binding (GO:0001664),-0.1769702298696668,-0.7747251321818782,0.9633802816901409,0.9685170917622514,1.0,32/132,23.80%,CCDC88C;BICD1;GNAO1;SDCBP;HOMER1;ARHGEF12;PRKN;HSPA8;WNT4;LRP6;REEP2;NDP;GNAI1;HSPA1B;CCL5;WNT9A;SFRP1;BAMBI;NTS;FLNA;TAFA5;NPB;ADM;GNA13;S1PR2;ACE;WNT7A;WNT6;PTCH2;WNT8B;GHRL;PNOC
prerank,NADP binding (GO:0050661),0.24813748431262897,0.7743307839050694,0.8361266294227188,0.9756380398314585,1.0,9/32,18.66%,QDPR;DUOX1;NOS2;CRYM;HSD17B1;NNT;CRYZL1;KCNAB1;NOS1
prerank,5'-nucleotidase activity (GO:0008253),-0.29376976373812763,-0.7742970520854725,0.756043956043956,0.9657833217059799,1.0,1/13,3.95%,NT5C3B
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.2927084548479521,-0.7723502843968421,0.7991266375545851,0.9654465670005085,1.0,4/13,10.97%,PIK3C2A;PIK3C2B;PIP5K1B;PIK3C2G
prerank,glycerophospholipid flippase activity (GO:0140333),-0.30586191265368134,-0.7705056654482348,0.7599164926931107,0.9648507641321462,1.0,5/11,18.04%,ATP11A;ATP11C;ATP8B2;ABCA4;ATP10B
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.2976790897095399,0.7683657324019914,0.7759562841530054,0.9815531112683163,1.0,2/14,9.36%,SLC1A3;SLC17A8
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.29943999670876154,-0.7671740213139873,0.8008474576271186,0.966327597485574,1.0,2/12,8.89%,XDH;ISCA2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.23081946884375437,0.7654414200690403,0.8622448979591837,0.9828129330079326,1.0,13/44,20.54%,KMT2D;ASH1L;CXXC1;EHMT2;KMT5C;EED;SETD2;SETD4;EZH2;SETD3;PRDM9;WDR5;SMYD1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.23729048917933224,0.7654086149220729,0.8309859154929577,0.9796491195274392,1.0,10/35,21.10%,QTRT1;AARS2;PTRH1;BCDIN3D;QTRT2;ELAC2;DUS3L;DUS1L;TRDMT1;FTSJ1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.2394208027826094,-0.7643821009671289,0.8171021377672208,0.9671567586277425,1.0,11/27,26.37%,ITPR1;ATP2B1;TMEM165;ATP2A3;MMGT1;SLC4A8;MAGT1;AQP1;SLC12A3;KCNA1;TUSC3
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.21388056488779048,0.7639780097997126,0.8894645941278065,0.9786346708089418,1.0,22/60,28.72%,LRRC39;PPM1H;PPM1L;PP2D1;ILKAP;CDC14B;RPAP2;TIMM50;LRRK1;PPP1CB;PPP1CC;CTDSP2;PPM1B;PPM1F;PPP3CB;MTMR6;PPEF2;PPP1CA;CTDSPL2;LRRC2;PTEN;UBLCP1
prerank,cardiolipin binding (GO:1901612),0.32755437187812264,0.7604617223697737,0.7635270541082164,0.9806784474409586,1.0,3/10,19.14%,NME4;STOML2;OPA1
prerank,methylated histone binding (GO:0035064),0.21183152025169144,0.7602741662191282,0.8991304347826087,0.9777393979812335,1.0,18/62,22.38%,CHD8;ZMYND11;CXXC1;KDM4A;JMJD7;MORC3;DPF2;KDM5A;KDM7A;KDM8;TAF1;CBX8;WDR5;PHF8;GLYR1;ZCWPW1;RRP8;SUZ12
prerank,anion:anion antiporter activity (GO:0015301),-0.2704446522842676,-0.7581877003354921,0.805045871559633,0.9727382402905242,1.0,6/17,23.85%,SLC26A7;SLC26A2;SLC26A3;SLC4A1;SLC26A4;SLC26A8
prerank,ATP hydrolysis activity (GO:0140603),-0.2117280374116765,-0.7578584510956266,0.877030162412993,0.9697700635170616,1.0,6/41,7.50%,ATP2B1;ATAD1;TOR1A;CLPX;VWA8;KIF14
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.21542113374456573,0.7570161342246177,0.9066666666666666,0.9793050565190303,1.0,11/55,19.72%,SLC7A8;SLC16A6;SLC36A1;SLC7A5;SLC38A10;SLC19A1;SLC16A7;SLC25A10;SLC38A7;SLC38A1;SLC16A4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.3031409855699289,-0.7565691450237365,0.7920353982300885,0.9682004553545146,1.0,5/12,25.59%,CDK7;CDK12;CDK4;CDK6;MAPK1
prerank,retinoic acid receptor binding (GO:0042974),0.27982379713911354,0.7563677509812707,0.7863720073664825,0.9770563329516366,1.0,3/17,5.21%,CNOT1;PRMT2;TACC1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.23904173256956593,-0.7538489611221459,0.8443935926773455,0.9687089631393788,1.0,7/28,18.12%,EDA;TRIM37;TRAP1;BID;BABAM2;TNFSF9;TRAF1
prerank,serine-type endopeptidase activity (GO:0004252),-0.18759135901951504,-0.7527549219967982,0.9591836734693877,0.9669259671717517,1.0,27/80,31.10%,PCSK2;DPP4;PCSK5;CD5L;PARL;F7;RHBDF2;MMP8;PLAT;PRSS12;HP;HPR;MASP2;ACR;F11;PRSS53;RHBDL3;RHBDL2;GZMM;MMP9;PCSK1;F3;GZMB;GZMA;PRSS56;RHBDL1;TMPRSS3
prerank,nucleotide diphosphatase activity (GO:0004551),0.2976211648750649,0.7526071978836,0.8011049723756906,0.9793143187862614,1.0,1/14,1.24%,FHIT
prerank,protein phosphatase activator activity (GO:0072542),0.2951322538857236,0.7519433953897635,0.8023255813953488,0.9770330143143651,1.0,5/13,28.17%,IGFBP3;CALM2;PPP2R5B;PPP2R5A;B3GAT3
prerank,hormone receptor binding (GO:0051427),0.2912715145465482,0.7511825782308712,0.8103448275862069,0.9749591696891199,1.0,5/14,26.72%,TYK2;VIP;PTHLH;NPPC;NCOA6
prerank,amino acid:sodium symporter activity (GO:0005283),0.31493818806480445,0.747936710240308,0.8092485549132948,0.9761707913309504,1.0,1/11,1.20%,SLC1A3
prerank,phosphatase activity (GO:0016791),-0.18859364450487678,-0.7451667727381863,0.9384236453201971,0.9739942658716111,1.0,17/73,18.71%,PLPPR4;PTPN22;PLPP5;DUSP16;PLPP4;HDDC2;DUSP10;ACP5;DUSP26;PLPPR1;PXYLP1;OCRL;PLPP3;ENOPH1;DUSP28;MDP1;PLPPR3
prerank,5'-3' RNA polymerase activity (GO:0034062),0.24806085519874735,0.7442669227308436,0.8407407407407408,0.9780834837903886,1.0,11/27,30.14%,POLR2D;POLR2J;POLR3H;POLR1D;POLR1C;POLR2E;POLR2I;MED20;POLR3A;POLR1A;POLR1B
prerank,N-acetyltransferase activity (GO:0008080),0.2704621712250614,0.7423293891724566,0.8235294117647058,0.9775489879873521,1.0,10/19,35.38%,NAA50;ATAT1;GNPNAT1;NAT8L;KAT2B;EP300;NAA10;SAT2;NAA80;AANAT
prerank,acid-thiol ligase activity (GO:0016878),0.29232406141051426,0.7378704870006912,0.839851024208566,0.9801842356230642,1.0,3/13,21.29%,ACSS1;ACSS2;AASDH
prerank,alpha-tubulin binding (GO:0043014),-0.22669060413147446,-0.7377391059830132,0.8647342995169082,0.9807181190411698,1.0,9/31,20.48%,RACGAP1;ARL4C;TTLL7;EFHC1;SNCA;TBCE;BBS4;FNTA;FYN
prerank,Notch binding (GO:0005112),0.2587063316672774,0.7368857308550241,0.8603839441535777,0.9784495267553697,1.0,5/22,10.54%,JAG2;NOTCH4;GALNT11;DTX1;DLL1
prerank,bHLH transcription factor binding (GO:0043425),0.2662907315220547,0.7365974152985684,0.8496376811594203,0.9757676272664807,1.0,6/19,24.85%,SMAD3;MAP3K10;TCF3;TWIST1;KDM1A;LMO2
prerank,phosphatase binding (GO:0019902),0.18754444639058737,0.7349059433445743,0.9508448540706606,0.9748495462467363,1.0,21/105,18.47%,SIRPA;SMAD3;PPP6R3;PIK3R1;CRY2;MET;VRK3;CEACAM1;WNK1;SH2D4A;FBXL2;KIF3A;DLG4;MTMR4;MAPK14;PPP6R1;CD33;SNX3;PPP1R3F;PXN;CDKN1B
prerank,carbohydrate:cation symporter activity (GO:0005402),0.29857139994473536,0.7345360706988269,0.8237547892720306,0.9723038052933487,1.0,5/11,34.26%,SLC5A11;SLC5A3;SLC23A2;SLC23A1;SLC2A9
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.29491840394339947,0.7339350658801516,0.8222222222222222,0.9700409491039583,1.0,7/13,33.55%,SLC15A4;SLC38A7;SLC7A7;SLC66A1;SLC25A29;SLC7A4;SLC7A3
prerank,thyroid hormone receptor binding (GO:0046966),0.2374772232254927,0.7338038819542754,0.8739054290718039,0.9672254713487269,1.0,3/28,5.21%,BRD8;PRMT2;TACC1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.252253370450593,0.7313592179071992,0.866913123844732,0.967226133822971,1.0,9/22,24.79%,ZFP36L1;ZFP36L2;RBM24;CPSF1;CPEB2;ELAVL3;ZC3H12A;EXOSC8;ELAVL1
prerank,ATPase binding (GO:0051117),-0.18661067872739498,-0.731023919119363,0.9501385041551247,0.986156360141502,1.0,15/71,20.19%,ANK2;PDE4D;EGFR;SNU13;PTPN3;PKD2;ATP1B3;TMTC4;TOR1AIP2;PIH1D1;METTL21A;S100A1;ATP6V0A1;BRSK2;EZR
prerank,phospholipase activator activity (GO:0016004),-0.3030355750908591,-0.7305402409907203,0.8119469026548672,0.9833773743784032,1.0,5/10,24.68%,ARHGAP6;BTK;CCL5;FYN;LCK
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.303337233054617,-0.7186775037930387,0.8017057569296375,0.9941177164703939,1.0,2/10,4.01%,PRKAG2;PKIA
prerank,wide pore channel activity (GO:0022829),-0.23648353923881568,-0.7169428729377945,0.8811659192825112,0.9927917908314499,1.0,5/23,22.48%,PANX2;GJB2;PANX1;GJD2;GJA5
prerank,lysine N-methyltransferase activity (GO:0016278),0.25224978729891745,0.716909912272235,0.8563829787234043,0.9812680349056513,1.0,6/20,19.75%,EEF2KMT;EHMT2;ANTKMT;SETD2;SETD4;SETD3
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.19451798457164698,-0.7164510278471482,0.9418886198547215,0.9900412292451023,1.0,8/49,13.46%,MPPED2;PTPN22;DUSP16;PLCXD2;DUSP10;PXYLP1;GDPD1;SAMHD1
prerank,phosphatase activator activity (GO:0019211),0.2794368631646566,0.7151027990715666,0.8455598455598455,0.9802769976642459,1.0,6/14,28.17%,FRS2;CALM2;PPP2R5B;BMP2;PPP2R5A;B3GAT3
prerank,U6 snRNA binding (GO:0017070),0.275170555173936,0.7142540639599007,0.8640429338103757,0.9782090221805895,1.0,8/14,31.72%,SART3;DDX39B;LSM7;PRPF4;LSM8;METTL16;PRPF8;LSM2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.2388208577531537,-0.714158530296246,0.8783185840707964,0.9892494701014837,1.0,5/22,14.77%,OTUD7A;RNF169;ZRANB3;IKBKE;PARP10
prerank,lipase activator activity (GO:0060229),-0.2992484190331772,-0.7138032556246738,0.8191964285714286,0.9863158653426041,1.0,5/10,24.68%,ARHGAP6;BTK;CCL5;FYN;LCK
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.26059240288165436,0.7127217824796168,0.8546511627906976,0.9769877966210533,1.0,3/18,14.31%,HSD3B2;HSD17B1;HSD17B10
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2405248947874048,0.7095480280392062,0.8797127468581688,0.9772703876352812,1.0,5/24,16.82%,NME4;CMPK1;NME6;NME1;IP6K1
prerank,gap junction channel activity (GO:0005243),-0.23734629286828554,-0.7088217341090677,0.8928571428571429,0.9885595943226982,1.0,5/22,22.48%,PANX2;GJB2;PANX1;GJD2;GJA5
prerank,acetyltransferase activity (GO:0016407),0.2247260757970751,0.7049959422077194,0.8933566433566433,0.9790431654658072,1.0,15/31,33.80%,DBT;NAA50;PAFAH2;LCAT;KAT6B;GNPNAT1;NAT8L;KAT2B;EP300;NAA10;SAT2;ELP3;ACAT1;NAA80;PAFAH1B2
prerank,signal sequence binding (GO:0005048),0.21576481447121015,0.7045291964305987,0.9423076923076923,0.9765227664802963,1.0,12/35,29.45%,TOMM20L;TNPO1;IPO4;SEC61A1;KPNA3;KDELR2;NUP214;TOMM20;TOMM70;KDELR1;CEMIP;SEC61A2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.29493531130389494,-0.701736091303467,0.8595744680851064,0.992392505864742,1.0,5/10,20.49%,NSD3;NSD1;SETD5;SMYD2;SETMAR
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.27536423018269945,0.6947391358454977,0.8747697974217311,0.9831962600117898,1.0,2/13,8.98%,GDI2;RGS14
prerank,MHC class I protein binding (GO:0042288),0.27142816844434875,0.6936891508083922,0.8685714285714285,0.9812611224308266,1.0,3/13,13.00%,TUBB;TAP2;PILRA
prerank,lipid phosphatase activity (GO:0042577),-0.2573360904030382,-0.6909174538555638,0.8830022075055187,0.9997610802676373,1.0,6/14,28.09%,PLPPR4;PLPPR1;PLPP3;PLPPR3;EPHX2;SGPP1
prerank,carboxypeptidase activity (GO:0004180),0.2122025270041106,0.6856344084307713,0.9295774647887324,0.9860037799637398,1.0,6/35,14.12%,NAALAD2;CPE;CPA4;CPB1;MINDY2;AGBL3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.22233882166789015,-0.6846096408370603,0.9298245614035088,1.0,1.0,7/24,24.21%,ZDHHC21;ZDHHC17;ZDHHC23;ZDHHC15;ZDHHC18;ZDHHC24;ZDHHC19
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.27399866557264674,-0.6828206183701843,0.8865096359743041,1.0,1.0,2/11,12.67%,UBR5;UBE2K
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2037460890501693,0.6816300854064415,0.9456706281833617,0.9867052338584253,1.0,8/42,18.47%,CCNG2;INCA1;CKS1B;CCND3;CCNL1;CCNE1;CCNY;CDKN1B
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.21355591486289033,0.6804274680640213,0.9322916666666666,0.9848341076257288,1.0,6/33,17.71%,DIS3L2;REXO2;EXOSC5;ISG20;ERI3;EXOSC10
prerank,protein kinase regulator activity (GO:0019887),0.17415100216671936,0.6784721884733017,0.9901639344262295,0.9835877805502485,1.0,15/95,14.33%,FGF13;PRKRIP1;CCNG2;NCKAP1L;STRADA;ITPRIP;GPRC5A;CCND3;RPTOR;WNK1;MAPK8IP1;CCNL1;MARK2;CCNE1;QARS1
prerank,miRNA binding (GO:0035198),-0.20558104456036702,-0.6779320583978676,0.9348314606741573,1.0,1.0,30/30,79.49%,AGO4;MATR3;TUT4;AGO2;FMR1;PUM2;ZC3H10;PNPT1;ZC3H7B;AGO3;SOX2;DDX21;RC3H1;TUT7;RBM10;DND1;POU5F1;LIN28A;TRIM71;YBX1;ZC3H7A;SPOUT1;HNRNPA1;ZNF346;ELAVL1;ZC3H12A;PUM1;HNRNPA2B1;RBM4;AGO1
prerank,telomeric DNA binding (GO:0042162),0.21354479405546337,0.6771963847958502,0.929701230228471,0.9818316553447586,1.0,17/32,33.56%,CTC1;BLM;TEN1;TERF1;XRCC6;TELO2;ACD;ZBTB48;KDM1A;HNRNPA2B1;UPF3A;UPF2;RPA1;STN1;HMBOX1;NCL;TERF2
prerank,TBP-class protein binding (GO:0017025),0.2376750331254326,0.6755905486096642,0.911660777385159,0.9802478383166932,1.0,6/21,20.79%,BRF2;TAF12;PSMC2;PSMC1;TAF1;YEATS2
prerank,telomerase RNA binding (GO:0070034),-0.22312536690288287,-0.6717674816302631,0.9119496855345912,1.0,1.0,4/22,13.83%,SMG7;SMG6;SMG5;WRAP53
prerank,DNA replication origin binding (GO:0003688),-0.22007730495290928,-0.6663536311807583,0.9212962962962963,1.0,1.0,2/23,4.14%,POLA1;MCM9
prerank,glucuronosyltransferase activity (GO:0015020),-0.22754739387644288,-0.6577383252756916,0.9200913242009132,1.0,1.0,11/19,32.12%,EXT1;EXT2;B3GAT2;EXTL1;CSGALNACT1;UGT1A7;UGT1A4;UGT1A8;UGT1A1;LARGE2;B4GAT1
prerank,"DNA binding, bending (GO:0008301)",-0.24544479099169578,-0.6565372836249949,0.8971553610503282,1.0,1.0,4/14,20.71%,TOP2A;HMGB1;FOXC1;LEF1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.23084204459721105,-0.6538561645359584,0.913232104121475,1.0,1.0,6/16,23.24%,MTMR2;INPP5F;MTMR3;MTMR1;MTM1;SACM1L
prerank,amino acid transmembrane transporter activity (GO:0015171),0.19090985247443654,0.6531809119804455,0.9808027923211169,0.9947509362063145,1.0,5/47,10.29%,SLC7A8;SLC36A1;SLC7A5;SLC22A2;SLC38A10
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.1907225392846718,-0.6530914127071201,0.9629629629629629,1.0,1.0,3/38,4.70%,HIP1;SESTD1;DENND1A
prerank,general transcription initiation factor binding (GO:0140296),-0.21340357372482083,-0.6530904894998574,0.937046004842615,0.9985536066388981,1.0,5/25,12.92%,DRAP1;GTF2B;THRA;RELA;AHR
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.2163861208119116,0.6495008996622463,0.9547038327526133,0.9945019996064977,1.0,2/25,3.33%,ART4;SIRT2
prerank,nucleotidase activity (GO:0008252),-0.23227903252787588,-0.6452421161314994,0.9174107142857143,1.0,1.0,1/15,3.95%,NT5C3B
prerank,proton transmembrane transporter activity (GO:0015078),0.19476051042988757,0.6429498404016997,0.965,0.9959859006765508,1.0,8/39,25.97%,COX8A;COX7A2L;NNT;CTNS;COX5A;COX6B1;COX6A2;COX6A1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.25427179749622186,0.6419380273437338,0.9203539823008849,0.993861714974243,1.0,2/13,11.42%,SLX4;EXO1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.20513354703826492,0.6377973185255037,0.9291044776119403,0.9936627491411132,1.0,3/32,7.73%,SLC7A8;SLC36A1;SLC7A5
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.23463854089145175,-0.6355761247833377,0.9430523917995444,1.0,1.0,4/15,18.57%,SESTD1;PLEKHA5;PLEKHF1;VEPH1
prerank,ribonuclease P RNA binding (GO:0033204),-0.2607508652913318,-0.6347687290053243,0.9077568134171907,1.0,1.0,4/10,19.10%,POP4;RPP38;POP7;RPP30
prerank,NADPH binding (GO:0070402),-0.243827054222444,-0.6345063446510141,0.9381443298969072,0.9983090986642362,1.0,9/13,36.45%,LBR;HMGCR;GRHPR;DUS2;CBR4;DHFR;CRYZ;CBR3;DECR1
prerank,protein phosphatase 1 binding (GO:0008157),0.22087840587733318,0.6342126300222084,0.9290909090909091,0.9929847730953464,1.0,2/21,6.41%,PPP1R9B;PPP1R3E
prerank,CoA-ligase activity (GO:0016405),-0.24184940510411257,-0.631703102276547,0.9206349206349206,0.9966275393791956,1.0,7/14,34.62%,ACSF3;ACSM3;SLC27A5;ACSBG2;ACSL1;ACSBG1;AACS
prerank,gamma-tubulin binding (GO:0043015),-0.20871840078261128,-0.6289160656640326,0.960352422907489,0.9950939858003318,1.0,5/22,16.62%,RACGAP1;CDK5RAP2;PAK1;BRSK1;RAD51D
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.23854590182700414,-0.6286655699441847,0.9327902240325866,0.9920853588698559,1.0,7/14,31.48%,USP15;USP13;MINDY3;YOD1;OTUD7B;ATXN3;USP27X
prerank,ribonuclease P activity (GO:0004526),-0.25461770326194805,-0.6280952997573745,0.922077922077922,0.9893336487932282,1.0,4/11,19.10%,POP4;RPP38;POP7;RPP30
prerank,MAP kinase phosphatase activity (GO:0033549),-0.24709876615506088,-0.6255050691480689,0.9327548806941431,0.9877398343284639,1.0,6/12,35.28%,DUSP16;DUSP10;DUSP2;DUSP4;DUSP9;DUSP8
prerank,exoribonuclease activity (GO:0004532),0.24946476270057666,0.6209791559362743,0.9384328358208955,0.9976856989664594,1.0,4/12,24.49%,EXOSC5;EXOSC10;ZC3H12A;EXOSC8
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.20413580470020956,-0.6158865672185249,0.973741794310722,0.9899530124575838,1.0,4/22,13.27%,DUSP16;MTMR2;DUSP10;MTMR3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.18783394686906985,-0.6079159706001702,0.9787234042553191,0.9909946339650249,1.0,9/28,24.31%,POP4;RPP38;DROSHA;POP7;ENDOV;RPP30;FEN1;AGO2;EDC3
prerank,disordered domain specific binding (GO:0097718),-0.19436873558867154,-0.5903504077863211,0.9775784753363229,0.9953297127652778,1.0,6/23,20.48%,FN1;CALM1;HSP90AB1;HSPA2;MDM2;FYN
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.24534549577235043,-0.5864085625883882,0.9478260869565217,0.9938404172468317,1.0,3/10,16.34%,CDKN2A;CDKN1A;HEXIM2
prerank,RNA stem-loop binding (GO:0035613),0.23715612990759397,0.5843137355501079,0.9593908629441624,1.0,1.0,6/12,29.04%,DHX9;EPRS1;DDX3X;ZC3H12A;RC3H2;METTL16
prerank,tRNA methyltransferase activity (GO:0008175),0.2198643449703974,0.5771988574621637,0.9628942486085343,1.0,1.0,7/16,26.12%,BCDIN3D;TRDMT1;FTSJ1;ALKBH8;METTL2A;METTL2B;TRMT9B
prerank,peptidoglycan binding (GO:0042834),0.24009699461676628,0.5722882364080588,0.9515503875968992,1.0,1.0,2/10,17.78%,NLRP3;NOD2
prerank,voltage-gated anion channel activity (GO:0008308),-0.21091665353728656,-0.5663294648084187,0.9642857142857143,0.9978857235670328,1.0,2/15,9.69%,CLCN5;ANO6
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.2405888671111263,0.5610495126485439,0.9564393939393939,1.0,1.0,5/10,29.30%,GALM;GNE;RPE;GALE;GFUS
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.22082611200001115,-0.5587990851083239,0.9739130434782609,0.9970276465941945,1.0,5/12,30.96%,RRH;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.2233187766650866,0.5551347055535863,0.9680284191829485,1.0,1.0,1/13,2.80%,SRC
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.21073274710384196,0.5483811894425925,0.966131907308378,1.0,1.0,3/14,18.59%,MTMR10;MTMR4;MTMR14
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.21767025451742983,-0.5470222282086779,0.9803063457330415,0.9972465049405554,1.0,3/11,19.43%,RDH13;DHRS13;RDH12
prerank,BMP receptor binding (GO:0070700),0.22332053452838752,0.5438054035587718,0.9734982332155477,1.0,1.0,1/12,2.80%,SRC
prerank,phosphatase inhibitor activity (GO:0019212),0.18964042225827415,0.5402790008875699,0.9824253075571178,1.0,1.0,7/20,30.27%,PPP1R9B;MGAT5;BOD1L1;ENSA;STYXL1;URI1;SAG
prerank,nuclear localization sequence binding (GO:0008139),0.19053011353520904,0.531006945882083,0.9851576994434137,1.0,1.0,4/18,22.66%,TNPO1;IPO4;KPNA3;NUP214
prerank,filamin binding (GO:0031005),-0.21306445747746128,-0.5302529521300037,0.9766454352441614,0.9978723139329811,1.0,4/11,27.88%,NEBL;MICALL2;RFLNB;DPYSL4
prerank,antiporter activity (GO:0015297),-0.17991910047095575,-0.5294839556067641,0.9912087912087912,0.9949631822988082,1.0,4/20,20.70%,SLC25A30;SLC25A16;SLC35E1;SLC35C2
prerank,CoA hydrolase activity (GO:0016289),-0.1810989010989011,-0.5041725216296109,0.9952267303102625,0.9963259651653463,1.0,16/16,81.91%,ACOT13;HIBCH;ACOT11;ACOT12;BAAT;ACSBG2;ACOT9;NUDT7;ACOT6;ACOT2;ACOT7;ACOT4;ACOT1;ACOT8;ACAA2;ABCD1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.21507318590716235,0.501685712470515,0.984070796460177,1.0,1.0,5/10,31.96%,ANKRD13B;FAN1;LAPTM5;ANKRD13D;FAAP20
prerank,protein phosphatase regulator activity (GO:0019888),0.1434179774054589,0.49537116866596076,1.0,1.0,1.0,17/53,30.27%,PPP1R9B;PPP6R3;PPP4R2;EIF2AK2;MGAT5;PPP6R1;CALM2;PPP2R5B;RCAN1;PPP2R1B;PPP2R5A;BOD1L1;ENSA;STYXL1;B3GAT3;RCAN2;SAG
prerank,protein phosphatase inhibitor activity (GO:0004864),0.16204369979076377,0.4835663946914185,0.9982300884955753,1.0,1.0,7/26,30.27%,PPP1R9B;MGAT5;PPP1R1A;BOD1L1;ENSA;STYXL1;SAG
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.18941486690105463,0.4796355218180242,0.9883040935672515,1.0,1.0,13/13,81.07%,TRMT10B;TRMT1L;FTSJ1;THUMPD3;TRMT11;METTL1;WDR4;TARBP1;THUMPD2;TRMT10A;TRMT5;TRMT10C;TRMT1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.158579468256331,0.4697803173234082,0.9982300884955753,0.9992689347326549,1.0,5/26,22.26%,SLC16A6;MPC1;SLC16A7;SLC16A4;SLC26A6
prerank,ribosomal large subunit binding (GO:0043023),-0.1699309478970496,-0.43156696681699275,0.9978213507625272,0.9989717171649062,1.0,11/11,83.02%,NPM1;DHX33;NMD3;MRRF;MALSU1;RBM3;CPSF6;EIF6;LTN1;CPEB2;NEMF
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.17651450634376542,0.4236601538391624,0.9981481481481481,0.9990440909863104,1.0,2/11,17.82%,DCPS;NUDT16
